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SUMMARY    Research to improve artificial renal replacement therapies is varied across the many different parts of a hemodialysis system. Work largely focuses on developing a better dialyzer – the component that is directly responsible for removing wastes from the blood – but less study is devoted to the entire hemodialysis system. 
This work seeks to improve hemodialysis in two ways: by proposing a new renal replacement therapy that does not rely on traditional hemodialysis components, and by investigating the feasibility of adapting current hemodialysis practices to a portable format. 
While an alternative renal replacement therapy may be the best solution to today’s dialysis problems, this work further focuses on reducing hemodialysis to a portable format through systematic engineering design. In that process, a detailed system model is made in Simulink that can account for the large number of inputs of such a system – the blood flow rate, dialyzer size, treatment time, etc. – allowing for detailed exploration of the design space. 





MOTIVATION FOR MODELING AND DESIGNING A HEMODIALYSIS SYSTEM 
1 Motivation for Modeling and Designing a Hemodialysis System 
Research to improve artificial renal replacement therapies is varied across the many different parts of a hemodialysis system. Work largely focuses on developing a better dialyzer – the component that is directly responsible for removing wastes from the blood – but less study is devoted to the entire hemodialysis system. 
This thesis serves as a thorough investigation of the hemodialysis process from a systematic engineering design perspective. This first chapter provides the motivation and context of this work. Chapter 2 provides a brief history of renal replacement and surveys current hemodialysis research. Chapter 3 provides a functional analysis of the human kidney and traditional hemodialysis, and then develops two concepts based on each examination. Chapter 4 documents the creation of a detailed system model of traditional hemodialysis, accounting for such things as urea generation rates and dialyzer size. Chapter 5 verifies the model created in Chapter 4 and then explores different system configurations through manipulation of the model. Chapter 6 concludes this thesis by providing analysis of the work provided, acknowledgements, and suggestions for future work. 
1.1 Renal replacement therapies The human kidney fills many life-sustaining roles; most importantly, it balances the solutes commonly found in the blood – like urea, creatinine, and sodium. It also plays an indirect role in many other important functions, like regulation of blood pressure and glucose metabolism. 
The functional output of the kidney is measured by its glomerular filtration rate (GFR). End-Stage 
Renal Failure (ESRD) is a disease inflicting hundreds of thousands of patients worldwide that is 
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defined by a GFR below 15% of normal kidney function. Patients diagnosed with ESRD have two survival options: receive a donor kidney, or begin dialysis – a renal replacement therapy that relies on concentration gradients across a membrane to remove solutes from the blood. 
While organ transplant is the best option, there are simply not enough donor kidneys available. Consequently, most patients begin peritoneal dialysis – a reasonable form of treatment that uses the body’s own peritoneum as a membrane – allowing users to retain many aspects of their normal pre-ESRD lifestyle. After a few years of peritoneal dialysis, the filtration ability of the peritoneum becomes inadequate for peritoneal dialysis and patients are usually forced to begin traditional hemodialysis. 
Hemodialysis requires most patients to visit a clinic three times a week for three- to five-hour treatment sessions. Blood is circulated out of the body, cleansed through dialysis, and then returned to the body. Unfortunately, modern hemodialysis fails in two major ways: it is unable to clean the blood perfectly, and it is a very invasive process. 
In this thesis, two primary methods of improving hemodialysis have been identified. Hemodialysis can be made more effective (by improving its ability to remove solutes from the blood), can have its 
experience improved (by developing a system that casts less restraint on a patient’s life), or both. 
1.2 Research questions and hypothesis The goal of this thesis is to improve hemodialysis. First, the human kidney’s functionality will be analyzed to see if any of its waste-processing strategies can be leveraged in the development of an artificial kidney. Then an analysis of current hemodialysis from a systems-level perspective will attempt to reveal shortcomings of common practice that can be improved upon. 
This thesis seeks to answer the following research questions: 
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 Research Question 1:  
Can a renal replacement therapy be developed that provides an alternative filtration 
method while matching or exceeding current hemodialysis performance? 
Hypothesis 1:  
A renal replacement system that more closely mimics the behavior of a human kidney 
can provide a more effective treatment. 
There are many shortcomings of today’s hemodialysis – it does not remove all solutes that need to be removed, and its intervallic nature disrupts homeostasis. Either a renal replacement system that can provide more exacting solute removal or one that can run continuously should improve patient health. Additionally, a treatment that is small enough to be portable will improve the patient’s lifestyle – granting newfound mobility to a process that currently requires tethering to a machine several hours per week. 
Research Question 2:  
Can a detailed hemodialysis system model be created that accurately takes into 
account different patient and dialysis variables? 
Hypothesis 2:  
By improving upon the work of Sargent & Gotch (1989), a detailed computer model 
can be created that offers optimization of the fundamental dialysis equations and 
considers patient variables. 
Hemodialysis can be performed on nearly any scale – but any system that is developed must remove enough solutes to maintain homeostasis. Therefore, while a portable system is easily developed, certain constraints must be placed on the system to make it effective. 
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Research Question 3:  
Is a portable hemodialysis system possible? What are the detailed system 
configurations that are possible? 
Hypothesis 3:  
By exploring the physics that govern hemodialysis, portable system configurations can 
be developed that meet the needs of chronic renal failure patients. 
Once a system model is built, a thorough investigation of the model is necessary. Because of the expected overwhelming number of inputs and outputs in such a model, the dominant factors must be determined. It is expected that a portable system will be possible with traditional hemodialysis equipment. 
Table 1-1. Organization of research questions. 
Research Question Corresponding Chapter 
Question 1 Chapter 3 
Question 2 Chapter 4 
Question 3 Chapter 5 
1.3 Validation and verification strategy The primary aspect of this thesis in need of verification is the system model created in Chapter 4. Because this system model is used to predict different system configurations and treatment schedules, its validity is paramount to the relevancy of this work. 
The model is verified in two different ways: through in vitro experiments carried out at the Georgia Institute of Technology in Dr. David Ku’s laboratory and by comparing the model’s results to published hemodialysis data from actual patients receiving treatment. 





PAST AND PRESENT WORK IN RENAL REPLACEMENT 
2 Present Work in Renal Replacement 
Chronic kidney disease (CKD) is a health disorder that will affect an estimated 660,000 Americans in 2010 (National Kidney Foundation, Inc., 2002). CKD is defined by five stages of decreasing renal function: from Stage 1, which is defined by a slightly reduced glomerular filtration rate; to Stage 5, which requires medical treatment. Unless receiving a donor kidney, these patients need an artificial renal replacement therapy (RRT) in order to avoid death. 
Renal replacement therapy comes in several forms: peritoneal dialysis, hemodialysis, hemofiltration, or hemodiafiltration. Often patients begin treatment with peritoneal dialysis (a unique form of dialysis that uses the body’s own peritoneum as a membrane) because it is the most convenient and requires the least lifestyle modification. As the body’s peritoneum loses its ability to act as a membrane (details in Section 2.2), patients must switch to another form of treatment. In the United States, this is hemodialysis. In other countries, patients might begin treatment with hemodiafiltration. Hemofiltration is often used for treatment of acute renal failure. 
2.1 A brief history of renal replacement Kidneys fail for a variety of reasons, although most hemodialysis patients have a history of diabetes, 
high blood pressure, or a disease of the glomerulus (glomerulonephritis). For most of the history of humankind, renal failure was a death sentence – without properly functioning kidneys, a human would quickly succumb to the buildup of toxic solutes in his or her blood. 
The following brief history of renal replacement is drawn largely from the excellent Haemodialysis: 
A Historical Review by William Drukker (Drukker, 1989). 
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2.1.1 The first dialyzer designed for human use The first attempt to recreate the function of a renal system artificially was by a group of researchers at John Hopkins University, led by John J. Abel in 1913 (Abel, Rowntree, & Turner, 1913). His device 
(Figure 2-1) consisted of several 40 cm colloid tubes. Some success was had with dialyzing uremic dogs, but he was unable to try his device on humans due to lack of a suitable anticoagulant. The 
popular anticoagulant of the time, hirudin (made from ground leech heads), was not readily available (Drukker, 1989). 
 
Figure 2-1. Abel's dialyzer (Abel, Rowntree, & Turner, 1913). 
2.1.2 The first trial of dialysis on a human Dr. Georg Hass, working without knowledge of Abel’s work in Germany, performed the first successful human dialysis (Paskalev, 2001). His device (Figure 2-2) – similar to Abel’s – was connected to a terminally ill renal failure patient for 15 minutes in 1924. 
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Figure 2-2. Haas' 1924 dialyzer (Gottschalk & Fellner, 1997). 
While the results of this first dialysis are lost to history, Haas continued his human dialysis experiments. Like Abel, Haas had difficulty with blood coagulation. While he had access to ample hirudin, its toxic properties forced him to limit dialysis doses to no more than 60 minutes – too short to have any therapeutic effect (Drukker, 1989). By the end of his published work in the late 1920s, Haas had succeeded in removing some uremic toxins from patients, but had not been able to replace kidney function. 
2.1.3 The drum dialyzer and the first successful renal replacement therapy The next advancement in dialysis came by means of a Dutch doctor named Willem Kolff by combining two then-recent advances: heparin and cellophane. Heparin was a new, biocompatible anticoagulant that allowed for meaningful treatment times. Cellophane was also new at the time and proved to be well suited as a membrane material for dialysis. 
In Kolff’s dialysis machine (Figure 2-3), blood travels through cellophane tubing wrapped around a drum that was bathed in a dialysate solution (Kolff, 1965). Rotating the drum allowed for better concentration gradients. His first two attempts to dialyze unconscious uremic patients were unable 
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to revive them. The first patient, in February 1943, died following the dialysis. The second attempt was more successful, keeping the patient alive for twenty-six days (Drukker, 1989). 
 
Figure 2-3. The Kolff drum dialyzer (Gottschalk & Fellner, 1997). 
Kolff’s first successful implementation of his dialyzer came in 1945. A 67-year-old unconscious patient suffering from end-stage uremia (from acute renal failure) regained consciousness after being dialyzed for eleven hours. 
During his spare time during World War II, Kolff managed to build extra dialyzers that he sent around the world to various hospitals at the conclusion of the war (Figure 2-4). This exposed doctors all around the world to the science of dialysis, allowing for incremental advances of the Kolff dialyzer, like the Kolff-Brigham machine developed in Boston (Drukker, 1989). 
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Figure 2-4. The first Kolff dialyzers ready to be sent around the world following the 
end of World War II, September 1944 (Kolff, 1965). 
2.1.4 The coil and twin coil dialyzer The coil dialyzer was developed by Drs. Gordon Murray, Edmund Delorme, and Newell Thomas 
(Murray, Delorme, & Thomas, 1947) in Toronto, Canada. Their dialyzer wound cellophane tubing in a coil that sat in a bath of dialysate solution. Kolff improved their design and presented a “twin coil” dialyzer at the first meeting of the American Society for Artificial Internal Organs in 1955. A patient with prolonged acute renal failure was kept on twin coil dialysis for 181 days, but each time dialysis 
was performed (eleven times total), new arterial and venous blood lines had to be made (Drukker, 
1989). 
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2.1.5 The development of reusable vein access The next leap in renal replacement came in the 1950s when Belding Scribner used Teflon to create 
a shunt (the Scribner Shunt, as it became known) that allowed regular access to a patient’s arterial and venous blood streams. The Kolff dialyzer had proven successful in treating acute renal failure; the new shunts allowed a patient to dialyze regularly over a long period. Scribner combined his new shunt with a dialyzer designed by Frederik Kiil of Norway, to create the most effective and easiest to use dialyzer. The Kiil dialyzer had several incremental improvements, including a new 
membrane material (Cuprophane instead of cellophane), a pumpless design, and a flat-plate configuration of membrane tubules (Drukker, 1989). 
2.1.6 Successful treatment of chronic renal failure The first successful treatment of a patient with chronic renal failure came in March of 1960 
(Drukker, 1989). Dialysis was first performed weekly (without any improvements in technology), and then twice weekly. The patient survived eleven years. Treatment of chronic renal failure patients quickly spread throughout the world, thanks to the Scribner shunt. 
Scribner, when he opened one of the first dialysis clinics, quickly ran into problems. Demand outpaced availability, a problem facing nearly all places offering dialysis to chronic kidney failure patients. In response to this ethical issue, he created what is now considered the first bioethics committee to determine which patients received dialysis – via an anonymous panel of regular citizens and doctors. 
2.1.7 Single-pass dialysis and home hemodialysis Incremental improvements continued during the 1960s. Doctors began running dialysis machines in single-pass mode to increase dialysis efficiency. Previously, a large volume of dialysate was continuously cycled through the Kiil dialyzer. In order to prevent bacteria growth, the dialysate was 
  11  
kept cold, and the blood was warmed before it was returned to the body. Using only fresh dialysate not only improved mass transport, but it also reduced infections. 
Moving dialysis out of the clinic and into the home was also a focus of research. Home hemodialysis became popular during the 1970s, but declined in some parts of the world when peritoneal dialysis became available in the late 1970s. Today, where and how patients dialyze varies from continent to continent. 
2.1.8 The hollow fiber dialyzer In the late 1960s, the flat-plate Kiil dialyzer was replaced with the shell-and-tube hollow fiber dialyzer (Drukker, 1989). This configuration of the tubules allowed for greater effective surface 
area in a smaller package. Interestingly, Abel’s 1913 dialyzer design (Figure 2-1) closely resembles 
modern dialyzers (Figure 2-5). 
 
Figure 2-5. A shell-and-tube hollow fiber dialyzer. 
2.2 Peritoneal dialysis When patients are first diagnosed with Stage 5 chronic kidney disease, a first method of treatment is peritoneal dialysis. In 2001, 8.8% of dialysis patients were using some form of peritoneal dialysis for treatment, down from 10.5% in 1998. Peritoneal dialysis removes wastes from the blood much 
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like traditional dialysis, but uses the body’s own peritoneal membrane surrounding the abdomen as a filter. 
Dialysis fluid enters the abdominal cavity via a catheter. In a common form of peritoneal dialysis, continuous ambulatory peritoneal dialysis (CAPD), the patient’s abdomen is filled with two to three liters dialysate, and dialysis occurs without the patient tethered to a machine. The dialysis process occurs via natural diffusion, and after a few hours, the dirty dialysate is drained. This process is performed four to five times per day, depending on the size of the patient. 
An alternative form of peritoneal dialysis requires the patient to remain attached to a machine during dialysis. Continuous cycler-assisted peritoneal dialysis (CCPD) often occurs at night. The patient connects their catheter to a machine before sleeping that will automatically perform dialysate exchanges throughout the night. In the morning, a volume of dialysate is left in the abdominal cavity for a long exchange throughout the day. 
Which form of peritoneal dialysis is used depends on the individual patient. Those with more residual kidney function might be more able to perform exchanges at night, while leaving their abdominal cavity empty throughout the day. As a patient’s kidney functionality deteriorates, more frequent peritoneal dialysis can complement their dwindling renal function. 
However, peritoneal dialysis has its limitations. Patients must be able to dialyze on a continuous schedule. While they are able to perform the procedure at home, they still must commit to it several times per day, every day of the week. Conversely, hemodialysis performed at a clinic requires only a few hours per day, but patients must rely on treatment schedules dictated by the clinic. 
Peritoneal dialysis loses its effectiveness after several years of treatment because the dialysate used reduces the usability of the peritoneum as a membrane. The use of peritoneal dialysis has several 
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negative effects on the human body. Studies have found that after extended use of CAPD, the peritoneum membrane thickens, even to the point of complete occlusion (Di Paolo & Sacchi, 1989). This deterioration of the peritoneum is associated with the glucose in the dialysate. 
Specifically, the glucose breaks down into glucose degradation products (GDPs) during the autoclaving process employed by dialysate manufacturers. These products, found primarily in 
dialysate that has been sterilized via heating (but can also develop during normal storage of the 
dialysate), have negligible short-term effects on human peritoneal mesothelial cells, but have been associated with the long-term degradation of the peritoneal membrane, ultimately reducing 
filtration rates (Witowski, et al., 2003). 
Another issue of bioincompatibility of the dialysate fluid is its relatively low pH. Typical peritoneal dialysate fluid has a pH around 5.2; while the body’s natural pH is 7.4. As the dialysate enters the body, the intracellular fluid rapidly drops in pH. This more acidic state has been associated with a negative impact on cell function. As the dialysate remains in the body, the pH is eventually raised to physiological levels after about two hours. However, even after the pH has normalized, cell function is still abnormal. 
Current research is responding to these problems with new peritoneal dialysate formulae. Manufacturers of dialysate have developed multi-bag systems that keep the glucose separate from the buffer (Rippe, et al., 2001). The glucose, stored at a lower pH, is combined with the electrolyte-buffer prior to usage. This system helps inhibit the development of GDPs and provides a near pH-neutral system. Using two bags also allows bicarbonate to be used as a buffer (the body’s natural buffer), instead of lactate (McIntyre, 2007). Both Fresenius and Baxter offer two bag solutions, while Gambro offers a three-bag system that also separates the hypertonic glucose (McIntyre, 
2007). 
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Another way to address the development of GDPs is to replace glucose (the primary osmotic 
ingredient) with a more bio-friendly solution. Icodextrin-based dialysate, marketed by Baxter, has shown to be superior to traditional solutions (McIntyre, 2007). Icodextrin’s high molecular weight makes it ideal for long dwells. 
These newly available peritoneal dialysate solutions are awaiting the rigors of long-term trials, but short-term studies have verified their enhanced claims over traditional peritoneal dialysate fluids. Studies have reported improved peritoneal dialysis experiences and results due to the development of these new fluids and techniques. 
2.3 Hemofiltration In 1977, an alternative form of renal replacement was developed in response to intensive care patients who suffered from severe hemodynamic instability (John & Eckhardt, 2006). Hemofiltration, as it became known, acts in a very similar manner to the human kidneys: nearly all extra-cellular fluid is removed, and then desirable fluids are replaced in a second stage before the blood is returned to the body. 
This method provides a distinct advantage over traditional hemodialysis. The molecules that the diffusion-based hemodialysis removes poorly – such as myoglobin and insulin – are easily cleared through hemofiltration (Forni & Hilton, 1997). Only the desired solutes are returned to the blood after filtration. Table 2-1 outlines a typical replacement fluid regimen. 
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Table 2-1. Solute concentration in a typical hemofiltration fluid (Forni & Hilton, 
1997). 







Glucose 11  However, there are serious limitations to widespread adoption of hemofiltration as an alternative to traditional hemodialysis. The large amounts of fluids lost during filtration must be replaced – amounting to large quantities of sterile fluid that must be provided during treatment. This has provided a serious barrier to market entry to prevent any commercialization of the technology for home use in the United States. 
Recent research in hemofiltration has worked to apply this technique better in the intensive care setting. Many patients suffer renal failure while in the ICU, even if their primary affliction is not their renal system. Additionally, doctors must also provide for fluid losses, setting hemofiltration as an ideal solution: providing both renal replacement and a means to infuse fluids back into the blood at desired doses. 
Studies published recently have recommended its use in place of isotonic-saline hydration in patients undergoing percutaneous coronary interventions (Marenzi, et al., 2003). Another study has shown the advantage of using high-volume continuous hemofiltration in acute pancreatitis patients 
(Jiang, et al., 2005). 
In an attempt to draw on the benefits of hemodialysis (superior small-molecule removal) and hemofiltration (superior large-molecule removal), researchers have created a hybrid process. This 
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more recent renal replacement therapy – hemodiafiltration – works by using both a dialyzer and a hemofilter in series. Blood passes through both devices before it is returned to the body. 
A recent study noted the effectiveness of hemodiafiltration (Saudan, et al., 2006). In that study, the three-month survival rate of patients with acute renal failure receiving hemodiafiltration was nearly twice that of patients receiving traditional hemofiltration. However, the study failed to show any improvement in recovering residual renal function of the patients’ kidneys. 
2.4 Bioartificial kidneys Hemodialysis is effective at keeping a patient alive for several years after his or her progression to Stage 5 chronic kidney disease. However, physiological conditions slowly degrade after long-term treatment with hemodialysis. As the short-term problems associated with hemodialysis have been addressed and resolved in past decades, today’s researchers are beginning to address the long-term consequences of artificial renal replacement. 
Chief among these long-term concerns is replacing the tubular functions of the human kidney that provide metabolic, endocrine, and immune functions (Tiranathanagul, Eiam-Ong, & Humes, 2005). Aside from medical benefits of more kidney-like membranes, bioartificial membranes are not as susceptible to occlusion as traditional membranes, allowing dialyzers to last longer than just one treatment (Saito, et al., 2006). 
The largest challenge facing the development of bioartificial membranes is growing proximal tubular cells in a lab. In order to meet the expected future demands of renal cells, a reliable source that can produce such cells is required. Researchers have begun using pig kidneys as cell donors 
(Humes, MacKay, Funke, & Buffington, 1999). Pig kidney cells were chosen because they closely resemble human kidney cells, and there is a plentiful supply of donor pigs. Cells are grown in the lab in Petri dishes, and implanted on high-flux dialyzers (Humes, MacKay, Funke, & Buffington, 
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1999). Traditional high-flux dialyzers are then used as scaffolds to hold the living cells on the membrane. 
Hemodialysis systems that utilize bioartificial membranes do so by using two dialyzers simultaneously connected in series (Tiranathanagul, Eiam-Ong, & Humes, 2005). Like in traditional hemodialysis, the blood exits the body and it pumped through a traditional dialyzer. Instead of returning to the body, the blood leaves the dialyzer and enters the bioartificial tubule. The same dialysate used in the traditional dialyzer is reused after processing in the bioartificial tubule. After exiting the bioartificial tubule, the blood returns to the body. While in the tubule, the blood regains substances that would have otherwise been lost in traditional hemodialysis. 
Initial testing of a bioartificial hemodialysis device began in 2001 on nephrectomised dogs 
(Tiranathanagul, Brodie, & Humes, 2006). Dogs were administered a dose of Escherichia coli (E. 
coli) proportional to their body weight, and then treated with either a bioartificial tubule or a placebo tubule. Among the many indications that the bioartificial tubule provided better treatment was that the dogs treated with the bioartificial tubule survived longer than the dogs receiving the placebo tubule. These promising results led to testing on pigs, which provided similar positive results (Tiranathanagul, Brodie, & Humes, 2006). 
Buoyed by these results, the Food and Drug administration approved human testing in 2003. Ten participants were selected at two U.S. hospitals that had predicted hospital mortalities ranging from 
55% (ethylene glycol poisoning) to 97% (motor vehicle accident). Each patient was to be dialyzed with the bioartificial system for 24 hours, but five did not receive a complete dose for various medical reasons. While the study was conducted primarily to test the safety of the bioartificial tubule, some promising health results did emerge. Chief among these was the improved health of the patient for the three to seven days following bioartificial dialysis. While the study was too brief 
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and small to draw any conclusions, larger human trials were planned at the conclusion of the 2004 ten-patient study. 
2.5 MEMS renal replacement research Polymer membranes have successfully been used for hemodialysis since the 1960s. Pores are created naturally through a curing process. Because the pores are created through the solidification of the polymer, the exact size of the pores cannot be exactly defined to meet needed specifications. Instead, polymer membranes have a pore size distribution that takes the form of a bell curve. Advances in membrane creation over the last half century have allowed scientists to sharpen its curve and shift it to a desired location, but the fact remains that pore size distribution is not ideal. 
Ideally, pore sizes would exactly correspond to the molecules desired to be removed. There would be little or no random distribution in pore size – the only variance in pore size would be to align intentionally with given molecules. While the shortcomings of polymer membranes have been known since their inception, researchers have been limited by the manufacturing technologies to realize an ideal membrane. 
Microelectromechanical systems, or MEMS, are parts produced by a novel manufacturing process that can fabricate parts on scales that were unachievable when polymer membranes were first conceived for use on human patients. 
The push for new membrane manufacturing processes is driven by the need for an implantable artificial kidney. While polymer membranes have their limitations, some of them can be addressed by frequently changing membranes. However, if an implantable system is developed, it must use a membrane that is sustainable for long periods inside the human body. For that reason, it must be resistant to occlusion and be biocompatible. 
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A MEMS membrane could address these problems and provide for an implantable renal replacement. Silicon is the primary material used in the manufacture of MEMS membranes, although the process used to create the pores is quite complex. The MEMS manufacturing process is able to create pores that can vary from 8 to 90 nm in size, with a resolution of 1 nm. Because of the pores’ small size, novel tests have verified their size and distribution (Fissell, Fleischman, Humes, & Roy, 2007). 
In an attempt to increase the effectiveness of the membranes, researchers have leveraged advances in bioartificial membranes. Proximal tubule cells from humans have been successfully implanted onto the silicon MEMS membrane, creating a membrane that has both ideal pore sizes and suitability for cell implantation. 
An alternative approach has been taken by another research group at the Massachusetts Institute of Technology. Using mathematical models to predict the flow and mass transport inside small channels, they have designed a MEMS-based dialyzer that features hundreds of channels and layers. 
Each layer of their dialyzer features countercurrent dialysate and blood flow through microchannels with a membrane separating the two flows. Plans for a renal replacement device call for 100 stacked layers to form one dialyzer. While this work has only produced a single layer device, tests from it indicate that it is twice as effective as traditional membranes (Kaazempur-
Mofrad, Vacanti, Krebs, & Borenstein, 2004). 
2.6 Computational efforts Researchers seeking to improve the performance of traditional hollow fiber dialyzers have long sought to leverage the power of computers to understand better the physical processes occurring inside the dialyzer during dialysis. Early computer models are primitive by today’s standards, but provided a foundation for future research that has access to much more powerful computers. 
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Efforts in the 1970s attempted to account merely for two-dimensional mass transport in a single hollow fiber (Ross, 1974). The model created allowed researchers to explore the effects of varying the tubule diameter, flow rate, and tubule length quantitatively. While simple, this model provided relationships between key tubule characteristics and dialyzer physics. 
With the rise of more powerful computers, more telling computer models could be developed. A dialyzer’s sieving coefficient is the ratio of the volume flux to the mass flux, as shown in Equation 2-1. 
 𝑆𝑆𝐷𝐷 = 𝐾𝐾𝑞𝑞  (2.1) 
A high sieving coefficient corresponds to relatively high mass crossing the membrane for a giving 
flow rate. Fluid mechanists were unable to create an accurate model for the sieving coefficient in hollow fiber dialyzers until the 1990s. One-dimensional models in use predicted a steady decline in a dialyzer’s sieving coefficient as the volume flux increased. However, experimental results showed that as the volume flux was increased, the sieving coefficient would fall and then subsequently rise. 
A simple examination of the physics behind dialyzer performance would assume that as the volume 
flux increased, the sieving coefficient would decrease. While this holds true at lower flow rates, at high fluxes the sieving coefficient experiences a slight rise due to concentration polarization. Models that are more accurate account for this thin boundary layer that develops on the inner surface of the membrane. 
Three-dimensional computational efforts have been the focus of recent work. A model created at Ghent University in Belgium funded by Fresenius in 2002 accounted for flow, viscosity, hemocrit effects, and backfiltration (Eloot, De Wachter, Van Tricht, & Verdonck, 2002). Their work more closely examined the physics at distances very close to the membrane surface and within the 
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membrane itself, providing the most accurate model to date of the hydraulic permeability of the membrane. 
2.7 Wearable renal replacement therapy A prototype wearable renal replacement device has been developed by Gura et al. (2005). While their device does not introduce any significant advances in hemodialysis technology, its attempt to transform the hemodialysis experience is itself noteworthy. 
In order to overcome issues surrounding the large amounts of dialysate used during a hemodialysis dose, the creators have employed modified REDY sorbent cartridges. Dialysate, after passing through the dialyzer and becoming dirty, is passed through the sorbent cartridge where activated carbon, urease, zirconium phosphate, and hydrous zirconium oxide absorb the wastes in the dialysate. The dialysate can then be returned to the dialyzer to remove more solutes from the blood. They claim to use less than 1 L of dialysate according to their 2007 patent filing of their best embodiments (Gura 
& Rambod, 2007). 











Pig C 20.10 0.91 29.40 7.61 
Pig D 21.10 0.76 26.80 5.75 
Pig E 23.50 1.14 27.30 5.37 
Pig F 23.50 1.14 27.30 6.37 
Pig G 22.30 0.95 25.70 6.46 
Pig H 22.30 1.02 26.30 6.24 
Mean 22.13±1.34 0.99±0.15 27.13±1.27 6.13±0.85  
Preliminary tests of the device on six pigs (Table 2-2) had promising results without any complications. 
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Additionally, Gura et al. have developed a specialized pump for their prototype wearable artificial kidney. Special consideration has to be given to a pump’s size and weight when designing a wearable device. For their device, they have developed a specialized dual-channel pulsatile pump controlled by microcontrollers. 
2.8 Conclusion Most research conducted in the science of renal replacement focuses on improving the filtration method of the system. This is understandable – dialyzers and the peritoneum provide inadequate emulation of the human kidney. Many researchers are looking for a complete replacement of concentration gradient-based dialyzers with new technologies (like MEMS) or they are looking to augment biological functions through implanting of renal cells on a membrane. 






3 Conceptual Development 
This chapter is devoted to the development of two renal replacement concepts: one that relies on established hemodialysis techniques, and one that is derived from the behavior of the human kidney. First, the functional performance of the human kidney is characterized, and then it is exploited to develop a concept that mimics its behavior. The functional analysis is also used to find alternative solution principles, which are used to develop a more traditional hemodialysis concept. 
3.1 Basic physiology of the human kidney All living organisms must constantly regulate their physiological condition in order to maintain life. The human kidneys play an important role in this process (called homeostasis) by providing several functions that help to maintain a healthy balance inside the body. While the primary function of the kidney is to balance solutes in the body, it is also responsible for secreting hormones that play an important role in other organs’ regulation of homeostasis. 
The basic functional unit of the human kidney is called a nephron. It is composed of five main parts: the renal corpuscle, the proximal tubule, the loop of Henele, the distal tubule, and the collecting ducts. In these parts, the kidney utilizes three main functions to regulate solutes in the blood: 
filtration, reabsorption, and secretion. 
First, the kidney filters most substances across the glomerulus, a collection of capillaries surrounded by the Bowman’s capsule, which together form the renal corpuscle as shown in Figure 3-1. There are many factors affecting glomerular filtration: size and charge of the molecules being 
filtered; size of the filtration slits of the glomerulus; charge of the glomerular basement membrane; 
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and several hemodynamic factors. Hemodynamic features include blood flow, convection, diffusion, the glomerular capillary pressure difference, and the Bowman’s capsule pressure difference 
(Jennette, Hepinstall, Olson, Schwartz, & Silva, 2006). 
 
Figure 3-1. The figure on the left shows a complete nephron. In the figure on the 
right, the dark-red glomerulus is surrounded by the pink Bowman’s capsule, forming 
the renal corpuscle. 
After the substances have passed through the glomerulus, important substances are reabsorbed or excreted back into the blood stream in the proximal tubule, loop of Henele, the distal tubule, or collecting ducts. Lastly, substances that were not filtered across at the glomerulus can be excreted from the kidney at one of the later stages. 
Approximately 625 mL of plasma flows through each kidney every minute. Of this 625 mL, each kidney filters approximately 20%, or 125 mL, across the glomerulus. However, only 1 mL⁄min of urine is excreted to the bladder. This discrepancy between the filtered and excreted amounts is 
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accounted for by reabsorption and secretion. After removing so much from the blood, the human kidney then works to reabsorb those substances that are beneficial for homeostasis. 
As an example, all glucose found in the blood in the renal artery is filtered out of the blood in the renal corpuscle. However, glucose is vital for homeostasis, so it is immediately reabsorbed in the proximal tubule. 
A hierarchical model of the kidney’s waste removal process is displayed in Figure 3-2. The top 
figure shows how the basic functionality of the kidney – a filter – is used to separate the wastes out the blood. The bottom figure shows in detail how the five parts of the kidney use four different functional strategies to behave as a filter. 
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In Figure 3-2, at the kidney-level of abstraction, dirty blood comes in from the renal vein and wastes are filtered out into the urine, while the remaining clean blood returns to the body through the renal artery. The subsystem level of decomposition includes the Bowman’s capsule, proximal tubule, loop of Henle, distal tubule, and the collecting duct. At this level, the blood plasma and its solutes are convected and diffused across the Bowman’s capsule. The solutes in the plasma then go through several steps of reabsorption and secretion, finally being excreted through the collecting duct as urine. 
There are two striking things to note about the function of the human kidney: that it uses thousands 
of small identical functional units (nephrons) instead of one large unit, and it uses a multi-step 
filtration process. 
Its use of many small functional units instead of one large unit seems similar to many other biological systems. By dividing the function amongst many small units on a large scale, the kidney allows a small output item (the nephron) to produce big results. This idea is not only realized in biological realms, but also in industrial settings – like solar arrays. If there is a technology that works on a small scale, research can be dedicated not to making it larger, but rather to finding an effective way to replicate its functionality on a large scale. 
The other interesting functional behavior of the human kidney is its filtration method. Instead of simply removing the undesirable molecules in the exact quantity in one pass, it clears both the desirable and undesirable solutes, and then reabsorbs those that it would like to retain. This interesting concept serves to create a multiphase filter, allowing for specialized molecule removal. Hemodiafiltration, an effective combination of hemodialysis and hemofiltration, relies on a similar principle. The primary drawback of this method is that large amounts of fluids are lost from the blood and must be replaced immediately – relegating this treatment to intensive-care settings. 
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3.2 Functional analysis of current renal replacement therapies This section will focus on the development of two key forms of renal replacement therapy: hemodialysis and hemodiafiltration, which were introduced in Chapter 2. 
3.2.1 Review of current renal replacement therapies A summary of current research in the field of hemodialysis, hemofiltration, and hemodiafiltration was provided in Chapter 2. This section provides a further review of their function. 
3.2.1.1 Hemodialysis The first major innovation in treating kidney desease came in the 1940s. Williem Kolff is credited with constructing the first hemodialysis machine in 1943. His artificial kidney utilized blood 
flowing through cellophane tubing in a rotating drum assembly. This drum rotated in a tank of dialyzer medium (Davita, Inc., 2008). In the 1950s, Kolff’s invention was advanced enough to solve the problem of acute renal failure. 
It was not until the works of Belding Scribner that a solution for chronic end stage renal disease was envisioned. Scribner devised an idea of using Teflon tubes inserted into the artery and veins. After treatment, these tubes were connected using a U-shaped device, completing the circulatory circuit. This advancement allowed direct access to the circulatory system and ended the need for making incisions every time. Although several incremental advances have been made with traditional hemodialysis, the basic ciruit and principle has remained the same. 
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Figure 3-3. Functional performance of hemodialysis. 
In hemodialysis, displayed in Figure 3-3 and Figure 3-4, solutes are filtered by diffusion across a semipermeable membrane. The primary component of modern hemodialysis is the dialyzer 
(labeled filter in Figure 3-3), which contains the semipermeable membrane. In the dialyzer, blood from the patient flows along one side of the membrane countercurrent to that of the dialysate, creating a concentration gradient across the membrane. Unlike the human renal system, the kidney has no deeper level of abstraction. 
 
Figure 3-4. A hemodialysis circuit (YassineMrabet, 2008). 
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concentrations of those solutes to be kept in the blood is equal to that of the blood. Based on the laws of diffusion, the larger the molecule, the slower the rate of transfer across the membrane will be. Given that, molecules of small molecular weight, such as urea (60 Daltons), are filtered efficiently, while molecules with higher molecular weights, such as creatinine (113 Da), will be cleared less efficiently (Forni & Hilton, 1997). The waste, which is filtered across the membrane into the dialysate, is disposed of as dirty dialysate. 
3.2.1.2 Hemodiafiltration  
Another key innovation came by way of combining hemodialysis with a convective (filtration-
based) renal replacement therapy known as hemofiltration. This hybrid process is called hemodiafiltration. In the 1960s, hemofiltration was introduced to enhance the removal of larger substances from the blood and improve hemodynamic tolerance (Forni & Hilton, 1997). 
Building on benefits of hemofiltration, in the 1970s work began on creating a renal replacement therapy harnessing the benefits of hemodialysis (small molecular weight substance removal) and hemofiltration (middle molecular weight solute removal). Hemodiafiltration works in a similar fashion to the human kidney; a large amount of filtrate is filtered from the blood and then desirable components are replaced. In hemodiafiltration, blood and dialysate are pumped through the filter in a counter-current manner. 
Similar to that of glomerular filtration, water and substances up to a molecular weight of 20,000 Da are convected and diffused across the membrane and into the dialysis fluid. Desirable substances are then replaced in the distal part of the hemodiafiltration circuit using a replacement fluid. The typical composition of the replacement fluid is displayed in Table 2-1. A typical hemodiafiltration circuit is displayed in Figure 3-5. 
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Figure 3-5. A typical hemodiafiltration circuit (Asahi Kasei Medical Company). 
As displayed in Figure 3-5, blood and dialysate are pumped through the filter and the filtrate is drained. The substitution fluid containing the desired substances is then infused into the blood in the distal part of the circuit. 
3.2.2 Performance assessment of hemodialysis and hemofiltration In this study, these renal replacement techniques are compared based on solute removal and mortality rate. A summary of results from recent studies is as follows: 
Studies on small molecular weight solute removal: 
 Clearance of small solutes (< 500 Da) such as urea (60 Da) and creatinine (113 Da) is largely dependent on diffusion processes. Hemodialysis and hemodiafiltration both showed effective removal of these small solutes, while hemofiltration did not. There was little difference between hemodialysis and hemodiafiltration in clearance of these small solutes 
(Maduell, 2005). 
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 Studies by Ward, et al. (2000) showed small improvements (10 to 15%) of urea and creatinine removal for hemodiafiltration and high-flux hemodialysis.  
Studies on medium molecular weight solute removal: 
 In a study by Ahrenholz, et al. (1997), the experimenters showed a 123% improvement in 
clearance of inulin (5200 Da) in hemodiafiltration versus high-flux hemodialysis (Maduell, 
2005). 
 β₂-microglobulin (11,800 Da) is not removed at all by hemodialysis because it is larger than the typical hemodialysis membrane pore. Kerr et al. (1992) reported 54.8% reduction of β₂-microglobulin of high-flux hemodialysis and 62.7% reduction in hemofiltration after a 3 hour session. Lorney et al. (1998) reported a 49.7% reduction using high-flux hemodialysis, compared to 72.7% with hemodiafiltration, in a 4 hour session. In a 245-minute session, Maduell et al. (2005) reported −0.2, 60, and 75% reductions with hemodialysis, high-flux hemodialysis, and hemodiafiltration, respectively. 
 In a study by Ward et al. (2000), hemodiafiltration resulted in greater removal of β2-microglobulin than high-flux hemodialysis, as indicated by a significantly higher pre- to post-treatment change in concentration (73 ± 1% versus 58 ± 1%, respectively). 
 In renal failure, β₂-microglobulin accumulates in the body and can be deposited in bone and joints in the form of amyloid. In the HEMO study (Cheung, et al., 2006), a significant relationship was found in pre-dialysis β₂-microglobulin and all causes of mortality; mortality increased by 11% for every 10 mg⁄L rise in β₂-microglobulin concentration 
(Petrie, Ng, & Hawley, 2008). 
 Dember and Jaber (2006) estimated yearly accumulation of 111, 97, and 51 g for 
hemodialysis (4 hours, 3 times per week), high-flux hemodialysis (4 hours, 3 times per 
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week), and hemofiltration (2 hours, 6 times per week), respectively. Hemodiafiltration should show results similar to that of hemofiltration (Petrie, Ng, & Hawley, 2008). 
Recent studies on mortality: 
 In the Dialysis Outcomes and Practice Patterns (DOPPS) study (Canaud, et al., 2006), after adjusting for demographic and other contributors to mortality, experimenters reported a 35% better survival rate with hemodiafiltration (11.9 deaths⁄100 patient years) versus 
hemodialysis (14.2 deaths⁄100 patient years). 
 In analysis of data from The European Clinical Database, Jirka et al. (2006) reported a 35.3% better survival rate with hemodiafiltration versus hemodialysis. This study was also adjusted for other contributors to mortality. 
Studies of small molecular weight solute removal such as urea and creatinine showed efficient removal in both hemodiafiltration and hemodialysis, with hemodiafiltration showing slight improvement. In studies of middle molecular weight solute removal, hemodiafiltration was shown to improve the removal of β₂-microglobulin significantly. β₂-microglobulin amounts were shown to correlate to increased mortality. In specific large-scale studies on mortality, hemodiafiltration was shown to have a nearly 35% improvement in survival rate. 
A summary of the use of kidney filtration strategies in renal replacement systems is displayed in Table 3-1. Two assessments of the human kidney function are given: High Level (a basic description 
of kidney function) and Detailed Level (a more detailed description of kidney performance). Table 3-1 shows that hemodialysis matches kidney functionality at a higher level than hemodiafiltration. Similarly, a concept will be developed that more closely mimics the functional performance of the human renal system. 
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Table 3-1. Summary matching functional relationship between hemodialysis and 
hemodiafiltration against the human kidney. 
Level of Decomposition Hemodialysis Hemodiafiltration 
High Level: “The composition of blood in the kidney is modified through 
filtration.” 
  
Removal of waste from the blood through one-step filtration process. 
Shows only good small 
solute removal. 
 
Detailed Level: “Filtration in the kidney is performed by removing mostly all substances from the blood through convection/diffusion in the Bowman’s capsule and reabsorbing and secreting needed substances in the proximal tubule, loop of Henle, and distal tubule, and collecting duct. The remaining solutes are excreted through the collecting duct.”  
 Removal of waste through a two-step filtration and reabsorption process. 
Shows good small, 
medium, and large 
solute removal.  
 In the early development of renal replacement therapies, engineers developed hemodialysis as a means to replace the function of the kidney and treat kidney disease. Hemodialysis mimics the general behavioral strategy of the kidney in filtering the blood of waste; however, it is not very efficient at removing harmful middle molecular weight solutes from the blood and does not have a particularly high survival performance on a long span of time. 
Scientists developed hemodiafiltration as a means of improving on the performance of renal replacement therapy. Hemodiafiltration functions in a similar fashion as that of the human kidney; hemodiafiltration filters large amounts of water and substances from the blood through convection and diffusion, and then replaces the substances needed for bodily function. This setup has shown improved performance in removal of small and middle molecular weight solutes, as well as significant improvements in the survival rates of patients receiving this form of treatment. 
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3.3 Functional analysis of the human kidney The goal of this section is to derive a superior renal replacement treatment by analyzing the performance of the human kidney. The failures of current RRTs have already been outlined; the goal now is to explore how the human kidney functions from a systems perspective to see if any strategies can be exploited in the design on a new RRT. 
3.3.1 Decomposition of human kidney function First, a simple model of the human renal function is modeled in Figure 3-6. The kidney inputs dirty blood and outputs urine and clean blood. There is also a control signal dictating kidney operation. 
 
Figure 3-6. Simple system model of the human kidney. 
3.3.2 Behavioral assessment of kidney The behavior of a kidney is displayed in Figure 3-7. The human kidney is modeled as a continuous system with the state of the system dictated by the composition of solutes at different places. The 
behavior of the kidney (filter) is represented by a two parallel lines. Blood in passes through the 
kidney (filter) and then is separated into two flows: Blood out (to the renal vein) and Urine (to the ureter). 
Kidney
Urine
Dirty Blood Clean Blood
Signals
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Figure 3-7. Model of the overall behavior of the human kidney. 
3.3.3 Decomposition of the kidney into subsystems The system is decomposed into its subsystems, as shown in Figure 3-8. The functional unit of the kidney is the nephron. The nephron can be further decomposed into its different subsystems, including the Bowman’s capsule, proximal tubule, loop of Henle, distal tubule, and the collecting duct. 
 
Figure 3-8. Structural decomposition of the human kidney. 
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Figure 3-9. Kidney subsystem interactions. 
3.3.4 Functional assessment of the behavior of subsystems The standalone behaviors of the subcomponents (Bowman’s capsule, proximal tubule, loop of 
Henle, distal tubule, and the collecting duct) are now identified. The individual behaviors of the kidney subsystems displayed in Figure 3-8 are defined in Figure 3-10. In Figure 3-10, the behaviors 
of three solutes (Ca²⁺, glucose, and urea) are represented. 
Consider the behavior of the proximal tubule. The mass flux of Ca²⁺, glucose, and urea at entry to the proximal tubule is 540, 800, and 933 mmol, respectively. In this tubule 70% of Ca²⁺, 100% of glucose, and 50% of urea are reabsorbed into the blood. The composition of the blood (in the vasa 
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3.3.5 Compiled functional analysis Figure 3-11 displays the completed model for the human kidney. In the figure, the transition filter 
(shown in the top half of Figure 3-11) is defined using a dashed line in the lower model. 
 
 
Figure 3-11. Hierarchical function representation of the human kidney.  
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Figure 3-12. High-level function of the human kidney. 
In this model (Figure 3-13) the dirty blood is first separated into blood filtrate and retentate. After reabsorbing the needed substances and secreting the unneeded ones, the now clean blood is circulated back into the body. The rate of reabsorption and secretion of the substances is regulated by the body. 
3.4 Requirements list for a renal replacement device The first step towards the development of a concept is to create a requirements list for the final design. In the case of an artificial kidney, the most obvious requirements set standards on solute clearance. Beyond solute clearance, the device must be biocompatible and practical for everyday use. 
A requirements list is presented below: 
 Operational Properties 1. Conform to target excretement rates(Guyton 1986): Na⁺  0.128 mEq⁄min K⁺  0.06 mEq⁄min 
separate Add/remove
separate
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Ca²⁺  0.0048 mEq⁄min Mg²⁺  0.015 mEq⁄min Cl⁻  0.134 mEq⁄min HCO₃⁻  0.014 mEq⁄min H₂PO₄⁻  0.05 mEq⁄min HPO₄²⁻  0.05 mEq⁄min SO₄²⁻  0.033 mEq⁄min Glucose 0.0 mg⁄min Urea  18.2 mg⁄min Uric acid 0.42 mg⁄min Creatinine 1.96 mg⁄min 
2. Does not coagulate the blood. 
3. Maintains blood pressure by regulating plasma output. 
4. Filtered blood is returned to the bloodstream. 
5. Waste is excreted from the system in a sanitary manner. 
Physical Properties 1. Materials and processes that are in contact with body and blood must be biocompatible. 
2. Materials must comply with government regulation. 
3. Provides  a superior experience to today’s hemodialysis 
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Important care was given to this list to ensure it was free from a specific design or technology. It can therefore be used at later stages of the design process to help make decisions and evaluate alternatives. 
3.5 Functional analysis of renal replacement In its most basic sense an artificial kidney must access the blood in the body, clean the blood, return the blood to the body, and properly manage the waste extracted. The human kidney is able to complete all these tasks completely inside the body, utilizing the human metabolism as a source of energy and the bladder to excrete wastes. The kidney is also able to decode hormonal signals to adjust its filtration process. 
The human kidney does an excellent job filtering wastes because it has an excellent hormonal feedback system tied to an exacting filtration process that is entirely biocompatible. Today’s dialysis machines rely on a few lumped parameters and weekly readings to determine dialysate dose. Worse, the dose of dialysis is not specific to individual solutes, but just to a general treatment of all solutes in the blood. While the human kidney can instantly respond to a condition – like dehydration – by decreasing the amount of water removed from the blood, hemodialysis takes out the same amount with each treatment. Patients attempt to account for their own homeostasis through dietary changes, but no artificial system adequately replaces the renal functions. 
Ideally, engineers could leverage some of the body’s natural solutions in designing a renal replacement device. However, the complex biological nature of the human kidney makes this unfeasible with today’s technology. A close examination of the basic functions might reveal a method alternative to both the kidney and today’s dialysis that is functionally similar. 
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3.5.1 Development of function structures and working principles In designing a new hemodialysis device, one must first break the process down to its most basic functions. Once the most basic functions are known, solutions can be derived. This method attempts to remove designer bias by treating every possible solution as equals. Table 3-2 compares the functional difference between the human kidney and clinical hemodialysis. 
Table 3-2. The functional difference between the human kidney and clinical dialysis. 
Functions Human Kidney 
Solution Clinical Hemodialysis Solution Filtration Cells Membrane Energy Human metabolism AC power Pressure Natural blood pressure Pump Waste output  Human bladder External bladder (drain) Feedback loop Hormones Artificial sensors  The five basic functions of the renal system are filtration, energy, pressure, waste output, and feedback. While the solutions to each of these functions are known for both the human kidney and traditional hemodialysis, it is best to expand the table to include every possible solution. Figure 3-13 expands the basic solutions to each function, including methods used by the kidneys, current dialysis machines, and new solutions. 
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Figure 3-13. Function structures and solution principles of an RRT. 
3.5.2 Analysis of working principles In order to develop a renal replacement concept, the functional space outlined in the previous section must be explored and evaluated. This means all options must be examined to determine what principles meet the functional needs, and then evaluate these working principles based upon design metrics. 
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actual technologies. For example, diffusion has several working principles, including hollow-fiber 
membranes (used in current dialysis machines) and other membrane configurations. 
3.5.2.1.1 Diffusion Diffusion is the primary form of mass transport in membrane-based filtration. Two fluids flow on opposite sides of a hollow-fiber membrane (either counter- or parallel-flow), and molecules and solutes are transported via a concentration gradient through the pores of the membrane. Those molecules and solutes whose concentration is equal on both sides of the membrane lack a strong driving force to traverse the membrane. 
Control over which solutes cross the membrane barrier is primarily done by modifying the relative concentration of the fluid on the dialysate side of the membrane. For example, the fluid travelling countercurrent to blood, dialysate, contains no urea, driving the urea in the blood across the membrane. Alternatively, blood contains glucose, which needs to remain in the blood. Dialysate contains glucose, deterring the glucose in the blood from diffusing across the membrane. 
The other primary factor affecting diffusion rates is the physical properties of the membrane itself. Specifically, the size and shape of the holes plays a large role in the mass transport properties of the membrane. Because solutes can only pass through holes larger than themselves, the holes of a semi-permeable membrane must correspond to the various solutes that need to diffuse out of the blood. 
Unfortunately, membranes cannot be made with specific hole sizes due to their manufacturing processes. Membranes are formed from a cured polymer that naturally creates tiny pores for the solutes to move across during dialysis. Because the pores are created through the curing of the polymer, there is a relatively uncontrollable size distribution. While some control can be exerted over the pore sizes, a bell curve distribution is inevitable. 
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One solution to this pore-size distribution problem is to create the pores manually of the exact size 
needed. But because of the pore’s extremely small size (around 20 × 10⁻⁶ in diameter), no existing manufacturing technology can create individual pores in the needed size range. If pores could be created that corresponded to the exact size of solutes, artificial kidneys could behave in a superior fashion: filtering out only the exact molecules needed in a stage like fashion. 
3.5.2.1.2 Filtration Ultrafiltration is a membrane-based separation strategy in which hydrostatic pressure forces particles in a mixture across a semi-permeable membrane. Large solutes in the mixture are retained, while smaller solutes and the liquid pass through the membrane. 
Ultrafiltration already has some use, but it has some serious drawbacks. First, the blood must be pressurized far beyond normal human blood pressure to force molecules across a membrane – a membrane that already lacks the exacting pore sizes, as explained before. Worse, this solution principle results in considerable water loss from the blood. In order to implement this method with today’s technology, an artificial kidney would have to account for large amount of water loss and raised blood pressures, creating two major obstacles to using ultrafiltration as a primary method of solute removal. 
3.5.2.1.3 Electrical charge Another separation strategy is driven by the electric charge of the solutes in a mixture. This process – termed electrophoresis – is commonly used to sort ions in a fluid. A fluid, full of ions to be sorted, is mixed with a buffer solution and run between two oppositely charged plates. As the fluid and buffer flow parallel along the plates, the charged ions are pulled towards the plates based upon their electric charge. 
  46  
While this system works quite well in a lab for non-biological fluids, using electrophoresis to remove solutes from the blood is not as easy. First, not all waste solutes have a distinguishable charge. More importantly, the need for a buffer solution to be mixed with the blood makes electrophoresis nearly impossible to implement. Another considerable factor is the biocompatibility and associated heat generation of electric fields needed to sort the solutes. 
Therefore, while electrophoresis holds some promise as a way to remove wastes from the blood in a precise manner, it has some serious technological hurdles that have not yet been overcome by today’s science. In addition, while electrophoresis holds promise as a better way to filter wastes, it seems that implementing it as part of an implantable device seems extremely difficult because of the electric fields and currents generated during its use. 
3.5.2.1.4 Bio-artificial Bio-artificial separation uses actual mammalian renal cells as part of a membrane-based filtering system. Living renal cells are suspended onto a polymer membrane scaffold, and behave as actual renal cells in the kidney: pumping solutes in and out of the blood (details in Section 2.4). A limit to using bio-artificial membranes is that as an emerging technology they are not ready for implementation yet. Only small-scale clinical trials have been run, meaning the technology is years away from any sort of application. 
3.5.2.1.5 Solute mass Centrifugation is a separation strategy involving the use of centrifugal force for the separation of substances in a mixture. In this case, the heavier components of the mixture move away from the axis of the centrifuge, while lighter components move towards the axis. 
The feasibly of using differences in solutes’ mass as a sorting principle is doubtful. The throughput and resolution associated with centrifugal sorting is orders of magnitudes smaller than what would 
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be required for any sort of renal replacement. While the idea works in theory, its application in a renal replacement device is limited. 
3.5.2.1.6 Adsorption Adsorption is a separation strategy that uses chemical affinity to separate specific substances from a mixture. In this case, a sorbent is used to adsorb the unwanted substances from the mixture. 
As discussed earlier in this chapter, sorbent cartridges have already been applied directly to the blood with unsuccessful results. Current sorbent technology is not capable of fulfilling this functional need. 
3.5.2.1.7 Parallel flow At very specific flow conditions, two fluids can flow parallel to one another without mixing. Considered a form a membrane-less dialysis, the solutes in the two fluids can diffuse across the 
fluid boundary without the transport of fluid molecules. This concept has been studied for use in hemodialysis by Leonard and coauthors (2005). 
3.5.2.2 Energy solution principles There are two obvious ways to power an artificial renal placement device: use the body’s natural 
power, or an external power source. In order to use a natural (human) power source, an artificial 
kidney would somehow have to convert heat (at a relatively cool 37 °C), translate motion, or rely on normal blood pressure as a source of energy. Alternatively, the artificial device could use an external electrical power source. 
If electricity is supplied to the kidney from an external (non-natural) source, there are two options: store the energy, within a battery in the system; or bring it to the system, via a cord, from an external source. Using a traditional wall socket is the only feasible method to bring power into the 
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system if it is not stored in a battery. A battery that stored the energy in the system could be of a variety of sizes, weights, and power. 
While a human-powered solution would be ideal, there is no feasible way to convert enough power that would be needed for the electrical components of a hemodialysis system. The powered parts – the pump and sensors – do not require remarkable amounts of energy, but enough to consider not using the body as a power source. 
Of the two other options, the best solution depends on the final concept. A device that depends on its size, weight, or portability as its competitive advantage would likely require a battery in its final design. Alternatively, a device that provided superior filtration capability – without regard to size or portability – could reasonably use a wall socket as its source of power. 
3.5.2.3 Pressure working principles In order to achieve mass transport across a semi-permeable membrane, there must be a transmembrane pressure (TMP). Other methods of filtration considered also require some sort of pressure to work properly. There are two obvious methods to create the needed pressure for proper filtration: use a pump to raise the natural human blood pressure, or adapt the renal replacement system to the normal human blood pressure. 
While using the body’s natural pressure would be ideal, there are limitations. For one, the use of a 
pump is already needed to move the dialysate (save for a potential energy-based pumping system), and the blood flow rate needs to be controlled for optimal dialysis. For these reasons, the use of a pump in a renal replacement system is nearly unavoidable. 
However, the inclusion of a pump into the system is not a considerable issue. The pressures and 
flow rates involved in dialysis are relatively slow and low enough that the size, weight, and power 
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requirements of the pump should be straight-forward to achieve. As outlined in later chapters, reducing the size and weight of a hemodialysis system is focused largely on other system components. Including a small pump to achieve desired TMP and blood flow rate is a reasonable solution principle. 
3.5.2.4 Waste output solution principles Two types of wastes are associated with hemodialysis: the waste removed from the blood that must 
be disposed (urine, in human kidneys), and any wastes created by the choice of cleaning method. For example, when diffusion is used as the primary method of waste removal with a semi-permeable membrane, the counter-flow liquid (dialysate) is dirtied and must be disposed. 
While the wastes collected from the blood account for about 1 mL⁄min in the human kidney, dirty dialysate can accumulate at rates from 100-500 mL⁄min, depending on the hemodialysis system configuration. At the extreme, a 500 mL⁄min treatment for four hours creates 120 L of dirty dialysate. This is a major obstacle if a hemodialysis system is to be reduced in size or made portable; however, if the system is focused on merely improving clearance rates while remaining plugged into the wall, expending dialysate at 500 mL⁄min is not a serious issue. Current dialysis machines tend to follow this principle: they are designed for clinical use, and the price of dialysate has been reduced enough that it is economical to design a system that operates at such high flow rates. 
An alternative solution principle is to find a way to regenerate the dirtied dialysate. Dirty dialysate is similar to clean dialysate, but contains enough wastes from the blood that if it were to run through the dialyzer for additional passes, there would be an insufficient concentration gradient to drive diffusion. Ultimately, a subsystem would have to be created that filtered the wastes from the dialysate, and then returned the cleansed dialysate to the dialyzer. 
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While it seems obvious, creating a sorbent system that cleans the blood directly – instead of the dialysate – is not possible. Cleaning the blood with dialysate, and then cleaning the dialysate seems wasteful from an overall systems perspective, especially if cleaning the dialysate creates more liquid that must be cleaned. However, all these issues have been addressed by past research. 
Dialysate cleaning methods have been developed that use absorbent cartridges. Dirty dialysate passes through a cartridge where the wastes are absorbed by various dry powders, all while the base dialysate solution is able to pass through. This system creates very little new volumes of wastes. Dialysate cleaning sorbents fell into disuse in the 1980s because the price of clean dialysate reached levels that are more economical. 
3.5.2.5 Feedback working principles One of the great discrepancies between artificial renal replacement and human kidneys is the way the human kidney can fine-tune its filtration to meet the body’s needs. In fact, the kidneys do much more than simply remove wastes from the blood – the kidneys work in concert with many other organs to maintain homeostasis. For example, while the human heart has primary control over blood pressure, the kidney also plays a role by controlling how much water is retained in the blood. The more water left in the blood, the higher the blood pressure. 
Several hormonal cycles give the kidney feedback. While hemodialysis systems do not have the ability to decode these hormonal signals, the real problem is that artificial filtration methods are not precise enough to respond to such signals. Semi-permeable membranes cannot adjust the diffusion rate of particular solutes instantly – only through methods previously discussed. 
An obvious alternative is to use electronic sensors to provide feedback. However, while more 
advanced sensors may be available (perhaps to measure urea concentration in real-time) there is 
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little a system with a semi-permeable membrane can do with such information. If the system uses an alternative form of filtering, however, sensor complexity could become a relevant issue. 
3.6 Concept formation These strategies can now be used to develop working principles for an artificial human kidney. Two solutions are devised from two different strategies: a bio-inspired design that leverages strategies from the human kidney; and a traditional (yet portable) hemodialysis system is conceptualized. 
3.6.1 A bio-inspired renal replacement therapy The two primary solution principles chosen for use in the bio-inspired renal replacement system are ultrafiltration-based separation followed by electrophoresis-based separation. Thus, the functions in the kidney function structure from Figure 3-12 can be replaced by specific working 
principles (from Section 3.5.2), as displayed in Figure 3-14. 
 
Figure 3-14. Specific working principles for a renal replacement therapy concept. 
Of the five different functions of a renal replacement therapy identified in Section 3.5.1, this concept will use electrophoresis and ultrafiltration as its filtration method, AC power as its power input 
(although further improvements could certainly allow it to be battery powered), a rotary pump to increase the fluid pressures, waste will be disposed of, and sensors will be used to control signals. 
ultrafiltration electrophoresis
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Two different filtration methods are used because this concept mimics the behavior of the kidney, which uses a multistage filtration method. Table 3-3 summarizes the working principles used in this concept. 
Table 3-3. Morphological chart for bioinspired concept. 
 Filtration Power Pressure Waste Signals 
Bioinspired 
Device 
electro-phoresis and ultra-filtration 
AC power rotary pump disposed of electronic sensors 
 The work done in Section 3.3 is leveraged to develop a system-level design of an RRT that mimics the behavior of a human kidney, as shown in Figure 3-15. Blood is removed from the body and then the plasma is separated from the blood via ultrafiltration. Electrophoresis-based separation principles are applied to the plasma to remove the unwanted solutes, while the remaining plasma is recombined with the retentate. Waste is collected in a reservoir, while power is supplied from a wall socket and a rotary pump provides the needed pressure increase. 
 
Figure 3-15. A bio-inspired renal replacement therapy (RRT) concept. 
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This system behaves in a similar manner to the human kidney. Just as the glomerulus separates all solutes – good and bad – from the blood, the filter in this setup acts in the same manner. And just as the proximal tubule, distal tubule, loop of Henle, and collecting duct absorb, excrete and secrete solutes; the stage-based electrophoresis correctly adjusts the solute concentrations in the blood. 
Based on the working principles in Figure 3-14, the concept displayed in Figure 3-15 is developed. 
3.6.2 A portable traditional hemodialysis system A more technologically safe path can be followed by attempting to modify a current hemodialysis 
system to make it more portable. This would use traditional solution principles (diffusion via a semi-permeable membrane) but would focus on how the system could be optimized with respect to portability. Table 3-4 summarizes the different working principles (examined in Section 3.5.2) used in this concept. 
Table 3-4. Morphological chart for portable hemodialysis system. 
 Filtration Power Pressure Waste Signals 
Bioinspired 
Device 
membrane battery rotary pump stored electronic sensors  As has been previously explained, any dialysis treatment that is more regular in nature is a more healthy treatment for the patient. Clinical hemodialysis dialyzes a patient every other day, allowing for extreme urea and solute build-up in the blood – which eventually causes long-term health problems. If traditional hemodialysis could be modified to be more portable (and could therefore be 
used more regularly), a patient’s health could be improved without the need for the development of far-reaching new technologies. 
This concept will only modify traditional dialysis as necessary to make it more portable. While many exciting advances in membranes and hemodialysis are being developed around the world, a 
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stable technology is best suited for the rigors of the transformation to a wearable configuration. The traditional idea of a membrane, pumps, and sensors will be retained while their size and weight is reduced to allow for the most portable configuration. 
A requirements list for a renal replacement device has already been formulated in Section 3.4. However, this list was not specific to a portable hemodialysis device. The previous requirements list should be augmented with additional requirements to satisfy the need for a portable system. 
3.6.2.1 Augmented requirements list for a portable hemodialysis device In addition to the requirements listed in Section 3.4, the following requirements are added to aide in the design of a portable renal replacement system: 
1. The device should be light. 
Defining a threshold for portability is difficult. Ten kilograms (22 lbs.) is chosen as a reference 
value for initial consideration. As concepts are explored in Chapter 4, the ratio of their 
performance to their weight will give a more accurate assessment of a concept. 2. The device remains independent during dialysis. 
The previous requirement set the weight limit of this device, which is strongly tied to patient 
mobility, but this requirement seeks to address another issue of mobility – connectivity. Even if 
a device is developed that is very light, if it requires that the patient remain tethered to a wall 
outlet or another machine, than portability has been lost.  3. The device is of a reasonable size. 
Now that the device is light and independent, it needs to be small enough to be portable. Like 
weight, this requirement does not have an exact value, but consideration needs to be given to 
its size if the device is either wearble or portable. 
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This augmented requirements list will be used as a reference in Section 3.7.2 to help shape a concept when considering the working principles of Section 3.5.2. 
3.7 Comparison and discussion of performance After the analysis presented in this chapter, two primary concepts have been developed: a more portable hemodialysis system, and a bio-inspired renal replacement therapy. 
3.7.1 A bio-inspired hemodialysis system One goal of this exploration was to design a renal replacement therapy that more closely mimics the waste removal strategy of the kidney. This comparison is summarized in Table 3-5 (referencing Figure 3-11). In Section 3.3, hemodialysis and hemodiafiltration were compared based on their behavioral similarity to the kidney. Hemodialysis can be seen as similar to the first level of behavior of the human kidney, which is simply filtration of the blood. 
Hemodiafiltration, on the other hand, possesses a deeper level of behavioral similarity by first 
filtering most of the substances from the blood, and then replacing the needed substances using a substitution fluid. Although this method is more similar to the actual behavior of the kidney than hemodialysis, it still lacks in allowing regulation of the reabsorbed solutes. In the kidney, needed substances are regulated through multiple steps of secretion and reabsorption throughout the nephron. The RRT concept developed in Section 3.6.1 allows for continuous regulation of the needed solutes using a multi-stage electrophoresis system. 
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Table 3-5. Renal replacement therapy comparison. 






















 The question now becomes, “What type of advantage would this RRT concept have over existing renal therapies?” As this is just a research concept, the performance of the system can only be theorized. To get a true estimate of performance, many years of development and trials are needed. However, the RRT concept presented in Figure 3-15 has several theorized advantages over the current renal therapies, including: 
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One of the key advantages of the RRT concept is its ability to reabsorb selectively molecules. There are two obvious ways to filter out individual molecules: by size or by charge. Size selectivity is limited by the manufacturing capabilities of current membrane technologies. In order to filter selectively by charge, a membrane must be made with the exact pore size of the selected molecule. 
Today’s technology is currently not capable of such precision manufacturing (pore sizes are around 15 µm in size). Even if this were possible, the membrane would still allow any molecule smaller than this cutoff point through the membrane. Charge selectivity, on the other hand, allows filtration of molecules by charge. The strength of the filter is defined by the electric field and the resolution of the charges of the molecules. Thus, the electrophoresis-based reabsorption strategy allows individual molecules to be selectively reabsorbed, which is not currently feasible with current membrane-based technologies.  
Another key advantage of the RRT concept is the two-stage solute processing. In the RRT concept, ultrafiltration is used to separate all of the substances from the blood and multi-stage electrophoresis is used to reabsorb selectively the needed substances. It is believed that it is much more efficient to remove all the substances from the blood and selectively reabsorb the needed substances than to try to remove only selected waste from the blood in a “one shot” fashion, as is done in current dialysis technologies. 
In addition, the electrophoresis-based separation process in the RRT concept allows for continuous solute regulation. In the RRT concept, solute regulation can be performed on a continuous basis, as opposed to intermittently when using a replacement fluid in hemodiafiltration. A continuous-based therapy will help to increase the hemodynamic stability and biocompatibility of the treatment. 
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3.7.2 A portable traditional hemodialysis system There are many ways that traditional hemodialysis can be improved. Improvements can be categorized into two main categories: effectiveness and experience. Today’s hemodialysis is reasonably effective but with a poor experience. The survival rate for patients on hemodialysis is approximately 35% after five years of treatment (Dijk & Jager, 2001). In those five years, patients are tethered to a machine twelve hours per week. Improvements in hemodialysis can seek to increase life expectancy or to make the dialysis experience less demanding. 
However, these seemingly independent goals actually converge: it has been shown that one of the reasons for patient mortality on hemodialysis is its intervallic nature (Francisco, 2006). By simply performing hemodialysis more often, many of the negative symptoms associated with hemodialysis improve (Locatelli & Buoncristiani, 2005). However, there is a realistic limitation to daily or perhaps continuous dialysis: patients cannot be expected to remain attached to a hemodialysis machine so often. 
While there are many novel ways to filter blood and achieve artificial renal behavior (Section 3.5.2), current hemodialysis technology might be best suited for portability. The augmented requirements list of Section 3.6.2.1 outlines the expectations of a portable system. These requirements could be met, but a more thorough investigation of current hemodialysis technology is needed. Chapter 4 serves as a thorough investigation of the behavior of a hemodialysis system in an attempt to determine hemodialysis’s feasibility as a portable system. 
Developing a more portable hemodialysis process will lead towards the realization of continuous 
hemodialysis. Unlike developments in dialyzer technology (like bio-artificial membranes), developing a more portable artificial kidney has the advantage to improve both effectiveness and 
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experience. Further, individual advances in hemodialysis technologies can be incorporated into a working portable design. 
Developing a more portable artificial kidney also brings hemodialysis patients closer to the realization of an implanted artificial kidney. Currently, all system processes associated with hemodialysis are performed external to the body inside a hemodialysis machine. By incrementally bringing the hemodialysis process away from external machines and towards the human body, we are opening doors to implantable research. Once items are adapted from their large, machine-based manifestations to wearable sizes, further research can bring them inside the body. 
3.8 Conclusion Two concepts were developed in this chapter – one that mimics the functionality of the human kidney, and one that seeks to shrink traditional components. While it would be ideal to pursue both concepts, a more realistic approach is to successfully develop the traditional concept first and then work on a more radical renal replacement concept. 
The research question this chapter focused on was: 
Can a renal replacement therapy be developed that provides an alternative filtration 
method while matching or exceeding current hemodialysis performance?  
This chapter has seen the development of two concepts – one derived from the function of the kidney, and one that seeks to shrink current hemodialysis. The bio-inspired design does provide an alternative filtration method (electrophoresis), but can only provide better hemodialysis performance in theory. 
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The theoretical performance increase of the bio-inspired concept can be attributed not to its exact separation method – electrophoresis – but rather to its exacting filtration specifications. The novelty of this concept lies in how it is designed to mimic the functionally of the human kidney and not in its implementation. 
By pulling everything out of the blood and then returning only the needed solutes, it guarantees that harmful solutes will not build up in the blood over time – the primary problem associated with long-term hemodialysis. 
However, because the bio-inspired concept requires clearing a technological hurdle that is beyond the scope of this thesis, further work will focus on improving traditional hemodialysis. Work towards improving traditional hemodialysis will give insight to renal replacement that will be invaluable if the bio-inspired concept is pursued in the future. 





CREATION OF A SYSTEM MODEL 
4 Creation of a System Model 
The challenge of designing a portable hemodialysis system is to modify a traditional system’s components so that they are small enough to be a part of a portable system. As discussed in the previous chapter, the largest hurdle towards this goal is managing the large volume of dialysate involved with the use of a counter-flow dialyzer. In order to create the most portable system, the volume of dialysate must be minimized – effectively creating a system with the slowest possible dialysate flow rate. 
Creating an effective system with the slowest possible dialysate flow rate leads to important design considerations throughout the entire system. Variables such as blood flow rate, clearance, and dialysate flow rate are all related – one cannot simply slow the dialysate and maintain an optimum clearance of undesirable solutes. This chapter will explore all the design considerations of a slowed dialysate flow rate, among other considerations. 
4.1 System model objectives While two concepts were developed in Chapter 3, it would be more realistic to pursue the traditional hemodialysis-based concept first to develop competency in the field, and then pursue a more advanced concept in the future. Because pursuing both concepts would be well beyond the expectations of a thesis, this work is devoted to the design of a portable hemodialysis system. 
Specifically, a system model will first be created that thoroughly covers all aspects of traditional hemodialysis, in order to determine how best it can be minimized for portability. The following subsections describe the exact objectives of this system model. 
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4.1.1 Identify parameters that have the largest impact on system weight As has already been discussed in Chapter 3, the volume of dialysate is the largest obstacle towards the development of a portable hemodialysis device. Chapter 3 discussed different ideas towards limiting the use of dialysate, but a system model is needed to test each concept thoroughly. For example, if dialysate is recirculated through the dialyzer (as discussed in Section 3.2.2), how much longer would the dialyzer need to run in order to adequately treat the patient? Is it even possible to develop a feasible system that relies on dialysate recirculation? Different combinations of dialysate flow rates and treatment schedules can be examined. 
4.1.2 Determine the relationship between blood and dialysate flow rate Solutes are removed from the blood via a concentration gradient in a counterflow dialyzer. The equations that govern this solute transport (Section 4.3) are complex and do not produce a clear relationship between the two flow rates. Modern published literature explains the rule-of-thumb among designers is that the dialysate flow rate should be twice the blood flow rate (Ward & 
Leypoldt, 2001), but a portable hemodialysis system uses blood flow rates far below clinical rates. A system model should be able to determine which dialysate flow rates are best for a portable hemodialysis system. 
4.1.3 Determine feasible treatment schedules of a portable system Once the dialysis process is accurately modeled, the model should then account for the day-to-day changes in a patient’s urea levels to see if the proposed concept is dialyzing enough to maintain homeostasis. For example, if a concept requires dialysis to run for an inadequeate amount of time, the patient’s average daily urea levels will rise, presumably to an unhealthy level. When the patient’s natural urea generation rate matches the amount of urea removed each day via hemodialysis, their condition is considered steady state. This concept is explored in Section 5.3. 
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4.2 Hemodialysis components In a typical hemodialysis system (Figure 4-1), blood leaves the body through an implanted port, 
flows through medical tubing, is passed through a pump to raise its pressure, enters the blood compartment of the dialyzer, and then is returned to the body at approximately the same pressure at which it was drawn from the body. Heparin is added as an anti-coagulant.  
 
Figure 4-1. A typical hemodialysis circuit (YassineMrabet, 2008). 
This entire process is listed as a flow chart in Figure 4-2. The blood loop is kept as simple and clean as possible to minimize infections and complications. 
 
Figure 4-2. The flow path of the blood during hemodialysis. 
Body Port Tub-ing Pump Tub-ing Dialyzer Tub-ing Body Port
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The dialysate loop is similar. Dialysate is drawn from a reservoir via a pump, and is then pumped through a dialyzer counter to the flow of the blood. After the dialysate has run through the dialyzer, it is disposed. 
A more detailed look at the primary components in a traditional hemodialysis system is provided next. 
4.2.1 Dialyzer Dialyzers take the shape of long cylinders, typically 16 to 25 cm in length and 3 to 5 cm in diameter. 
They house a collection (typically 10,000 to 15,000) of porous hollow tubules, with spacing between the tubules, as shown in Figure 4-3. The blood flows through the tubules, while the dialysate flows countercurrent in the spacing between the tubules. Solutes are driven by a concentration gradient through the pores of the membrane from one fluid to another. 
 
Figure 4-3. A typical dialyzer. The blood enters on the right and travels through 
thousands of tiny tubules before exiting on the left. The dialysate enters on the 
bottom left, fills the spacing around the tubules and exits on the bottom right. 
The most important characteristic of dialyzers is their overall mass transfer coefficient (𝐾𝐾0), a measure of how effective a dialyzer is at transporting a particular solute across a fixed area of its membrane. In turn, 𝐾𝐾0  (in conjunction with the surface area (𝐴𝐴) and the flow rates) can be used to calculate the clearance (𝐾𝐾), the rate at which blood is cleaned. 
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Typically, dialyzers are fixed in diameter, so the longer the dialyzer, the more surface area it has and therefore higher clearance rate. Membrane material typically does not vary between individual models from the same product line from a manufacturer, so increasing the dialyzer length from 16 to 20 to 24 cm brings about a linear increase in surface area. 
4.2.2 Dialysate Dialysate is the fluid that runs counter to the blood through the dialyzer. Because mass transport is based on a concentration gradient, the composition of the dialysate is very important in the removal of solutes from the blood. 
Substances that are to be removed have little presence in the dialysate, while substances that are to be left in the blood are present in dialysate. In between those two extremes are the substances that must be carefully balanced – the blood is not to be entirely cleaned of their presence, so the dialysate still contains a quantity of that particular substance. The substances that commonly appear in commercial dialysate solutions are sodium, potassium, calcium, magnesium, chloride, acetate, bicarbonate, and glucose (Ronco, Fabris, & Feriani, 1996). 
4.3 Fundamentals of dialyzer physics Perhaps the most important element of any hemodialysis system is the dialyzer. The dialyzer has the most direct impact on the overall solute clearance of the system, while other components can only affect clearance rates indirectly. 
Understanding the physics behind membrane clearance will allow the primary dialyzer characteristics – size, flow rates – to be integrated into a system model. First, the basics of membrane physics must be explored. 
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4.3.1 Fick’s Law The transportation of solutes across a semi-permeable membrane is measured by their flux (𝐽𝐽), which is a function of the concentration difference (𝑑𝑑𝑑𝑑), separation distance, (𝑑𝑑𝑥𝑥), area of diffusion 
(𝐴𝐴), and the diffusion coefficient (𝔻𝔻). The diffusion coefficient is a constant value for an individual solute, is dependent only on temperature, and is measured in cm³⁄s. In 1855, Adolf Fick, a German physiologist who created the first working contact lens, derived an equation that described the diffusion of a gas across a membrane: 
 𝐽𝐽 =  −𝔻𝔻𝐴𝐴𝑑𝑑𝑑𝑑
𝑑𝑑𝑥𝑥
 (4-1) 
Fick’s Law describes one-dimensional concentration flux. In order to develop the parameters for the semi permeable membrane inside a dialyzer, it is necessary to make simplifications and assumptions regarding Fick’s Law with regard to common properties of semi permeable membranes. 
 
Figure 4-4. The number of solutes passing through the membrane depends on the 
thickness of the membrane (∆𝒙𝒙), the ratio of the number of solutes on each side 
(∆𝑪𝑪), the size of the membrane (𝑨𝑨), and the diffusity constant (𝔻𝔻). 
First one assumes that the membrane thickness is constant the entire length of the membrane, and from tubule to tubule. This simplification highlights the primary factors of mass transport in 
MembraneBlood Dialysate
Δx
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membrane diffusion: the total concentration difference of the two fluids (∆𝐶𝐶), and the total contact area (𝐴𝐴). Because the diffusion coefficient (𝔻𝔻) only varies with temperature for a given solute, it can safely be left out (Sargent & Gotch, 1989). 
4.3.2 Overall mass transfer coefficient The next consideration to be made is how well a particular semi-permeable membrane can transport solutes for a given concentration difference. To compare two membranes, one might subject equal-sized (same area) samples of each to the same concentration difference. The amount of solutes that passed through each membrane in a given time could then be compared. 
The membrane that passed more solutes would have a higher overall mass transfer coefficient (𝐾𝐾0). The overall mass transfer coefficient is the ratio of the unit mass flux (mass flux per unit of area) to the concentration gradient, stated in Equation 4-2. While 𝐾𝐾0  is a function of the concentration gradient, it can be considered a constant for the gradients experienced in dialysis (Sargent & Gotch, 
1989). 
 𝐾𝐾0 = flux per unit areaconcentration difference= 𝐽𝐽 𝐴𝐴⁄−∆𝐶𝐶 (4-2) 
Individual membranes have a fixed 𝐾𝐾0  value for each solute. A membrane with a higher 𝐾𝐾0  value is capable of moving a larger number of that particular solute through its pores at a given concentration. The concentration difference can be equated as the driving force in diffusion and is measured in units of cm⁄min. 
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The mass transfer coefficient (𝐾𝐾0) is a common measure of a membrane’s effectiveness. When multiplied by the membrane’s total area (𝐴𝐴) and the concentration difference (∆𝐶𝐶), the mass transfer rate is known: 
 𝐾𝐾0 × 𝐴𝐴 × −∆𝐶𝐶 = 𝐽𝐽 (4-3) 
A unit balance for this equation can be shown: 
cmmin × cm2 × gcm3 = gmin 
Because both the mass transfer coefficient (𝐾𝐾0) and the effective surface area (𝐴𝐴) are fixed for a particular dialyzer, manufacturers often lump 𝐾𝐾0𝐴𝐴 together and publish the 𝐾𝐾0𝐴𝐴 specifically for urea (a primary target of dialysis) as a part of the membrane specifications. 
4.3.3 The concentration difference In a dialyzer, four concentrations are important for each substance of interest: the input blood 
concentration (𝐶𝐶𝐵𝐵𝐵𝐵 ), the input dialysate concentration (𝐶𝐶𝐷𝐷𝐵𝐵 ), the output blood concentration (𝐶𝐶𝐵𝐵𝐵𝐵 ) 
and the output dialysate concentration (𝐶𝐶𝐷𝐷𝐵𝐵 ). In a counter-flow dialyzer, the input concentration difference (∆𝐶𝐶𝐵𝐵) is the difference between the input blood concentration and the output dialysate concentration: 
 ∆𝐶𝐶𝐵𝐵 = 𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵  (4-4) 
Alternatively, the output concentration difference (∆𝐶𝐶𝐵𝐵 ) is the difference between the output blood concentration and the input dialysate concentration: 
 ∆𝐶𝐶𝐵𝐵 = 𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵  (4-5) 
 69  
The best way to determine a single overall concentration difference from the input and output concentrations is to use a log-mean concentration difference: 
 ∆ܥlog-mean = ∆ܥ௜ − ∆ܥ௢ln[∆ܥ௜ ∆ܥ௢⁄ ] = (ܥ஻௜ − ܥ஽௢) − (ܥ஻௢ − ܥ஽௜)ln [(ܥ஻௜ − ܥ஽௢) (ܥ஻௢ − ܥ஽௜)⁄  (4-6) 
The problem with this definition is that it requires the output concentrations of the blood and dialysate – the exact variables that need to be estimated in a system model. Fortunately, the concentration difference between the input blood and dialysate streams (ܥ஻௜  and ܥ஽௜) may be used instead of the log-mean concentration difference without any significant loss in accuracy (Sargent & Gotch, 1989): 
 ∆ܥ ≈ ܥ஻௜ − ܥ஽௜  (4-7) 
4.3.4 Dialysance While the overall mass transfer coefficient (ܭ଴) was derived from the concept of comparing two different membranes, the dialysance (ܦ) can be derived from the need to compare different blood and dialysate flow configurations on the same membrane. The diffusive dialysance is the magnitude of flux to be expected per unit of concentration driving force (Sargent & Gotch, 1989). Diffusive dialysance is defined as: 
 ܦ = concentration change of bloodconcentration gradient between blood and dialysate (4-8) 
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The dialysance (𝐷𝐷) will remain constant throughout a hemodialysis session, even as the concentration difference between the blood and dialysate decreases (as the blood becomes “cleaner” and the dialysate remains at a lower concentration), the amount of solutes leaving the blood will decrease. In terms of system variables, the dialysance can be defined as: 
 𝐷𝐷 =  𝑄𝑄𝐵𝐵(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐵𝐵𝐵𝐵 )
𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵
= 𝑄𝑄𝐷𝐷(𝐶𝐶𝐷𝐷𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵)
𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵
 (4-9) 
It should be noted that this definition of dialysance uses the simplified concentration gradient 
(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) instead of the log-mean concentration difference.  
Most significantly, a value for a hemodialysis configuration’s dialysance (𝐷𝐷) can be derived without the need for concentration values. Just the blood flow rate (𝑄𝑄𝐵𝐵), the dialysate flow rate (𝑄𝑄𝐷𝐷), and 
the membrane properties (𝐾𝐾0𝐴𝐴) are needed to determine the dialysance (𝐷𝐷). This can be shown in the following equations. 
First, the mass flowing in and out of a dialyzer must be equal: 
 𝑄𝑄𝐵𝐵(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐵𝐵𝐵𝐵 ) = 𝑄𝑄𝐷𝐷(𝐶𝐶𝐷𝐷𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) (4-10) 
Dividing both sides of Equation 4-10 by the simplified concentration gradient (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ): 
 𝑄𝑄𝐵𝐵(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐵𝐵𝐵𝐵 )
𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵
= 𝑄𝑄𝐷𝐷(𝐶𝐶𝐷𝐷𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 )
𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵
 (4-11) 
Defining the flux as the product of the blood flow rate and the concentration change of the blood through the dialyzer: 
 𝐽𝐽 = 𝑄𝑄𝐵𝐵(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐵𝐵𝐵𝐵 ) (4-12) 
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The unit balance for this is shown: 
mgmin = mLmin × mgmL 
Substituting Equation 4-9 and 4-12 into Equation 4-11: 
 𝐽𝐽
𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵
= 𝐷𝐷 (4-13) 
Therefore: 
 𝐽𝐽 = 𝐷𝐷(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵) (4-14) 
Substituting the log-mean concentration difference (Equation 4-6) into Equation 4-3: 
 𝐽𝐽 = 𝐾𝐾0𝐴𝐴 � (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) − (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵)ln[(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵) (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵)⁄ ]� (4-15) 
Setting Equation 4-14 and 4-15 equal to each other: 
 𝐷𝐷(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵) = 𝐾𝐾0𝐴𝐴 � (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) − (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵)ln[(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 )⁄ ]� (4-16) 
Rearranging the previous definitions for dialysance (Equation 4-9): 
 𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 = (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) �1 − 𝐷𝐷𝑄𝑄𝐷𝐷� (4-17) 
 𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 = (𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵) �1 − 𝐷𝐷𝑄𝑄𝐵𝐵� (4-18) 
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⎡ �(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵) �1 − 𝐷𝐷𝑄𝑄𝐷𝐷��− �(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) �1 − 𝐷𝐷𝑄𝑄𝐵𝐵��ln ��(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) �1 − 𝐷𝐷𝑄𝑄𝐷𝐷�� �(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵 ) �1 − 𝐷𝐷𝑄𝑄𝐵𝐵��� �⎦⎥⎥⎥
⎤ (4-19) 
Simplifying: 
 𝐾𝐾0𝐴𝐴(1 −𝑄𝑄𝐵𝐵 𝑄𝑄𝐷𝐷⁄ )
𝑄𝑄𝐵𝐵
= ln 1 − 𝐷𝐷 𝑄𝑄𝐷𝐷⁄1 −𝐷𝐷 𝑄𝑄𝐵𝐵⁄  (4-20) 
Solving for the dialysance (𝐷𝐷): 













The power of this equation is it allows the output blood and dialysate concentrations (𝐶𝐶𝐵𝐵𝐵𝐵  and 𝐶𝐶𝐷𝐷𝐵𝐵 )  to be calculated knowing only the blood flow rate (𝑄𝑄𝐵𝐵), the dialysate flow rate (𝑄𝑄𝐷𝐷), the membrane properties (𝐾𝐾0𝐴𝐴), and the input concentrations (𝐶𝐶𝐵𝐵𝐵𝐵  and 𝐶𝐶𝐷𝐷𝐵𝐵 ). This will be fully explored in Section 4.7 as an overall system model is developed. 
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In the special case when the input dialysate concentration is zero (as it is for most hemodialysis scenarios, this assumes that the dialyzer is run in “single-pass” mode), the previous equation can be restated as the Michaels equation (Ward & Leypoldt, 2001), where the overall clearance is solved: 




















4.4 Dialyzer design The membrane can be viewed as providing a resistance to solute diffusion, similar to how wires provide electrical resistance in current flow. Recalling the equation for the total flux across the dialyzer: 
 𝐽𝐽 = −𝐾𝐾0𝐴𝐴∆𝐶𝐶 (4-23) 
Rearranging (Sargent & Gotch, 1989): 
 unit flux = 𝐽𝐽
𝐴𝐴
= −∆𝐶𝐶1 𝐾𝐾0⁄  (4-24) 
The inverse of the mass transfer coefficient (𝐾𝐾0) can therefore be seen as resistance to mass flux: 
 𝑅𝑅0 = 1𝐾𝐾0 (4-25) 
The more resistance the membrane provides solute diffusion, the less solutes will be able to pass in a given area.  
Specifically, there are three resistances in membrane dialysis (Sargent & Gotch, 1989): resistance at the blood-membrane barrier (𝑅𝑅𝐵𝐵), the resistance of traveling through the membrane (𝑅𝑅𝑀𝑀), and the 
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resistance at the membrane-dialysate barrier (𝑅𝑅𝐷𝐷). Because the solutes traverse each of these resistances sequentially, the total resistance (𝑅𝑅0) is the sum of all three: 
 𝑅𝑅0 = 𝑅𝑅𝐵𝐵 + 𝑅𝑅𝑀𝑀 + 𝑅𝑅𝐷𝐷  (4-26) 
The only way to increase mass transfer is to decrease the resistances the solutes are subjected to, or increase the driving force. Because the driving force is the concentration difference between the blood and dialysate, there is little room for improvement: one is not free to increase the concentration of solutes already in the blood. This leaves decreasing the membrane-resistance as the primary focus. 
Knowing how these resistances are accounted for in mass transfer, one can evaluate different forms of membrane configurations for dialysis. While 𝑅𝑅𝑀𝑀  is a function of the physical properties of the 
membrane (thickness, material, pore geometry), both 𝑅𝑅𝐵𝐵  and 𝑅𝑅𝐷𝐷  will depend on the fluid flow at the surface of the membrane – which can vary greatly with the different physical configurations of membranes. 
There are two primary shapes dialyzers could come in: flat-plate designs, where membrane layers are sandwiched between counter-current fluid layers, or shell-and-tube designs where the blood 
flows through thousands of tiny tubes in a counter-flow of dialysate fluid. Studies in the 1970s showed that the membrane in flat-plate membranes accounted for 40–70% of the total resistance, while the membranes in shell-and-tube dialyzers accounted for around 90% of the total resistance 
(Sargent & Gotch, 1989). By reducing the resistance of the fluid flows to near-negligible levels in shell-and-tube designs, the flat-plate design was abandoned in favor of researching better membranes – to reduce the membrane resistance, now the primary resistance in dialyzers. 
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4.5 Modeling pump power requirements In the case of designing a hemodialysis system, there are more important factors than the flow characteristics. The most important concern is to maintain a sterile flow path for the blood and dialysate. Any pump used in the system must not allow harmful agents contact with the blood or dialysate, and it must maintain its sterility throughout its life.  
4.5.1 Overview of different types of pumps There are two primary types of pumps: centrifugal pumps and positive displacement pumps. Centrifugal pumps are the most common, because many feel they provide the best mechanical reliability. However, positive displacement pumps are preferred over centrifugal pumps under certain circumstances. Positive displacement pumps are traditionally preferred in industry when high pressure is coupled with low flow. 
In the case of designing a hemodialysis system, there are more important factors than the flow characteristics: the most important concern is to maintain a sterile flow path for the blood. Any 
pump used in the system must not expose harmful agents (such as bacteria or viruses) to the blood or dialysate, and it must maintain this sterility. Only one type of pump can easily provide this, and performs adequately at the system’s flow characteristics: a peristaltic pump. 
Peristaltic pumps are a special kind of rotary positive-displacement pumps. Moving rollers squeeze a flexible tube, providing for a pressure and velocity increase. Because the fluid only is exposed to the flexible tubing, and not the moving parts of the pump, it is very easy to maintain sterility. The pump life is also adequate – only the flexible tubing needs to be replaced on a regular interval. Additionally, peristaltic pumps are noted for their superior metering abilities. 
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4.5.2 Estimating the pressure drop across the dialyzer In the interest of designing a wearable artificial kidney, the two most important variables in pump selection and design are its size and its needed voltage. Unfortunately, there is no clear-cut way to relate pump size, power, and output. However, there are two very different ways to analyze peristaltic pumps to aid in the design of a wearable artificial kidney: an analysis of the fluid physics 
can provide a rough estimate to the power requirements (but cannot account for losses), or a survey of currently available peristaltic pumps could provide an average correlation between power, size, and weight. 
The first thing that must be calculated regarding the pump is the pressure rise it must provide in the hemodialysis circuit. In traditional hemodialysis, blood enters the circuit at about 120 mmHg 
(15.999 kPa) from the arterial side (systolic pressure), and reenters the blood stream at the venous 
side (diastolic pressure) around 80 mmHg (10.666 kPa) (Moffett, Moffett, & Schauf, 1993). If a hemodialysis system is designed for regular home use, the blood will most likely be drawn from the venous side for safety reasons. 
In order to calculate the pressure drop across the blood circuit, one must account for the three primary resistances: the resistance of the tubing from the vein to the dialyzer, the resistance of the dialyzer itself, and the resistance of the tubing from the dialyzer back into the vein. First, the resistances located inside the dialyzer will be examined. 
As discussed in previous chapters, a hollow fiber dialyzer consists of thousands of small, hollow tubes. Blood enters the dialyzer; its flow is split by a baffle into thousands of tubules, and then rejoined by an exit baffle before leaving the dialyzer. To calculate the pressure drop across the dialyzer, the pressure drop across just one tubule can be analyzed. 
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First, it is necessary to collect the known parameters of the system. There are typically 10,000 tubules in a dialyzer, each with an inner diameter of about 300 microns (0.0003 m). A large dialyzer has a length of about 20 cm (0.20 m). The blood is thinned before entering the dialyzer, creating a relative blood viscosity of approximately four times that of water, at 37 °C (Moffett, Moffett, & 
Schauf, 1993). 
Knowing these parameters, one can begin to apply them to the Navier-Strokes equations: specifically, the Hagen-Poiseuille equation dictating pressure driven flow through a circular cross-section: 
 𝑄𝑄 =  𝜋𝜋𝑅𝑅48𝜂𝜂𝐿𝐿 ∆𝑃𝑃 (4-27) 
First we will test this equation at a typical hemodialysis flow rate of 300 mL⁄min (5 × 10⁻⁶ m³⁄s), which is 5 × 10⁻¹⁰ m³⁄s per tubule, if there are 10,000 tubules. Solving for the pressure drop: 
5 × 10−10 = 3.1416 × 0.000448 × 0.04 × 0.20 ∆𝑃𝑃 
This equation predicts a 15.1 mmHg pressure drop across a dialyzer under typical hemodialysis conditions. However, it is known that the pressure drop is closer to 20 mmHg in a shorter (0.16 m) dialyzer, leaving the model presented here off by about 33%. 
This discrepancy can be accounted for by: 
1. The resistance in the baffles used to divert the flow into the tubules, located at both ends of the dialyzer; 2. The non-uniform shape of the tubules; and 
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3. The Fahraeus-Lindquist effect (Polaschegg & Levin, 1996), which modifies the viscosity of the blood in small diameter pathways. 
The Hagen-Poiseuille equation can be solved for various flow rates, dialyzer lengths, and tubule diameters in order to examine the effects various parameters have on the pressure drop of the dialyzer. Knowing the pressure drop of the dialyzer is an important step towards selecting a pump. Figure 4-5 shows the relationship between tubule size, flow rate, and pressure drop. Figure 4-6 shows the relationship between dialyzer size, flow rate, and pressure drop. 
 
Figure 4-5. The expected pressure drop according to the Hagen-Poiseuille equation 
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Figure 4-6. The expected pressure drop according to the Hagen-Poiseuille equation 
in tubules of 250 µm in dialyzer of lengths of 0.1 m, 0.15 m, and 0.2 m at various 
flow rates. 
While a more detailed analysis could remedy the shortcomings of simply using the Hagen-Poiseuille equation to calculate the pressure drop in the dialyzer, it would only achieve results that confirm already-available data. Suzuki et al. (2001) already provides data for the pressure drop of a hollow 
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The Hagen-Poiseuille equation can also be solved for the flexible tubing connecting the dialyzer to the human vein. Assuming 1.0 m of tubing length, a 0.005 m inner diameter, a flow rate of 300 mL⁄min (5 × 10⁻¹⁰ m³⁄s), and a viscosity of 0.04 cp, the equation looks as follows: 
5 × 10−10 = 3.1416 × 0.000548 × 0.04 × 1.0 ∆𝑃𝑃 
This yields a pressure drop of 3.2 mmHg, a small value compared to the pressure drop associated with the dialyzer. 
4.5.3 Relating the pressure drop to pump power requirements The goal of this section is to integrate the pump variables into a larger system model. Already it has 
been shown how increasing dialyzer size (tubule inner diameter and length) increases the pressure that must be supplied by the pump. This is important because changing the dialyzer is a simple way to modify the clearance-performance of the system directly. 
However, there are certain negative ramifications of a larger dialyzer, aside from the simple fact of 
increased physical size. A more powerful pump (and perhaps heavier) might be required to provide the needed pressure change if a larger dialyzer was selected. At this point, the flow rate, pressure change, and the specific gravity of the fluid are known. Hopefully this is enough information to relate those system variables to the power required by the pump. If the power required is known, the weight of the associated power source (batteries) can be integrated into the system model. 
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There are two types of power variables associated with positive displacement pumps. The fluid power is the power transmitted from the pump to the fluid. The brake power is the power transmitted to the pump, regardless of how much is imparted to the fluid. The differences between these two variables are the losses associated with the pump: 
 Losses = Brake Power− Fluid Power (4-28) 
Since the ultimate goal is to estimate the weight of the associated pump and batteries, we are interested primarily in brake power and not fluid power. However, the power imparted to the fluid is easily calculated by multiplying the flow rate and the output pressure: 
 Fluid Power = Flow Rate × Flow Pressure (4-29) 
In a scenario we might expect to encounter in the development of a small portable hemodialysis 
system (100 mL⁄min flow rate and 100 mmHg output pressure), the fluid power is 0.0222 W: 
1.667 × 10−6 m31 s × 13222 Nm2 = 0.0222 N ∙ m1 s = 0.0222 W 
The losses associated with the positive displacement pump are manifested in the equation for its brake power: 
 Brake Power = Flow Rate × Pressure Pump Efficiency  (4-30) 
At this point, this equation leaves us with two knowns and two unknowns. While the flow rate and pressure have already been calculated, the input power and the efficiency are both unknown. 
Usually one is known (for example, calculating the efficiency of a pump already in use), but if both are unknown, then significant modeling or estimation must be used to calculate the other. As a way to determine the input power required, specifications from currently available pumps could be 
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analyzed. While there are many different types of pumps available, only pumps with the following characteristics were analyzed: 
1. Peristaltic positive-displacement pumps 2. Powered by a direct current 3. Operates in the 1–1000 mL⁄min flow rates 4. Single roller head 5. Less than 5 kg in weight 
The goal is to select pumps that fall within the expected operating range of a portable hemodialysis system. Pumps that require alternating current are often not only too powerful and too large, but they operate at a very high voltage and current – making their brake power too high. Some pumps have multiple roller heads, which would obscure the relationship between the brake power and the 
fluid power. 
One particular manufacturer, Omega, not only has a large selection of peristaltic pumps available in specifications already outlined, but they also provide detailed specifications of all their pumps. This allows for the calculation of the efficiency of their entire line of pumps. Table 4-1 lists select pumps available, and from the voltage, amperage, and flow rates provided by the manufacturer the calculated the power and efficiency of the individual pump. 
Table 4-1. Selected pump data (Omega). 
Model Voltage (V) Amperage (A) Power (W) Flow Rate (m³/s) Efficiency 
FPU101 12 0.37 4.44 5 × 10⁻⁸ 0.02% 
FPU110 12 0.75 9.00 9.167 × 10⁻⁷ 0.14% 
FPU119 12 1.20 14.4 3.25 × 10⁻⁶ 0.30% 
FPU124 12 2.20 26.4 1.25 × 10⁻⁵ 0.63% 
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Every pump available from this manufacturer has an input voltage of 12 V. However, the amperage varies, so calculating the brake power is simple. Here is a sample calculation for the FPU110 pump: 
12 V × 0.75 A = 9.00 W 
Calculating the associated efficiency of the pump is also shown:  
9.167 × 10−7  m3 s⁄ × 13332 Pa9.00 W = 0.001358 
This pump has a remarkably low efficiency. All pumps from this manufacturer have an input voltage of 12 V, while the amperage varies between 0.37 and 2.2 A. Together, these account for a considerable power requirement of 9 W. On the other hand, the output flow rate and pressure 
(13,332 Pa is equivalent to 100 mmHg, an estimate of the maximum pressure inside the dialysis 
circuit) translate to a mere 0.01222 W imparted to the fluid. 
Typical peristaltic pump efficiencies are near 50%, but typical pumps also move much more than 55 mL⁄min of fluid. A brushless direct-current peristaltic pump used in a ventricular assist device had a measured efficiency between 31% and 34% – but it also had a flow rate of 5 L⁄min (Baker, 
Gardner, Gaumond, Geselowitz, & Snyder, 1998). 
The entire selection of pumps is graphed in Figure 4-7. While the line is smooth above 400 mL⁄min, below 200 mL⁄min the line becomes quite chaotic. The goal of this exploration of commercially available pumps is to relate flow rate and pressure to input power via efficiency. While this graph cannot provide a relationship that differentiates between individual flow rates for the system model, it clearly shows a very poor efficiency in the range of flow rates associated with a portable hemodialysis system– well below 0.30%. 
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Figure 4-7. The efficiency of various peristaltic pumps from the same manufacturer. 
Because no clear relationship between pump size and output can be drawn from either theoretical analysis or examination of commercially available pumps, pump size effects will not be integrated into the system model. 
4.6 Exploring the primary equations of a hemodialysis system Now that various aspects of a hemodialysis system have been analyzed, a unified system model can be constructed. The goal of this system model is to predict how different system configurations will influence the treatment schedule of a patient. The model should examine different combinations of 
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4.6.1 System parameters The individual solute clearance, 𝐾𝐾0 , is the measure of clearance of an individual solute. It is a function of the membrane material and the physics of the individual solute. Often this variable is lumped with the surface area to create a new parameter, 𝐾𝐾0𝐴𝐴. When manufacturers provide specifications for their dialyzers, the lumped parameter is usually provided only with regard to urea. This is the 𝐾𝐾0𝐴𝐴 that is used in Equation 4-22 for calculation of the overall dialyzer clearance. Because 𝐾𝐾0  is a function of the solute and the membrane material, it is constant for dialyzers of the same material but different lengths. As the size (length) of the dialyzer increases, the 𝐾𝐾0𝐴𝐴 increases in proportion to the increasing area. If the number of tubules and their diameter remains constant 
as the length is increased (which is common), then the 𝐾𝐾0𝐴𝐴 increases linearly with the length. 
Table 4-2. Various dialyzers and their clearance rates (Baxter Healthcare 
Corporation). 
Dialyzer Name 𝑲𝑲𝟎𝟎𝑨𝑨 (mL/min) Area (m²) 
Baxter Xenium 110 824 1.1 
Baxter Xenium 130 993 1.3 
Baxter Xenium 150 1123 1.5 
Baxter Xenium 170 1239 1.7 
Baxter Xenium 190 1487 1.9 
Baxter Xenium 210 1614 2.1  The blood flow rate and dialysate flow rate can be chosen to maximize the overall system clearance according to Equation 4-22. However, changing those flow rates has ramifications on the amount of dialysate used and treatment time. Additionally, there is a link between the dialysate flow rate and the blood flow rate: they work together to change the overall dialyzer clearance. Only through careful manipulation of the system model can the best flow rates be chosen. 
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4.6.2 Precursory analysis of the Michaels equation The most basic analysis of hemodialysis can be provided by examining the Michaels equation. As explained in Section 4.3, the Michaels equation (Equation 4-22) provides a relationship between blood flow rate, dialysate flow rate, dialyzer size, membrane material, and overall dialyzer clearance. Again, this equation only holds for the common hollow fiber dialyzer design in counter-current flow.  
As a first test of this equation, the blood flow rate (𝑄𝑄𝐵𝐵) will be increased as all other variables are left constant. The 𝐾𝐾0𝐴𝐴 parameter will be set at 100 mL⁄min and the dialysate flow rate (𝑄𝑄𝐷𝐷) will be 
fixed at 250 mL⁄min. This analysis will show the basic relationship between blood and dialysate 
flows for this specific case. 
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Figure 4-8. The relationship between the blood and dialysate flow rates with respect 
to overall dialyzer clearance. The K0A was 1000 mL/min and the dialysate flow rate 
(QD) was 250 mL/min. 
Keeping all other variables the same, the relationship between the dialysate and blood flow rates becomes clear in the simple case of Figure 4-8. There is a steep increase in overall dialyzer 
clearance at a 0.5 ratio (125 mL⁄min), and after a 1.5 ratio (375 mL⁄min) the clearance steadies. From this analysis, it seems as if selecting a ratio of at least 1.5 for this blood flow rate would be ideal. However, a more detailed analysis is needed. Since the dialysate flow rate needs to be minimized, tradeoffs between treatment time and dialysate flow rate should be considered. 
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lengthening it – the number of tubules remains unchanged. With the dialysate flow rate kept at 250 mL⁄min, the 𝐾𝐾0𝐴𝐴 was examined in ranges from 500 to 2000 mL⁄min at four different blood and dialysate flow ratios. From Figure 4-9, it seems that the largest factor is not the size of the membrane, but the ratio of the flow rates. 
The overall dialyzer clearance varied little between flow ratios of 1.5 and 2.0. There seemed to be little gain from increasing the dialyzer size in any case. While Figure 4-9 does not explore it, the largest dialyzers benefit from faster dialysate flow rates (Baxter Healthcare Corporation) – this data was plotted at a constant dialysate flow rate of just 250 mL⁄min. Clinical hemodialysis can have dialysate flow rates much higher. 
 
Figure 4-9. The relationship between the size of the dialyzer and overall dialyzer 
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One of the limiting factors in a portable hemodialysis system is the blood flow rate. Because blood is 
drawn from the veins (and not the arteries) in a portable system, the blood flow rate is limited to below 100 mL⁄min. This unique situation calls for special analysis of the Michaels equation. Most commercially available dialyzers are designed for much higher flow rates than what might be encountered in a wearable system, but the Michaels equation can calculate how they will respond to a slower blood flow rate. Figure 4-10 shows the clearance of different-sized dialyzers at a range of dialysate flow rates and a blood flow rate of 80 mL⁄min. 
 
Figure 4-10. Various dialyzer sizes are compared at an 80 mL/min blood flow rate. 
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80 mL⁄min). Previous manipulation of the Michaels equation (Figure 4-8) had implied that the best ratio was above 1.5. 
The unusual ratio is a product of the unusually slow dialysate flow rate. It was previously discussed that there were two primary factors of the Michaels equation – the blood flow rate and the large lumped parameter that accounts for the flow ratios and dialyzer size. However, by plotting several different curves of different fixed dialysate flow rates (Figure 4-11), it becomes clear that the best ratio also changes with the dialysate flow rate. At high clinical-level dialysate flow rates, it is best to have a ratio of about 2.0. When the dialysate flow rate is reduced, the ideal ratio is reduced along with it. 
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Because venous-side ports are limited to a blood flow rate of 80 mL⁄min, choosing a higher dialysate flow rate is unreasonable. From this analysis, it is clear that choosing a ratio of 1.0 will not only provide the highest overall clearance rates, but it will also reduce the need for dialysate. 
4.7 Modeling Hemodialysis in Simulink Because of the complex nature of a hemodialysis system, it is easiest to use a program such as Matlab Simulink to model its performance beyond simple manipulation of the Michaels equation. 
The only variable that is optimized by the simulation is the dialysate flow rate. Many of the variables in the simulation are dependent on patient specifics. For example, a patient’s urea generation rate and total blood volume are functions of his or her size and diet. Before the simulation can be run, values for these variables must be selected that correspond to a realistic scenario. In the examples in this thesis that contain urea generation, the assumed value was 17.3611 mg⁄min (unless otherwise noted), which corresponds to 25 g⁄day, a typical value (Moffett, 
Moffett, & Schauf, 1993). 
Similarly, the blood flow rate (𝑄𝑄𝐵𝐵) is limited by which method the blood is extracted from the body, and is therefore not subjected to optimization. It has already been shown through Equation 4-22 that a higher blood flow rate is the best way to increase solute clearance, so it is known that the port that provides the highest blood flow rate is the best choice. However, due to varying patient conditions, a port with a less-than-optimal flow rate might have to be selected.  
The total volume of dialysate can be defined by the system. There are two ways to determine the total amount of dialysate used by the system: if it is single-pass (no dialysate reuse), then the amount of dialysate used is the dialysate flow rate (𝑄𝑄𝐷𝐷) times the treatment length. However, if the dialysate is to be recirculated, then the total dialysate volume is independent of the dialysate flow 
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rate. The Simulink model accounts for both these scenarios by calculating both volumes and outputting only the lower value. 
This works because the model always recirculates dialysate. If a single-pass system is tested, the 
dialysate volume is simply set to a very large number (generally over a billion gallons of dialysate), so that the system is effectively always drawing from a reservoir of clean dialysate. However, when 
the system outputs how much dialysate is required, it reads both the input volume (again, in the 
billions) and the dialysate flow rate times treatment length volume. The lesser of these two values 
is the actual dialysate volume (𝑉𝑉𝐷𝐷). In the case where the amount of dialysate is limited, it will be less than volume based on the dialysate flow rate. 
The other two important variables are the initial concentrations of the blood and dialysate. In every case, the initial dialysate urea concentration is set to 0 mg⁄mL. Regardless of whether a system is single-pass or uses recirculation, its initial concentration should be zero (although the user has 
control over this parameter). The blood, however, depends on the individual patient’s BUN (blood urea nitrogen, the amount of nitrogen in the blood in the form of urea) reading, and is therefore dependent on how often they dialyze (among other factors). For example, patients who dialyze less frequently would have a higher initial BUN. So if the model were to test a system that dialyzed only a few times per week, a higher initial BUN should be selected for the input value. If a daily system is to be tested, a lower initial BUN should be selected to reflect the probable level of urea in their blood before dialysis began. 
The dialysis schedule is modeled as a pulse input; if the patient is dialyzing then the output is one and if they are in between treatments the output is zero. This value is then multiplied with the milligrams of urea removed from the blood. 
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4.7.1 Step-by-step procedure used in the model The model predicts the urea concentration of blood every minute. Figure 4-12 is a screenshot of the model in Simulink. 
 
Figure 4-12. A screenshot of the Matlab Simulink model. 
4.7.1.1 Step one: define inputs At a minimum, the blood flow rate (𝑄𝑄𝐵𝐵), dialyzer properties (𝐾𝐾0𝐴𝐴), initial blood volume (𝑉𝑉𝐵𝐵), initial 
dialysate volume (𝑉𝑉𝐷𝐷), urea generation rate (?̇?𝐺), trade-off coefficient (𝛼𝛼), residual kidney function 
(𝐺𝐺𝐺𝐺𝑅𝑅%), initial blood concentration (𝐶𝐶𝐵𝐵𝐵𝐵 ), initial dialysate concentration (𝐶𝐶𝐷𝐷𝐵𝐵 ), ultrafiltration coefficient (𝐾𝐾𝑈𝑈𝐺𝐺), dialyzer blood pressure (𝑝𝑝𝐵𝐵), dialyzer dialysate pressure (𝑝𝑝𝐷𝐷), and treatment 
schedule (𝑡𝑡1  and 𝑡𝑡2)  must be defined. A summary of these inputs, with their associated units, is available in Table 4-3. 
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Table 4-3. The inputs of the system model. 
Parameter Name Variable Units Blood flow rate 𝑄𝑄𝐵𝐵  mL⁄min Dialysate flow rate 𝑄𝑄𝐷𝐷  mL⁄min Dialyzer properties 𝐾𝐾0𝐴𝐴 mL⁄min Trade-off coefficient 𝛼𝛼 − Urea generation rate ?̇?𝐺 mg⁄min Residual kidney function 𝐺𝐺𝐺𝐺𝑅𝑅% − Total blood volume 𝑉𝑉𝐵𝐵  mL Total dialysate volume 𝑉𝑉𝐷𝐷  mL Incoming blood urea concentration 𝐶𝐶𝐵𝐵𝐵𝐵  mg⁄mL Incoming dialysate urea concentration 𝐶𝐶𝐷𝐷𝐵𝐵  mg⁄mL Dose length 𝑡𝑡1  min or hours Time between doses 𝑡𝑡2  min or hours Ultrafiltration coefficient 𝐾𝐾𝑈𝑈𝐺𝐺  mL⁄min⁄mmHg Dialyzer blood pressure 𝑝𝑝𝐵𝐵  mmHg Dialyzer dialysate pressure 𝑝𝑝𝐷𝐷  mmHg  
Table 4-4. The parameters calculated by the system model. 
Parameter Name Variable Units Dialysate flow rate 𝑄𝑄𝐷𝐷  mL⁄min Dialysance 𝐷𝐷 mL⁄min Dialyzer clearance 𝐾𝐾 mL⁄min Total dialysate volume 𝑉𝑉𝐷𝐷  mL Outgoing blood concentration 𝐶𝐶𝐵𝐵𝐵𝐵  mg⁄mL Outgoing dialysate concentration 𝐶𝐶𝐷𝐷𝐵𝐵  mg⁄mL  
4.7.1.2 Step two: calculate a trade-off dialysate flow rate The next step is to calculate the best dialysate flow rate (𝑄𝑄𝐷𝐷) from the blood flow rate (𝑄𝑄𝐵𝐵) and the dialyzer properties (𝐾𝐾0𝐴𝐴). The model tests every dialysate flow rate between 1–1000 mL⁄min, in 1 mL⁄min intervals, recording the highest possible clearance in accordance with Equation 4-22. While this is generally the clearance corresponding to a dialysate flow rate of 1000 mL⁄min, this 
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value is then used to find the slowest possible dialysate flow rate that corresponds to a clearance that is 95% of the maximum. 
The model then tests every dialysate flow rate again, starting at 1 mL⁄min at 1 mL⁄min intervals until it achieves the desired 95% clearance. The 95% value was chosen arbitrarily; choosing 90% also works well, but percentages below that begin to select dialysate flow rates with insufficient clearances. From Figure 4-11, the 95% value attempts to find the best dialysate flow rate. In the following simulations, the 95% value is termed the trade-off coefficient and is symbolized by 𝛼𝛼. 
 
Figure 4-13. The trade-off dialysate flow rate. The maximum clearance is 100 mL/min 
(at QD > 200 mL/min), and the trade-off clearance is 95 mL/min (at QD = 
114 mL/min). 




















Dialysate Flow Rate (mL/min)
Maximum clearance 
at QD > 200 mL/min
95% of maximum
at QD = 114 mL/min
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(the model calculates from 1–1000, but the plot was truncated to better show the trade-off curve). The maximum possible clearance of 99 mL⁄min is shown to be at a dialysate flow rate (𝑄𝑄𝐷𝐷) of greater than 200 mL⁄min. Multiplying the maximum possible clearance by 95% yields a clearance of 95 mL⁄min. The model starts its search at 1 mL⁄min, gradually increases the dialysate flow rate, and then stops once 95% value is found. In this case, the model would stop its search after testing the clearance corresponding to a dialysate flow rate of 114 mL⁄min. 
4.7.1.3 Step three: calculate the urea concentration of the blood leaving the dialyzer The time-dependency of the model begins at this step. The model works in one-minute increments, so this step begins the iterative nature of the model. The dialysance (𝐷𝐷) was already calculated in 
Step 2, this value is used with the initial blood and dialysate concentrations (𝐶𝐶𝐵𝐵𝐵𝐵  and 𝐶𝐶𝐷𝐷𝐵𝐵 ) and the dialysate flow rate (𝑄𝑄𝐷𝐷 , calculated in Step 1) to determine the amount of urea removed in the first minute. Recalling Equation 4-9: 
𝐷𝐷 =  𝑄𝑄𝐵𝐵(𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐵𝐵𝐵𝐵 )
𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵
= 𝑄𝑄𝐷𝐷(𝐶𝐶𝐷𝐷𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵)
𝐶𝐶𝐵𝐵𝐵𝐵 − 𝐶𝐶𝐷𝐷𝐵𝐵
 
In the case when the blood flow rate (𝑄𝑄𝐵𝐵) is 100 mL⁄min, the dialysate flow rate (𝐷𝐷) is 114 mL⁄min, and the 𝐾𝐾0𝐴𝐴 is 1000 mL⁄min, the calculation for the dialysance (𝐷𝐷) is 95.16 mL⁄min: 





𝐷𝐷 = 95.16  mL min⁄  
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Continuing, if the initial blood concentration (𝐶𝐶𝐵𝐵𝐵𝐵 ) is 6.43 mg⁄mL, the initial dialysate concentration 
(𝐶𝐶𝐷𝐷𝐵𝐵 ) is 0.0 mg⁄mL, then the concentration of the blood out (𝐶𝐶𝐵𝐵𝐵𝐵 ) is: 
95.16 = 100 × (6.43 − 𝐶𝐶𝐵𝐵𝐵𝐵 )6.43 − 0.0  
𝐶𝐶𝐵𝐵𝐵𝐵 = 0.31 mg mL⁄  
The dialyzer has significantly reduced the urea concentration of the blood leaving the dialyzer after one minute. 
Calculating the output dialysate concentration provides an easy way to calculate the mass of urea transported, and is needed if dialysate is recirculated: 
95.16 = 114 × (𝐶𝐶𝐷𝐷𝐵𝐵 − 0.0)6.43 − 0.0  
𝐶𝐶𝐷𝐷𝐵𝐵 = 5.37 mg mL⁄  
A simple mass balance can be performed to verify the results: 
Incoming Mass = Outgoing Mass (𝑄𝑄𝐵𝐵 × 𝐶𝐶𝐵𝐵𝐵𝐵 ) × (𝑄𝑄𝐷𝐷 × 𝐶𝐶𝐵𝐵𝐵𝐵 ) = (𝑄𝑄𝐵𝐵 × 𝐶𝐶𝐵𝐵𝐵𝐵 ) × (𝑄𝑄𝐷𝐷 × 𝐶𝐶𝐵𝐵𝐵𝐵 ) (100 × 6.43) × (114 × 0.0) = (100 × 0.31) × (114 × 5.37) 643 = 31 + 609 643 ≈ 640 
The discrepancy can be accounted for by rounding. 
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4.7.1.4 Step four: calculate the new concentrations of the blood and dialysate volumes After the fluids (blood and dialysate) leave the dialyzer, they are mixed with the remaining volumes. In the case of this example, this is 5 L of blood. Dialysate is often disposed of, but its total volume can be arbitrarily set by the user. 
Once the cleaned blood mixes with the remaining blood, the concentration of the total blood volume has decreased. The new urea concentration in the blood is calculated by first calculating the previous total mass of urea in the blood volume: 
 mg𝑡𝑡𝐵𝐵𝑡𝑡𝑡𝑡𝑡𝑡 = 𝐶𝐶𝐵𝐵𝐵𝐵 × 𝑉𝑉𝐵𝐵  (4-31) 
Following the example in Step 3: 
mg𝑡𝑡𝐵𝐵𝑡𝑡𝑡𝑡𝑡𝑡 = 6.43 mgmL × 5 000 mL mg𝑡𝑡𝐵𝐵𝑡𝑡𝑡𝑡𝑡𝑡 = 32 150 mg 
The patient started with 32 g of urea in their blood. 
Next, the mass of urea removed in the first minute can be determined by multiplying the concentration of the dialysate leaving the dialyzer (𝐶𝐶𝐷𝐷𝐵𝐵 ) and the dialysate flow rate (𝑄𝑄𝐷𝐷): 
 mg𝑟𝑟𝑒𝑒𝑟𝑟𝐵𝐵𝑟𝑟𝑒𝑒𝑑𝑑 = 𝐶𝐶𝐷𝐷𝐵𝐵 × 𝑄𝑄𝐷𝐷 × 𝑡𝑡 (4-32) 
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In the example: 
mg𝑟𝑟𝑒𝑒𝑟𝑟𝐵𝐵𝑟𝑟𝑒𝑒𝑑𝑑 = 5.37 mgmL × 114 mLmin × 1 min mg𝑟𝑟𝑒𝑒𝑟𝑟𝐵𝐵𝑟𝑟𝑒𝑒𝑑𝑑 = 612.18 mg 
In this case, 612.18 mg of urea has been removed from the blood. At this point, the generation of urea and residual kidney function must be accounted for. Because many dialysis patients still have 
some kidney function (generally a glomulur filtration rate [GFR] less than 15%), their residual 
kidney function (𝐺𝐺𝐺𝐺𝑅𝑅%) can be considered by lessening the urea generation rate (?̇?𝐺). A typical human generates 25 g of urea per day, which is 17.361 mg⁄min. 
 mg𝑔𝑔𝑒𝑒𝑔𝑔𝑒𝑒𝑟𝑟𝑡𝑡𝑡𝑡𝑒𝑒𝑑𝑑 = (1 − 𝐺𝐺𝐺𝐺𝑅𝑅%) × ?̇?𝐺 × 𝑡𝑡 (4-33) 
In this example, a urea generation rate (?̇?𝐺) of 17.261 mg⁄min has been assumed, but no residual kidney function: 
mg𝑔𝑔𝑒𝑒𝑔𝑔𝑒𝑒𝑟𝑟𝑡𝑡𝑡𝑡𝑒𝑒𝑑𝑑 = (1 − 0) × 17.361 mgmin × 1 min mg𝑔𝑔𝑒𝑒𝑔𝑔𝑒𝑒𝑟𝑟𝑡𝑡𝑡𝑡𝑒𝑒𝑑𝑑 = 17.361 mg 
The new total mass of urea in the blood can be calculated by subtracting this value from the previously determined total mass of urea and adding the amount of urea generated: 
 mg𝑡𝑡𝐵𝐵𝑡𝑡𝑡𝑡𝑡𝑡 ′ = mg𝑡𝑡𝐵𝐵𝑡𝑡𝑡𝑡𝑡𝑡 − mg𝑟𝑟𝑒𝑒𝑟𝑟𝐵𝐵𝑟𝑟𝑒𝑒𝑑𝑑 + mg𝑔𝑔𝑒𝑒𝑔𝑔𝑒𝑒𝑟𝑟𝑡𝑡𝑡𝑡𝑒𝑒𝑑𝑑  (4-34) 
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In the case of the example presented: 
mg𝑡𝑡𝐵𝐵𝑡𝑡𝑡𝑡𝑡𝑡 ′ = 32 150 mg − 612.18 mg + 17.361 mg mg𝑡𝑡𝐵𝐵𝑡𝑡𝑡𝑡𝑡𝑡 ′ = 31 555.18 mg 
Now that the new total mass of urea in the blood is known, the new blood concentration can be 
determined by dividing the new total mass by the total blood volume (𝑉𝑉𝐵𝐵):  
 𝐶𝐶𝐵𝐵𝐵𝐵 ′ = mg𝑡𝑡𝐵𝐵𝑡𝑡𝑡𝑡𝑡𝑡 ′𝑉𝑉𝐵𝐵  (4-35) 
In the example, this results in a new urea concentration of 6.311 mg⁄mL: 
𝐶𝐶𝐵𝐵𝐵𝐵
′ = 31 555.18 mg5 000 mL = 6.311 mg mL⁄  
These calculations are also performed on the dialysate. When the dialysate is run in single-pass 
mode, the volume of the dialysate is set to an arbitrarily high value (above 1 × 10⁹ mL). While the dirty dialysate is still “mixed” with the total volume of dialysate, the extremely high dialysate volume ensures that it does not affect the results. If dialysate is to be recirculated, its value can be set by the user. 
4.7.1.5 Step five: iterate The previous step is performed at one-minute intervals. The new blood concentration (𝐶𝐶𝐵𝐵𝐵𝐵 ′  in the 
previous step) is now the incoming blood concentration (𝐶𝐶𝐵𝐵𝐵𝐵 ) of the dialyzer. While the dialysance 
(𝐷𝐷) and total volumes (𝑉𝑉𝐵𝐵  and 𝑉𝑉𝐷𝐷) do not change between iterations, the blood and dialysate concentrations are constantly updated. 
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4.7.1.6 Outputs of the model 
The model’s primary output is a matrix of the urea blood concentration (𝐶𝐶𝐵𝐵) and the time. An example of actual output from the model is in Table 4-5. The same parameters were used as the example of this section, so the validity of the model can be confirmed. Section 4.7.1.4 predicted the urea concentration in the blood would be 6.311 mg⁄mL after the first minute; the model predicts 6.309 mg⁄mL. The discrepancy can be attributed to rounding (the model does not round; the 
example did). 
Table 4-5. The output from the model of the first four minutes from a simulation. 
Time 
(minutes) 
Blood Urea Concentration 
(𝑪𝑪𝑩𝑩, mg/mL) 0 6.428571 1 6.309173 2 6.192048 3 6.077152 4 5.964442  How long the simulation runs depends on the dose length (𝑡𝑡1) and the time between doses (𝑡𝑡2). To 
simulate clinical dialysis (2-hour treatment, every-other day), 𝑡𝑡1  and 𝑡𝑡2  could be set to 2 and 46 hours, respectively. 
4.7.2 Other considerations of the model Aside from what was detailed in Section 4.7.1, the model makes other considerations. 
The primary factor not already mentioned is the role of ultrafiltration in dialysis. Ultrafiltration (𝑄𝑄𝐺𝐺 , mL⁄min) accounts for a small amount of mass transport due to the pressure gradient between the blood and dialysate flows in the dialyzer. It is accounted for by the pressure difference (𝑝𝑝𝐵𝐵 − 𝑝𝑝𝐷𝐷) 
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and a new parameter, the ultrafiltration coefficient (𝐾𝐾𝑈𝑈𝐺𝐺 , mL⁄min⁄mmHg) (Sargent & Gotch, 1989): 
 𝑄𝑄𝐺𝐺 = 𝐾𝐾𝑈𝑈𝐺𝐺 × (𝑝𝑝𝐵𝐵 − 𝑝𝑝𝐷𝐷) (4-36) 
The mass flux associated with ultrafiltration is the product of the ultrafiltration coefficient (𝑄𝑄𝐺𝐺) and 
the urea blood concentration leaving the dialyzer (𝐶𝐶𝐵𝐵𝐵𝐵 ): 
 𝐽𝐽𝑈𝑈𝐺𝐺 = 𝐾𝐾𝑈𝑈𝐺𝐺 × (𝑝𝑝𝐵𝐵 − 𝑝𝑝𝐷𝐷) × 𝐶𝐶𝐵𝐵𝐵𝐵  
𝐽𝐽𝑈𝑈𝐺𝐺 = 𝑄𝑄𝐺𝐺 × 𝐶𝐶𝐵𝐵𝐵𝐵  (4-37) 
The model has the ability to account for this mass transport, but in the cases presented in this thesis it is not accounted for. It was left out because there is no easy estimation of either the pressure 
gradient (𝑝𝑝𝐵𝐵 − 𝑝𝑝𝐷𝐷) or the ultrafiltration coefficient (𝐾𝐾𝑈𝑈𝐺𝐺). While accounting for ultrafiltration would have ostensibly provided greater accuracy, using poorly estimated values would negate any benefit. Additionally, the role of ultrafiltration is minor (Sargent & Gotch, 1989), so not accounting for it is reasonable. 
4.7.3 Assumptions in the model The model makes several assumptions. The equations used to calculate the changing concentrations do not use the actual concentration gradient between the dialysate and the blood, but rather the simplified concentration difference between the blood inlet and the dialysate inlet. As explained before, this is not expected to have a serious impact on the results. 
Another assumption made by the model is perfect mixing. When the dirty dialysate and blood leave 
the dialyzer, they are returned to a hypothetical vat (or body), and then perfectly mixed with the existing blood or dialysate to create a new concentration level. A real-world hemodialysis experiment would probably have imperfect mixing. For example, blood returned from the body would be returned on the venous side of the bloodstream, while the blood drawn into the dialyzer 
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would come from the arterial side. The blood drawn into the dialyzer would not be diluted by the clean blood, and would actually have a higher concentration of urea, resulting in model that predicts slightly lower clearances. On the dialysate side, dialysate is usually not recirculated, but if it was, the dialysate drawn would be a little cleaner than predicted by the model, also resulting in clearances higher than predicted. 
This is considered a one-compartment model, in reference to the how the model treats the body’s fluid volume. In a one-compartment model, the dialyzer interacts with a hypothetical reservoir of all the fluid in the body. In a two-compartment model, the body’s fluid volume is divided into fluids: extracellular and intracellular. In two-compartment hemodialysis models, the dialyzer interacts directly with the extracellular fluid, and the extracellular fluid in turn interacts with the intracellular fluid. 
Two-compartment models were developed to reflect a sudden rise of solutes in the patient’s blood after dialysis ends. Once dialysis ends, the extra- and intercellular fluids equalize, and the 
extracelluar fluid gains solutes from the intercellular fluid, which was not as well dialyzed. Ziólko and coauthors (2000) studied the accuracy of both one- and two-compartment models, and noted that they both have similar accuracy. They concluded that two-compartment models should only be used when “explaining a steep increase of toxin concentration immeadiatly after the end of dialysis” 
(p. 1163). Because this model will be used to determine day-to-day changes in patient BUN, and not intricate BUN changes, a one-compartment model will suffice. 
Constant flow rates are assumed, which would probably not be the case during a typical hemodialysis session. As the dialyzer is primed, and during its use, the blood flow rate can easily 
fluctuate. Because these fluctuations are expected to be minor, this oversight in the model is not of concern. 
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Further, the equations used in this model also assume there is no blood- or dialysate-side resistance to diffusion – that all resistance lies in the transport across the membrane. Because the membrane accounts for 90% of the resistance (Sargent & Gotch, 1989), this is a reasonable assumption. 
4.8 Conclusion The creation of a detailed system model has allowed for an exploration of all the different parameters associated with hemodialysis. The final goal is to put together a system configuration that best meets the goals stated in Chapter 3 of a portable system. 
A summary of what has been learned in this chapter: 
1. Blood flow rate is one of the most important variables in hemodialysis. Because of the large volume of blood in the body, the only way to sufficiently remove urea in a satisfactory time scale is to increase the blood flow rate. Unfortunately, a home-based system is limited to blood flow rates below 100 mL⁄min due to the types of blood ports that must be used in a non-clinical setting. Any system that is embodied must work around this limiting flow rate. 
2. Optimal dialysate flow rate is closely tied to the blood flow rate. At slower blood flow rates, the dialysate flow rate does not need to exceed about a one-to-one ratio. This actually works in the favor of a home hemodialysis system. At high blood flow rates, the best dialysate flow rate can be double the blood flow rate, vastly increasing the volume of dialysate needed. Since one of the goals of this chapter was to devise a system that uses less dialysate, having a system with a slower blood flow rate is advantageous. 
3. Peristaltic pump efficiency is terrible for pumps in the flow rate range needed for dialysis. For machines that are plugged into the wall, this is inconsequential. However, if a battery-powered system were developed, designing a pump that is more efficient would be 
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important. The effect of pump power on the system was not integrated into the Simulink model, but its importance is noted. 
4. The size of the dialyzer has a marginal impact on the clearance of urea during hemodialysis. 
Because the physical size of a large dialyzer (with a 𝐾𝐾0𝐴𝐴 of 1600 mL⁄min) is not limiting, at this point in the design process there is no reason not to use the largest available dialyzer. Portable systems that rely on slow blood flow rates need all the help in urea clearance available. 








MODEL VERIFICATION AND PROPOSED SCENARIOS 
5 Model Verification and Proposed Scenarios 
In Chapter 3, a concept was developed that could provide better hemodialysis for patients. A model was developed in Chapter 4 that can thoroughly test different arrangements of the concept developed in Chapter 3. 
Before concepts can be generated with the model, it must first be verified. Verification of the model is found in Section 5.1. After verification, Section 5.2 models very basic dialyzer configurations and tests different dialysate-reducing ideas (recirculation, regeneration, etc.). Finally, Section 5.3 uses information gathered in Section 5.2 to create reasonable system concepts. 
5.1 Validation of the hemodialysis system model This one-compartment model can be verified in two ways: comparing its results to published hemodialysis patient data, and against an in vitro laboratory setup involving hemodialysis components. 
5.1.1 Laboratory setup 
Porcine blood was obtained during desanguination at a local abattoir and heparin (APP 
Pharmaceuticals) was added to the blood immediately after collection at a dose of 3.5–7.0 USP⁄mL blood. The heparinized porcine blood was then transferred to the laboratory in a thermally insulated container and left to separate until the erythrocytes settled to the bottom and the plasma formed a distinct layer on the top. Dialysate was prepared by mixing concentrates with deionized water at a ratio of 1: 1.72: 42.28 (acid concentrate: bicarbonate concentrate: deionized water). 
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Two modes of dialysis were experimentally tested: 
1. passing only fresh dialysate through the dialyzer (“single-pass”), and 2. recirculating dialysate (“recirculation”).  
Recirculation uses less dialysate, but lessens the mass transfer rate from the blood due to a smaller concentration gradient. 
 
Figure 5-1. The laboratory setup. From left to right: the blood reservoir (1), the blood 
pump (2), the dialyzer (3), the dialysate pump (4), and the dialysate reservoir (5). 
The plasma and dialysate flowed through the circuit shown in Figure 5-1 at flow rates of 100 mL⁄min and 150 mL⁄min, respectively. For single-pass mode, the dialysate flowed out of the dialyzer into a waste container. A Polyflux dialyzer (Gambro) was used to perform the dialysis. 
Small volume samples (less than 1 mL) were removed from the blood reservoir during the experiments at specified time points and the blood urea nitrogen (BUN) was measured with an 
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Figure 5-2. The dialysate reservoir seen early in (left) and later in (right) dialysis 
when the dialysate is recirculated through the dialyzer. 
As dialysate is recirculated through the dialyzer, some of the plasma is transferred into the dialysate. This is not desirable – only the unwanted solutes are supposed to cross – and is due largely to a pressure gradient (TMP) across the membrane walls. In Figure 5-2, the dialysate 
reservoir is shown early (left) and late (right) in dialysis. At the start of the experiment, the dialysate was clear. 
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Figure 5-3. A close-up of the dialyzer after dialysis. Porcine blood has filled the baffle 
at the entrance of the dialyzer and the thousands of tubules that run the length of 
the dialyzer. Dialysate flows counter to the blood and exits in the tube on the right. 
Most dialyzers are designed for single-use. After dialysis, their narrow tubules are still filled with blood and much more likely to clot if used more than once. Figure 5-3 shows a dialyzer after dialysis. The area where the blood has pooled is a baffle that is designed to evenly distribute the blood to each of the thousands of tubules seen at the bottom of the picture. However, despite the baffle, blood flows most readily through the inner tubules and the least through the outer tubules. 
5.1.2 Validation via laboratory tests The results of the BUN versus time for the in vitro experiments had good results. Figure 5-4 (single-pass) and Figure 5-5 (recirculation) compare experimental results to the model. The model agrees well with the experimental data as can be seen in the figures. 
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It should be noted that there is some error associated with the iStat Analyzer. According to the manufacturer-provided specifications, measurements in the BUN ranges provided have a standard deviation of 0.76 mg⁄dL. 
 
Figure 5-4. Single-pass mode: 450 mL of porcine plasma through a (K0A = 
450 mL/min) dialyzer at 100 mL/min and dialysate flow rate of 150 mL/min. The light 
gray line is the model and the dark gray line is the experimental results. 
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Figure 5-5. Recirculation mode: 750 mL of porcine plasma through a dialyzer (K0A = 
450 mL/min) at 100 mL/min. A fixed volume of 500 mL of dialysate was recirculated 
through the dialyzer at 150 mL/min. The light gray line is the model and the dark 
gray line is the experiment results. 
5.1.3 Validation via published hemodialysis data Published data on the changing BUN of a dialysis patient is available in the work of Ziólko et al. 
(2000). In their study, a 23-year-old 58 kg male was dialyzed for 3.5 h. Figure 5-6 plots their results against the one-compartment model presented in this thesis. The discrepancy of the model in the 
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Figure 5-6. The one-compartment Matlab model (dashed line) compared to the 
published results (solid line) of Ziólko et al. (2000). 
Given the validity of the model, the next step is to design a feasible portable daily hemodialysis 
system. The great variance in patient variables (blood volume, urea generation rate, etc.) prevents one from proposing a single system configuration for all patients. 
5.2 Modeling basic hemodialysis scenarios The model created can now be used to model outcomes of various hemodialysis situations. 
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Table 5-1. The simulations in Section 5.1. 
Section Recirculation Urea Generation Figure 
5.2.1 No No Figure 5-7 
5.2.2 Yes No Figure 5-8 
5.2.3 No Yes Figure 5-10 
5.2.4 Yes Yes Figure 5-11  
5.2.1 Basic system with no recirculation or urea generation The first test to run on the model is the most basic configuration: blood and dialysate running counter current through a typical-size dialyzer until the urea has been cleared from the blood. The blood flow rate was arbitrarily set at 100 mL⁄min and the initial BUN was set at 500 mg⁄L 
(10.1743 mg of urea per mL of blood). Detailed test conditions are in Table 5-2. 
Table 5-2. Input parameters associated with Figure 5-7. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 500 mg⁄L 
Blood flow rate (𝑸𝑸𝑩𝑩) 100 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 1,200 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 1,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 0.000 mg⁄min 
 
Table 5-3. Output parameters associated with Figure 5-7. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 108 mL⁄min 
Clearance (𝑲𝑲) 95.11 mL⁄min 
Dialysate Volume (𝑽𝑽𝑫𝑫) 8,640 mL 
Dialysance (𝑫𝑫) 95.08 
Final BUN 0.1689 mg⁄L  The results from this simulation, graphed in Figure 5-7, were not surprising. The largest rate of urea clearance is experienced in the beginning of the experiment when there is the greatest 
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gradient between the blood and dialysate concentrations. While the dialysate concentration of urea remains 0 mg⁄mL throughout the simulation, as the blood is cleaned its concentration decreases. 
 
Figure 5-7. A simple dialyzer circuit without dialysis recirculation or urea generation. 
The predicted BUN drops below 1 mg/L after 63 minutes. See Table 5-2 for a detailed 
list of the parameter values. 
The dialysance (𝐷𝐷) of this experiment does not change (the model predicts a value of 95.08), even as the blood concentration decreases. Since dialysance is the ratio of the concentration change of the blood to the concentration gradient between the blood and dialysate, as the concentration gradient decreases, less urea will be removed from the blood. 
After 63 minutes, the BUN of the blood is predicted to drop below 1 mg⁄L, resulting in blood that is effectively free of urea. 
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5.2.2 Basic system with recirculation but no urea generation When the dialysate volume is capped and recirculated through the dialyzer, its increasing urea concentration becomes a concerning issue. As urea is transferred from the blood to the dialysate, the concentration gradient between the blood and dialysate decreases, reducing the driving force in membrane-based dialysis. 
When the same variables are run through the same model as in Section 5.2.1, but the dialysate volume is capped at 2.0 L, the effects of dialysate recirculation become clear. Figure 5-8 is the plot of this simulation, which shows the final BUN of the blood settling around 167 mg⁄L. Also plotted 
(as a dashed line) are the results of the exact same simulation without dialysate recirculation. Details of the simulation are in Table 5-4 and Table 5-5. 
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Verification of this simulation can be provided by assuming that after sufficient time the urea will be evenly distributed between the blood and dialysate volumes. Because the initial concentration of urea in the blood is 10.1743 mg⁄mL, and there is 1000 mL of blood, there is 10174.3 mg of urea initially in the blood. The total fluid volume in the simulation (dialysate volume and blood volume 
combined) is 3000 mL, so an even distribution of urea would result in a urea concentration of 3.5714 mg⁄mL, or a BUN reading of 166.6667 mg⁄L. This is exactly what the model predicts, with a BUN dropping below 167 mg⁄L after 44 minutes. 
Table 5-4. Input parameters associated with Figure 5-8. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 500 mg⁄L 
Blood flow rate (𝑸𝑸𝑩𝑩) 100 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 1,200 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 1,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 0.000 mg⁄min  
Table 5-5. Output parameters associated with Figure 5-8. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 108 mL⁄min 
Clearance (𝑲𝑲) 95.11 mL⁄min 
Dialysate Volume (𝑽𝑽𝑫𝑫) 2,000 mL 
Dialysance (𝑫𝑫) 95.08 
Final BUN 166.67 mg⁄L  This test also raises concern for the feasibility of dialysate reuse in a hemodialysis system. The alternative to recycling 2 L of dialysate through the dialyzer is to simply use 2 L of dialysate in single-pass mode, and stop dialysis once the dialysate runs out. This will always provide the dialyzer with the maximum concentration gradient, but it will not run as long. 
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When the exact same parameters are run through the model as listed in Table 5-4, but the dialysate is run in a single-pass mode and shut off after 19 minutes (using 2.052 L of dialysate, approximately 
the same volume used in the previous test), the blood reaches a significantly lower urea concentration (63.72 mg⁄dL) than when the dialysate is recirculated (166.67 mg⁄dL). The dark line in Figure 5-9 is 2.0 L run in single-pass mode, while the dotted line is 2.0 L continuously recirculated. 
In a human, there is constant urea generation (the impact of which is explored in the next section). If the dialyzer is shut off after 19 minutes, any urea that is generated is left in the blood if the dialyzer is shut off. 
 
Figure 5-9. Two liters of dialysate are used in single-pass for 19 minutes, and then 
the dialyzer is shut off. The dotted line is the same parameters, but the 2 L is allowed 
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5.2.3 Basic system with urea generation and no recirculation One would expect that the steady state value of a system with urea generation would be slightly higher than a system without it – eventually there will be a balance after the dialyzer has removed all residual urea from the blood. This is exactly the case, as shown in Figure 5-10. The darker line – the case with urea generation – always has a urea concentration slightly higher and settles on a higher final value. Detailed system parameters are listed in Table 5-6 and Table 5-7. 
 
Figure 5-10. A simple dialysis circuit with no dialysate recirculation, but a constant 
urea generation rate of 17.3611 mg/min. The dotted line is the expected 
performance when there is no urea generation. 
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inconsequential: its effects become very important in a daily or weekly model of urea removal 
(explored in Section 5.4). 
Table 5-6. Input parameters associated with Figure 5-10. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 500 mg⁄L 
Blood flow rate (𝑸𝑸𝑩𝑩) 100 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 1,200 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 1,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 17.3611 mg⁄min  
Table 5-7. Output parameters associated with Figure 5-10. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑭𝑭) 108 mL⁄min 
Clearance (𝑲𝑲) 95.11 mL⁄min 
Dialysate Volume (𝑽𝑽𝑫𝑫) 8,640 mL 
Dialysance (𝑫𝑫) 95.08 
Final BUN 8.69 mg⁄L  
5.2.4 Basic system with recirculation and urea generation The question arises over whether it is better to run the dialyzer in single pass mode for a shorter period, or use the same volume of dialysate and recirculate it for a longer period. 
The issue of urea generation becomes more important in this discussion. While it was shown in the scenario presented in Figure 5-9 that it was beneficial to run the dialyzer in single-pass mode, there was no urea generation in that simulation. Figure 5-11 is the same simulation run with a urea generation rate of 17.361 mg⁄min, corresponding to a healthy human’s generation rate of 25 g⁄day. 
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Figure 5-11. Comparing dialysate recirculation to single-pass. Both simulations used 
approximately the same volume of dialysate. 
Even with this relatively high urea generation rate (dialysis patients typically lower their urea 
generation rate through dietary changes), after 80 minutes the single-pass simulation still has a lower urea concentration (127.08 mg⁄dL) than the simulation with mixing (182.06 mg⁄dL). In this particular scenario, the single-pass was superior. However, it is conceivable that the recirculation model could provide better urea clearances under certain conditions – perhaps when the fixed volume of dialysate is higher or the urea generation rate is greater. 
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automatically which method is best for the given scenario, so each needs to be tested before drawing any conclusions. 
5.3 Steady state behavior and sample size Before hemodialysis scenarios are modeled, two additional behaviors of the model must be investigated. First, Section 5.3.1 explores the effect picking different initial BUNs has on the final outcome of the model. Then Section 5.3.2 examines the effect of different sample sizes in long-term hemodialysis modeling. 
5.3.1 Initial BUN selection and steady state behavior When a hemodialysis scenario is modeled, many different variables must be selected (see Section 4.7.1.1). While nearly all variables have an important impact on accurately modeling (such as the blood and dialysate flow rates), the initial BUN actually has no long-term impact on the results. 
Regardless of the initial BUN, the system will decay to a steady state. In Figure 5-12, three different hemodialysis scenarios are plotted, each corresponding to a different initial BUN. All other variables were kept identical to highlight the effect of different initial BUNs. 
Plots are provided corresponding to initial BUNs of 70 mg⁄dL, 30 mg⁄dL, and 10 mg⁄dL. Each plot decays to a steady state daily cycling between 21 mg⁄dL and 3 mg⁄dL. 
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Figure 5-12. Regardless of the initial BUN, after several days the daily BUN cycle is 
the same. The only difference between the plots is the initial BUN – every other 
parameter (K0A, QB, QD, etc.) is the same. 


















Time (hours)Initial BUN = 10 mg/dL Initial BUN = 30 mg/dL Initial BUN = 70 mg/dL
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Figure 5-13. When the peaks of the simulation corresponding to an initial BUN of 
70 mg/dL are connected (dashed line) an exponential curve is formed. 
To completely examine the effect of different initial BUNs, the daily maximums from all three different initial BUN plots are plotted in Figure 5-14. Exponential curves (listed in Table 5-8) are 
fitted to each plot. 
Table 5-8. The curve fit equations for the plots in Figure 5-14. 
Curve Fit Equation Initial BUN 
ݕ = 21.185 + 48.815݁ି଴.଴଺଼ସ଴ଽ௫  70 mg⁄dL 
ݕ = 21.183 + 8.817݁ି଴.଴଺଼ସ଴ଽ௫  30 mg⁄dL 
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Interestingly, the time constant for each curve is the same (𝜏𝜏 = 1⁄−0.068409 = −14.618). That means that for each set of hemodialysis conditions (𝑄𝑄𝐵𝐵 , 𝑄𝑄𝐷𝐷 , 𝐾𝐾0𝐴𝐴, etc.) there exists a fixed time constant that dictates how quickly the patient’s BUN cycle will reach a steady state condition. 
 
Figure 5-14. The daily peaks of each plot in Figure 5-12 are plotted. A simple 
exponential curve accurately describes how each plot decays to the same steady 
state conditions. 



















Initial BUN = 10 mg/dL Initial BUN = 30 mg/dL Initial BUN = 70 mg/dL
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When devising hemodialysis configurations, one can select an initial BUN that corresponds to the steady state daily maximum – even if a different value is selected, the system will decay to it anyway. In each of the simulations presented in this thesis, different initial BUNs were tested to determine the steady state value. Each simulation is plotted with an initial BUN that roughly corresponds to the steady state value. 
5.3.2 Examining the effects of sample size in the model By default, the model samples and recalculates the urea concentration of the blood in one-minute intervals. However, this sample size could be too large for long-term predictions (simulating one 
week of dialysis would require over 10,000 samples). To test the model flexibility to other sample sizes, identical hemodialysis conditions were plotted (corresponding to the published data of Ziólko et al. (2000), Figure 5-6) at six-second, one-minute, and ten-minute intervals in Figure 5-15. 
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Figure 5-15. The published hemodialysis input data (Figure 5-6) is modeled at three 
different time intervals: 1 min, 10 min, and 0.1 min. 
The discrepancy between the three plots is smaller than errors than can be expected from patient variablilty and other assumptions. The six-second interval predicted a final BUN of 35.360 mg⁄dL 
(1.04 mg⁄dL difference from experimental results), the one-minute interval predicted 34.869 mg⁄dL (1.531 mg⁄dL difference), and the ten-minute interval predicted 34.234 mg⁄dL 
(2.166 mg⁄dL difference). 

















Time (minutes)1 min 10 min 0.1 min
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Figure 5-16. Two different sampling sizes are plotted. The 10-minute interval line 
(grey, long dashes) is able to predict the final BUN calculated equally as accurate as 
when using 1-minute intervals. 
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  128  
 
Figure 5-17. The discrepancy between the two plots of Figure 5-16 are plotted. As 
time increases, the difference between the two plots decreases. 
In this thesis, one-minute intervals are used unless otherwise noted. 
5.4 Modeling hemodialysis The next step in the development of the model is to recreate human physiology, instead of a lab setup. The important difference between these two settings is that when selecting parameters for human hemodialysis, daily or weekly cycles must be taken into account. 
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Table 5-9. The scenarios modeled in this section. 
 Section Recirculation Regeneration Figure(s) 
Clinical 
Hemodialysis 
5.4.1 No Yes Figure 5-18 
Home 
Hemodialysis 









5.4.4 No Yes Figure 5-23 Figure 5-24  
5.4.1 Recreating a typical clinical hemodialysis scenario The first test of this model is to recreate traditional clinical hemodialysis. Figure 5-18 is the results from the model when parameters commonly associated with traditional dialysis are used. The blood flow rate was kept high at 300 mL⁄min (resulting in a trade-off dialysate flow rate of 442 mL⁄min), and 2-hour treatments every other day. Table 5-10 and Table 5-11 list the inputs and outputs of this simulation. 
The various inputs of this model are selected to be as typical as possible. The dialyzer was chosen to 
be large (𝐾𝐾0𝐴𝐴 = 1600 mL⁄min), because clinics are free to use the largest dialyzer available to them. Additionally, the model predicts no negative impact from choosing the largest possible dialyzer 
(Figure 4-9). The blood flow rate was set at 300 mL⁄min (Ward & Leypoldt, 2001), although higher flow rates are very common (Berkoben & Schwab, 2003) and the urea generation rate was set to 12.5 g⁄day – half the rate of a healthy human (Moffett, Moffett, & Schauf, 1993), to account for dietary changes patients commit to. There is not a standard treatment schedule for dialysis patients, but three times a week is often cited (Piccoli, et al., 2000) (Kjellstrand & Ing, 1998) 
(Daugirdas, 1993). 
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Determining the total fluid volume of a patient is complicated, and many different formulae are employed (Ziólko, Pietrzyk, & Grabska-Chriząstowska, 2000). The simplest (and most commonly 
used model) simply considers the patient’s gender and dry weight, as shown in Equation 5-1. 
 𝑉𝑉𝑟𝑟𝑡𝑡𝑡𝑡𝑒𝑒 = 0.58 × 𝐷𝐷𝐷𝐷              𝑉𝑉𝑓𝑓𝑒𝑒𝑟𝑟𝑡𝑡𝑡𝑡𝑒𝑒 = 0.55 × 𝐷𝐷𝐷𝐷 (5-1) 
In the following simulations, a fluid volume of 32,000 mL was chosen because it is the same value as the patient used in the verification of the model in Section 5.1. 
 
Figure 5-18. The model predicting the results of traditional hemodialysis. The patient 
is dialyzed every other day for two hours. 
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they are dialyzed for another two hours. This repeats every other day, and the patient’s BUN never surpasses 53 mg⁄dL. 
Table 5-10. Input parameters used for simulation in Figure 5-18. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 55 mg⁄dL 
Blood flow rate (𝑸𝑸𝑩𝑩) 300 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 1,600 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 32,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 8.681 mg⁄min 
Treatment length (𝒕𝒕𝟏𝟏) 2 hours 
Time between treatment (𝒕𝒕𝟐𝟐) 46 hours 
Simulation sample interval 10 minutes  
Table 5-11. Output parameters of simulation in Figure 5-18. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 442 mL⁄min 
Clearance (𝑲𝑲) 280.25  mL⁄min 
Dialysate Volume (𝑽𝑽𝑫𝑫) 53,040 mL per dose 
Dialysance (𝑫𝑫) 280.21 mL⁄min  
5.4.2  A daily hemodialysis schedule without recirculation If patients dialyze at home, some of the parameters need to be adjusted. If blood is drawn from the venous side of the circulatory system, the blood flow rate is limited to below 100 mL⁄min 
(compared to over 300 mL⁄min for clinical dialysis). This reduces the rate at which urea can be cleared from the blood and lengthens the treatment, but it is a safe flow rate that can be expected at home. 
Detailed inputs and outputs of this simulation are listed in Table 5-12 and Table 5-13. 
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Table 5-12. Input parameters associated with Figure 5-19. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 45 mg⁄dL 
Blood flow rate (𝑸𝑸𝑩𝑩) 100 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 1,600 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 32,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 8.681 mg⁄min 
Residual kidney function 0.000% 
Treatment length (𝒕𝒕𝟏𝟏) 3 hours 
Time between treatments (𝒕𝒕𝟐𝟐) 21 hours  
Table 5-13. Output parameters associated with Figure 5-19. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 103 mL⁄min 
Clearance (𝑲𝑲) 95.36 mL⁄min 
Dialysate Volume (𝑽𝑽𝑫𝑫) 25,720 mL 
Dialysance (𝑫𝑫) 95.32 mL⁄min  Because of the slower blood flow rate the treatment time is increased to three hours to adequately dialyze the patient, as shown in Figure 5-19. After three hours of treatment, the BUN drops just below 28 mg⁄dL, and then rises throughout the day to a peak of around 44 mg⁄dL. This simulation assumes that the patient is generating 12.5 g of urea per day, which might lie at the high end of estimations. Most dialysis patients can reduce their urea generation rate significantly through dietary changes, which would allow for shorter or less frequent dialysis treatment lengths. 
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Figure 5-19. A daily hemodialysis schedule with a limited blood flow rate. 
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Figure 5-20. A daily home hemodialysis schedule with a reduced urea generation 
rate of 6.25 g/day. The dotted line is 12.5 g/day urea generation rate. 
The next section will examine a daily treatment with dialysate recirculation. 
5.4.3 A daily hemodialysis schedule with recirculation The idea behind dialysate recirculation is that a reduced volume of dialysate can be used to remove 

















Time (hours)Half Urea Generation Full Urea Generation
  135  
Table 5-14. Input parameters associated with Figure 5-21. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 76 mg⁄dL 
Blood flow rate (𝑸𝑸𝑩𝑩) 100 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 1,600 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 32,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 8.681 mg⁄min 
Treatment length (𝒕𝒕𝟏𝟏) 3 hours 
Time between treatments (𝒕𝒕𝟐𝟐) 21 hours  
Table 5-15. Output parameters associated with Figure 5-21. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 103 mL⁄min 
Clearance (𝑲𝑲) 95.36 mL⁄min 
Dialysate volume (𝑽𝑽𝑫𝑫) 1,200  mL per dose 
Dialysance (𝑫𝑫) 95.32 mL⁄min  In Figure 5-21, two dialysis scenarios are simulated (inputs and outputs in Table 5-14 and Table 5-15). The darker line is dialysis when 12 L of dialysate are recirculated perfectly during the 3-hour dose; the dashed line is 3 hours of dialysis without recirculation (more than 12 L was used). 
The difference between the two plots is considerable – the recirculated dialysate scenario never falls below a BUN of about 60 mg⁄mL despite a lengthy 3-hour dose. While the exact ramifications of such an elevated BUN cannot be determined from this simulation, the single-pass plot provides BUN levels that are far lower than with recirculation. 
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Figure 5-21. Daily hemodialysis with a fixed amount (12 L) of dialysate recirculating 
per treatment. The dotted line is the same simulation without recirculation (which 
uses more than 12 L of dialysate, but equal treatment time). 
The poor performance of dialysate recirculation, in conjunction with the results of Figure 5-11 
(which compared dialysate recirculation to a reduced dialysate dose), seems to indicate that dialysate recirculation is an ineffective way to reduce the dialysate volume. 
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Figure 5-22. A fixed volume of dialysate (12.36 L) is run in single-pass mode (light 
line) and recirculation mode (dark line). The treatment time for the single-pass 
simulation was shorter (2 h vs. 3 h) 
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Table 5-16. Input parameters associated with Figure 5-22. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 75 mg⁄L, 60 mg⁄L (single-pass) 
Blood flow rate (𝑸𝑸𝑩𝑩) 100 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 1,600 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑫𝑫) 32,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 8.681 mg⁄min 
Treatment length (𝒕𝒕𝟏𝟏) 3  hours, 2 hours (single-pass) 
Time between treatments (𝒕𝒕𝟐𝟐) 21 hours, 22 hours (single-pass)  
Table 5-17. Output parameters associated with Figure 5-22. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 103 mL⁄min 
Clearance (𝑲𝑲) 95.36 mL⁄min 
Dialysate volume (𝑽𝑽𝑫𝑫) 12,360 mL per dose 
Dialysance (𝑫𝑫) 95.32 mL⁄min  
5.4.4 Recommended system configurations Considering the results of the previous simulations, some final system configurations can be made. Because of the great variety of patient conditions – size, residual renal function, acceptable BUN ranges, etc. – not every possible concept can be presented. Fortunately, the model created in Chapter 4 can easily be reprogrammed to investigate a specific case not presented in this thesis. 
Three cases are developed: a best-case scenario, in which every parameter is chosen to favor a portable hemodialysis system; a realistic-case scenario, in which every parameter is chosen in line with expected patient variables, and a worst-case scenario. 
For example, in the best-case scenario, the largest dialyzer and blood flow rate are chosen, while the smallest urea generation rate and blood volume are selected as well (Table 5-18). In the worst-
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case scenario, the opposite values are picked (Table 5-20). The results of these two cases are shown in Figure 5-23 and Figure 5-24. 
It can be difficult to compare competing designs because they may have different treatment lengths or time between treatments. An example of this is Figure 5-20: a precursory examination might lead one to think that the dashed gray line is a superior treatment regimen because it corresponds to a lower average patient BUN throughout the week. 
However, a strong argument can be made for the solid dark gray line. Its treatment time is only 70 minutes – compared to 180 minutes for the dash gray line. In the case of Figure 5-20, the only difference between each simulation’s initial conditions was the urea generation rate (?̇?𝐺). Because of the reduced urea generation rate, a shorter treatment time was possible. 
Such tradeoffs must be made when suggesting treatment regimens. In the graphs that follow, two very reasonable options might be available – a higher average BUN with shorter treatment time, or a lower average BUN with longer treatment times. It is impossible to quantify these choices into any sort of model since preference will vary from patient to patient. To that end, such choices were made in the development of each simulation and are not easily visible to the reader. 
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Figure 5-23. The best-case scenario. 
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Figure 5-24. A realistic scenario. 
In a more realistic case (Figure 5-24), the treatment time was 2 hours every day, and used 11 L of dialysate per dose. This simulation used much more practical variables – including disregarding any residual kidney function and ultrafiltration, both of which would provide increased clearances. The simulated patient weighed 63 kg. 
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Table 5-18. Input parameters for a best-case scenario. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 70 mg⁄dL 
Blood flow rate (𝑸𝑸𝑩𝑩) 100 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 1,600 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 28,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 4.3403 mg⁄min 
Treatment length (𝒕𝒕𝟏𝟏) 1.5 hours 
Time between treatments (𝒕𝒕𝟐𝟐) 46.5 hours 
Residual kidney function (𝑮𝑮𝑭𝑭𝑮𝑮%) 15.000%  
Table 5-19. Output parameters for a best-case scenario. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 103 mL⁄min 
Clearance (𝑲𝑲) 95.36 mL⁄min 
Dialysate volume (𝑽𝑽𝑫𝑫) 9,270 mL per dose 
Dialysance (𝑫𝑫) 95.32 mL⁄min  
Table 5-20. Input parameters for a realistic scenario. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 72 mg⁄L 
Blood flow rate (𝑸𝑸𝑩𝑩) 80 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 800 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 38,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 8.68056 mg⁄min 
Treatment length (𝒕𝒕𝟏𝟏) 2 hours 
Time between treatments (𝒕𝒕𝟐𝟐) 22 hours 
Residual kidney function (𝑮𝑮𝑭𝑭𝑮𝑮%) 0.000%  
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Table 5-21. Output parameters for a realistic scenario. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 91 mL⁄min 
Clearance (𝑲𝑲) 76.1 mL⁄min 
Dialysate volume (𝑽𝑽𝑫𝑫) 10,920 mL per dose 
Dialysance (𝑫𝑫) 76.09 ml⁄min  Finally, a worst-case scenario can be examined. In this case, the smallest dialyzer (𝐾𝐾0𝐴𝐴 = 800 mL⁄min), the lowest blood flow rate (𝑄𝑄𝐵𝐵  = 80 mL⁄min), a large patient (𝑉𝑉𝐵𝐵  = 53 L corresponding to a body weight of 91 kg or 200 lbs), and the trade-off dialysate flow rate (𝑄𝑄𝐷𝐷  = 91 mL⁄min) is selected. 
With these inputs, a daily hemodialysis system is still possible. By increasing the range of BUN values to 80–90 mg⁄dL, a daily treatment length of 90 minutes (using 8.19 L of dialysate per dose) is possible, as shown in Figure 5-25. 
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Figure 5-25. The worst-case scenario. 
The inputs and outputs of Figure 5-25 are listed in Table 5-22 and Table 5-23, respectively. 
Table 5-22. Input parameters for a worst-case scenario. 
Parameter Value 
Initial BUN (𝑪𝑪𝑩𝑩𝑩𝑩) 91 mg⁄L 
Blood flow rate (𝑸𝑸𝑩𝑩) 80 mL⁄min 
𝑲𝑲𝟎𝟎𝑨𝑨 800 mL⁄min 
Trade-off coefficient (𝜶𝜶) 0.95 
Blood volume (𝑽𝑽𝑩𝑩) 53,000 mL 
Ultrafiltration flow rate (𝑸𝑸𝑭𝑭) 0.000 mL⁄min 
Urea generation rate (?̇?𝑮) 8.68056 mg⁄min 
Treatment length (𝒕𝒕𝟏𝟏) 1.5 hours 
Time between treatments (𝒕𝒕𝟐𝟐) 22.5 hours 
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Table 5-23. Output parameters for a worst-case scenario. 
Parameter Value 
Dialysate flow rate (𝑸𝑸𝑫𝑫) 91 mL⁄min 
Clearance (𝑲𝑲) 76.1 mL⁄min 
Dialysate volume (𝑽𝑽𝑫𝑫) 8,190 mL per dose 
Dialysance (𝑫𝑫) 76.09 ml⁄min 
5.5 Conclusion 
This chapter sought to provide relevant product concepts (Section 5.4) following verification of the 
model (Section 5.1) and investigation of model behavior (Sections 5.2 and 5.3). 
The model provided results as accurate as other published models (Ziólko, Pietrzyk, & Grabska-
Chriząstowska, 2000) when using actual hemodialysis data. The in vitro experiments also provided results that were predicted by the model. 
The exploration of steady state behavior and the discovery of a unique time constant associated 
with each set of dialysis inputs could provide, with some future work (Section 6.4), new ways for patients to choose their treatment schedule. 
The research question this chapter focused on was: 
Is a portable hemodialysis system possible? What are the detailed system 
configurations that are possible? 
With such a large variety of dialysis patients in the world, it is impossible to conclude this chapter with one definitive system configuration. However, the examples presented at the end of this chapter (Section 5.4) show that patient BUN levels can be maintained within acceptable ranges while only using as little as 9 L of dialysate per dose. Because the dialysate volume is the heaviest 
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component – and therefore the largest barrier to the development of a portable system – a possible system that only uses 9 L makes a strong case to pursue the development of a portable system. 
However, this model makes several assumptions (Section 4.7.3), and additional assumptions in the application of the model that have not been discussed. Specifically, this model only predicts the daily change of the patient’s urea levels, and disregards all other solutes of interest. This was done for two reasons: first, urea is the solute primarily targeted by dialysis; and second, the model’s prediction of different solutes relies on publication of dialyzer 𝐾𝐾0𝐴𝐴 specifications for additional solutes. Nearly all dialyzer manufacturers publish 𝐾𝐾0𝐴𝐴 only for urea, limiting the application of this model to other solutes. If more detailed dialyzer specifications were available, other solutes could be modeled. 
While basic parameters of a portable hemodialysis concept have been established, many more factors would need to be considered in order to develop a prototype. Because it relies on tradional, dialyzer-based dialysis, 40 years of experience could be leveraged to address biocompatibility, safety, legal, and manufacturing issues that would undoubtedly be raised.  





CLOSURE AND CONTRIBUTIONS 
6 Closure and Contributions 
The broad goal of this thesis was to develop a superior renal replacement therapy using systematic engineering principles. Chapter 3 provided a thorough functional analysis of the human kidney and current hemodialysis; both of which led to an RRT concept. Chapter 4 developed a system model that was used in Chapter 5 to create system concepts. 
In Chapter 1, three research questions were posed as the framework of this thesis. A hypothesis was provided with each research question. In Section 6.1, each hypothesis will be addressed in the context of the work completed in this thesis. 
6.1 Answering the research questions The purpose of this research was to determine the possibility of developing an alternative to 
traditional renal replacement therapies (dialysis), and to explore how traditional dialysis could be modified to make it more portable. 
This research was divided into three research questions, which are now tested. 
6.1.1 Research question one The first research question was addressed in Chapter 3. 
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Research Question 1:  
Can a renal replacement therapy be developed that provides an alternative filtration 
method while matching or exceeding current hemodialysis performance? 
Hypothesis 1:  
A renal replacement system that more closely mimics the behavior of a human kidney 
can provide a more effective treatment. 
In Chapter 3, an alternative to traditional hemodialysis was developed by reverse engineering the human kidney. It was discovered there was a striking functional difference between the human kidney and hemodialysis: the human kidney filters nearly everything out of the blood and then reabsorbs only the needed solutes, while hemodialysis attempts to remove only the bad solutes from the blood in one pass. 
The kidney uses two passes to clean the blood – a large filtering stage, and then a reabsorption stage. This idea was the foundation of the bio-artificial concept developed in Chapter 3. The concept separates out the plasma, filters the desirable solutes through electrophoresis, and then returns the 
desirable solutes and other additives (water, sodium, etc.) to the plasma filtrate. The filtrate is then returned to the patient. 
The limitations of current hemodialysis are well understood – its use for the last forty years has led to research that has exploited all its potential. The goal of this research question was to determine whether developing an alternative RRT was possible given today’s technology. 
To that end, this thesis addressed the first research question. The key was to show that the approach to designing a renal replacement system had to be changed. By mimicking the kidney’s functionality, an exacting filter (the largest hurdle towards an improved RRT and something that 
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researchers have been unable to develop) is no longer needed. The challenge with the proposed bio-inspired concept is not how to best remove solutes from the blood, but how to best add them in – a fundamental difference. 
However, without actually constructing such a system, no definitive answer can be provided for the first research question. At this point, enough is known to to claim that traditional concentration-based dialysis is unlikely to see any major performance improvements – its long-time use has fleshed out seemingly all possible advances. A behaviorally-novel method is needed to gain significant increases in performance. 
6.1.2 Research question two The second research question was addressed in Chapter 4. 
Research Question 2:  
Can a detailed hemodialysis system model be created that accurately takes into 
account different patient and dialysis variables? 
Hypothesis 2:  
By improving upon the work of Sargent & Gotch (1989), a detailed computer model 
can be created that offers optimization of the fundamental dialysis equations and 
considers patient variables. 
Following the dialyzer physics detailed by Sargent & Gotch (1989), a detailed system model was created in Chapter 4. The model was further augmented with considerations for dialysate recirculation, dialysate regeneration, treatment schedules, ultrafiltration, trade-off considerations, and urea generation. 
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These additional inputs and considerations are necessary because the model is used to design a system under very strict design constraints. Because a portable system can only provide minimal clearances, considering the body’s residual kidney function and other attributes is essential. A key difference between the model created in this thesis and published models is the context in which they were created – specifically, most models are created to simulate current hemodialysis practice. The model in this work is unique because it was created to explore all possibilities for hemodialysis system design. 
6.1.3 Research question three The third research question was addressed in Chapter 5. 
Research Question 3:  
Is a portable hemodialysis system possible? What are the detailed system 
configurations that are possible? 
Hypothesis 3:  
By exploring the physics that govern hemodialysis, portable system configurations can 
be developed that meet the needs of chronic renal failure patients. 
The augmentations of the model and the flexibility of Matlab Simulink allowed for a detailed exploration of hemodialysis concepts in Chapter 5. The primary limitation of a portable system is its weight; the concepts created all were designed with the goal of minimizing the total dialysate volume. 
The model was explored and the inputs were set knowingly to produce concepts that would have the smallest possible dialysate volume through trial and error. The concepts created used about 
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10 L of dialysate per treatment, a reasonable amount, although the definition of portable is subjective. 
Tricks could be deployed to reduce the 10 L figure; if treatment lasts 90 minutes, then dialysate weight could be viewed as 3 L per half hour – the patient could cycle dialysate volumes every half hour during treatment. While not everyone might agree that 10 L of dialysate is portable, most would probably concur that a 3 L system was. 
In the end, the ultimate solution to the portability problem lies in regenerating dialysate, as has been employed by other research groups. A dialysate regeneration system is not commercially available and would require significant additional research to achieve. Its development is further described in Section 6.4 as future work. 
6.2 Contributions Hemodialysis has existed in relatively the same form for the last fifty years. One of the overall goals of this thesis was to examine a novel way to re-imagine renal replacement therapies. In that scope, several contributions have been made. 
6.2.1 A functional analysis of kidney behavior and a related renal replacement therapy concept The functional analysis of the human renal system in Chapter 3 provides a unique look at how the kidney functions, combining commonly available medical information into a single functional model. The kidney’s method of filtering wastes is contrasted against the methods employed by artificial renal systems – highlighting how substantially different each system functions. 
In an attempt to create a superior alternative renal replacement therapy, the kidney’s functional behavior is mimicked in a novel renal replacement system. The proposed bio-inspired concept 
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provides a therapy that is functionally similar to the human renal system, and as a result, might provide superior treatment. 
Today’s treatments are insufficient because they require exact filtering. By mimicking the kidney, a concept is developed that does not require exacting one-stage filtering, but instead requires a multistage solute-replacement stage. While the proposed system is designed with a yet-to-be 
developed technology (electrophoresis has not been successfully implemented in this fashion, but it 
is feasible), which limited the development of that concept in this thesis, the option is left to future research. 
6.2.2 A thorough one-compartment model of hemodialysis Many one-compartment models of hemodialysis have been developed (Ziólko, Pietrzyk, & Grabska-
Chriząstowska, 2000). The model presented in this thesis provides several novel additions to traditional one-compartment models. 
Models available in published literature do not account for urea generation, dialysate recirculation, automatic determination of dialysate flow rate (based upon input blood flow rate and dialyzer 
properties), residual kidney function, and extended use (longer than one session). These features were included in the model presented in Chapter 4. With the addition of these features, and the power of Simulink, the robust hemodialysis concepts presented in Chapter 5 were possible. 
It was necessary to extend the work of previous models to develop a portable hemodialysis system. The design of a portable hemodialysis system has such stringent constraints on it that it is necessary to consider every possible source of urea generation and depletion in order to create feasible design concepts. 
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For example, patients with 15% residual kidney function may be on dialysis, but previous models did not account for their [limited] natural ability to clear urea. This can add up to several grams of urea cleared per day, which in turn has a direct impact on the treatment lengths and dialysis schedule. 
The model’s unique determination of the dialysate flow rate is very important, too. Traditional dialysis wisdom says that the dialysate flow rate should be twice the blood flow rate (Ward & Leypoldt, 2001). However, at the blood flow rates encountered in a portable system this rule breaks down – in fact, at low blood flow rates the dialysate flow rate should roughly match the blood flow rate. Having a higher dialysate flow rate does not have a negative impact, but there is a trade-off that is needed. The model automatically attempts to find a dialysate flow rate that balances clearance and total dialysate volume needed for treatment. 
Consideration of dialysate recirculation is also unique among models in published literature. 
Dialysate recirculation is an easy way to reduce the total weight of the system (by reducing the 
overall dialysate volume), but the results of such theoretical investigations did not gather promising results. In fact, it was shown in Chapter 5 that given a fixed reduced volume of dialysate, it is best to just run the dialysate in single-pass mode at the ideal flow rate, rather than let the dialysate dwell in recirculation mode for any time length. 
6.2.3 Relating a time constant to a given set of hemodialysis inputs One of the more interesting results of the examination of steady state behavior of dialysis (Section 5.3) was the relation of a time constant to a given set of hemodialysis inputs. Basically, this thesis revealed that all of the hemodialysis inputs – flow rates, dialyzer properties, patient urea generation, etc. – can be lumped into two variables: a time constant, 𝜏𝜏, and the initial BUN (𝐶𝐶𝐵𝐵𝐵𝐵 ), as shown in Equation 6-1. 
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Υ(𝜏𝜏,𝐶𝐶𝐵𝐵𝐵𝐵 ) = 𝑓𝑓(𝐶𝐶𝐷𝐷𝐵𝐵 ,𝐾𝐾0𝐴𝐴,𝑄𝑄𝐵𝐵 ,𝑄𝑄𝐷𝐷 , ?̇?𝐺,𝐺𝐺𝐺𝐺𝑅𝑅%,𝑉𝑉𝐷𝐷 ,𝑉𝑉𝐵𝐵 , 𝑡𝑡1, 𝑡𝑡2) (6-1) Because a unique time constant has been identified that lumps together all the input parameters associated with hemodialysis, patients and could have a much easier time relating all the variables, making the choice of a proper therapy (dose length and schedule) much easier. The time constants in this thesis were determined by manual inspection of output plots of the model. A simple method to reduce all the input variables into one time constant is not examined in this thesis and is left as future work. 
6.2.4 Feasible concepts of a portable hemodialysis system The model exploration in Chapter 5 yielded many feasible concepts for a portable hemodialysis system. If someone were to continue the work of this thesis, these concepts would be the natural starting point. 
Because of the model’s comprehensiveness, these concepts have a strong value toward the embodiment design of a hemodialysis system. Most importantly, this thesis has shown that portable hemodialysis concepts are possible without large changes in technology. 
6.3 Scope and limitations of this research Two major limitations exist in this thesis. In Chapter 3, the bio-inspired concept that was generated was never experimentally tested, so its full benefits and limitations are not fully known. 
The model created in Chapter 4 is a one-compartment model; two compartment models more accurately predict post-dialysis BUN but provide equally-accurate results for long term (several 
days) hemodialysis modeling (Ziólko, Pietrzyk, & Grabska-Chriząstowska, 2000). 
  155  
Finally, the most important limitation of this work is the patient variation that is impossible to account for when developing concepts in Chapter 5 from the model created in Chapter 4. The most obvious limitation is the range of patient sizes and their total blood volume, which has a significant effect on each dose length. To account for this variation, different scenarios were tested at the end of Chapter 5 that dealt with a range of patient sizes, although it is clear that there is no “one size fits all” concept for hemodialysis. 
More challenging, however, was determining the acceptable amount of urea to maintain in patients when modeling potential concepts. Unlike weight variations, of which there is considerable published data, determining values for acceptable BUN ranges is much less precise. Healthy humans have BUN levels in the 7–12 mg⁄dL range, but hemodialysis patients can run their BUN up to 1000 mg⁄dL between doses. 
Choosing an acceptable BUN range for a portable hemodialysis concept was not easy. Patients with high BUN levels experience symptoms of fatigue and poor fortitude, but how poorly they feel at particle BUN levels varies from patient to patient and is not readily available in published data. Furthermore, choosing the range has a significant impact on the dose length and other hemodialysis inputs. 
To that end, BUN ranges were kept as low as possible without sacrificing portability – generally in the 70–100 mg⁄dL range. 
6.4 Future work The following directions for future work have been identified. 
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6.4.1 Dialysate regeneration A dialysate regeneration system is necessary for a most portable hemodialysis system. The concepts developed in this thesis do not rely on a dialysate regeneration system; with one, the overall system weight could be significantly reduced. 
Dialysate regeneration would require dialysate to pass through a filtering system after leaving the dialyzer. The complications from cleaning used dialysate arise from urea’s inability to be absorbed by activated carbon. While nearly all other solutes can be cleaned from dialysate with activated carbon, urea must first be converted to urease via a chemical reaction, and then absorbed with charcoal. 
Only one company has developed a dialysate cleaning system, and it is not commercially available. It would be possible to develop a proprietary dialysate cleaning system to reduce the dialysate required per treatment significantly. 
6.4.2 System optimization and sensitivity analysis The inputs of the simulations performed in this thesis were selected with designer intuition. However, a thorough study could be performed that detailed the exact relationship between all the different variables in a hemodialysis system – the focus in this thesis was primarily on the relationship between the blood and dialysate flow rates. 
The model could be reconfigured in reverse: the designer would specify his or her desired output system parameters, and the model would select the best inputs to meet those needs.   
6.4.3 Improved pump design In Chapter 4, the efficiencies of pumps currently available for hemodialysis machines were examined. Their efficiencies were found to be below 0.5%. This was a surprising result; it is 
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surmised that minimal investigation and design work could create a pump that doubled or tripled the currently available efficiency. 
A graduate student in this laboratory has already begun the work to design a more efficient pump for hemodialysis, based upon the deficiencies outlined in this thesis. 
6.4.4 Dialyzer-free dialysis The ultimate “future work” to note is the development of a renal replacement system that does not rely on a dialyzer. While it should not be the goal to blindly reject membrane dialysis, research seems to indicate that to significantly improve the clearance of solutes from patients with ESRD, an alternative renal replacement therapy must be created. 











Bowman's capsule The part of the nephron surrounding the glomerulus. 
brake power The power required to operate a pump. Different from fluid power, which is the power associated with the moving fluid. 
CAPD Continuous Ambulatory Peritoneal Dialysis. Peritoneal dialysis where the dialysate fluid is injected into the abdomen, and then drained several hours later. 
CCPD Continuous Cycling Peritoneal Dialysis. Peritoneal dialysis where the dialysate fluid is continuously cycled through the abdomen. 
centrifugal pump A pump that relies on an impeller inside the fluid to provide a pressure rise. 
collecting ducts Ducts that form the final stage of the nephron; they exit to the ureter. 
convection The movement of particles across a membrane due to pressure gradients. 
diabetes A disease in which the pancreas stops producing insulin, causing high blood glucose levels. Often leads to renal disease. 
dialysance The magnitude of flux out of the blood to be expected per unit of concentration driving force between the blood and dialysate in the dialyzer. 
dialysate The solution that runs on the opposite side of membrane during dialysis. Solutes in the blood pass through the membrane and into the dialysate due to a concentration gradient. 
distal tubule The part of the nephron between the loop of Henle and the collecting ducts. 
electrophoresis The separation of particles based upon their electrical charge. As a 
fluid flows between two oppositely charged plates, the particles in the 
fluid stream migrate depending on their charge. 
endocrine Glands that secrete hormones into the blood. 
fluid power The power of the fluid leaving a pump. 
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glomerulus The small tuft of blood capillaries that are surrounded by the Bowman’s capsule. Blood flows from the capillaries to the Bowman’s capsule. With the Bowman’s capsule they form the renal corpuscle. 
glomular filtration rate The rate at which blood is filtered across the glamorous. A typical value for a healthy adult is 125 mL⁄min. 
glucose degradation 
products 
Solutes in peritoneal dialysis fluid that degrade the body’s peritoneum. After several years of exposure to GDPs, peritoneal dialysis patients are often forced to switch to traditional hemodialysis. 
hemodiafiltration A renal replacement therapy that combines hemodialysis and hemofiltration. 
hemofiltration A renal replacement therapy that uses convection as waste removal process. Often used in intensive care settings due to the high water-loss associated with it. 
heparin A common blood anticoagulant often used during hemodialysis. 
hirudin An anticoagulant used before the advent of heparin in the 1940s. 
hollow fiber dialyzer Today’s most common type of dialyzer. Thousands of small tubules carry blood through a counter flow of dialysate. 
homeostasis A balanced state of being: proper regulation of solutes and processes in the body. 
loop of Henle The section of the nephron between proximal and distal tubules. 
Matlab Computing software used to solve mathematical problems. 
MEMS Micro ElectroMechanical Systems are very small devices, with parts on the scale of micrometers. 
nephon The basic functional unit of the kidney. Each nephron is composed of a renal corpuscle, Bowman’s capsule, proximal tubule, distal tubule, and collecting ducts. 
nephrectomised The state of having one’s kidneys removed. 
peritoneal dialysis Dialysis that relies on the body’s peritoneum as a membrane. Dialysate 
fluid is pumped in and out the abdomen. 
peritoneum The membrane that forms the lining of the abdomen. Used in peritoneal dialysis as the barrier between the blood and dialysate. 
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persitaltic pump A type of positive displacement pump that is used during hemodialysis. Medical tubing is squeezed by rollers to create the pressure gradient. 
positive displacement 
pump 
Any type of pump that creates a rise in pressure by cyclic filling and emptying of a volume. Rotary pumps, the pumps most commonly used in hemodialysis, are positive displacement pumps. 
proximal tubule The section of a nephron after the Bowman’s capsule and before the loop of Henle. 
recirculation When dialysate is reused after it has passed through the dialyzer. 
renal corpuscle The corpuscle formed by both the Bowman’s capsule and the glomerulus. 
renal replacement 
therapy 
Any form of treatment that attempts to emulate the function of the kidneys. 
shunt An artificial connection between a vein and an artery that provides the blood for hemodialysis. 
sieving coefficient The ratio between the change of concentrations of the blood and dialysate. 
single-pass When dialysate is passed through the dialyzer just once during hemodialysis. 
transmembrane pressure The pressure difference between the blood and dialysate inside of a dialyzer during dialysis. 
tubule A very small tube, either inside of a dialyzer or a part of a nephron. 
ultrafiltration The convective process that occurs during dialysis.  
urea A byproduct of protein metabolism in humans. Must be cleaned from 
the blood (via the kidneys or dialysis) to avoid death. 
urease The chemical used in the REDY sorbent system that processes urea in the dialysate. 
uremea The buildup of toxins in the blood that are normally removed by healthy kidneys. 
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   DstBlock    " SFunction " 
   DstPort    10 
 } 
 Line { 
   Name     "bconc" 
   Labels    [0, 0] 
   SrcBlock    " SFunction " 
   SrcPort    2 
   DstBlock    "bconc" 
   DstPort    1 
 } 
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 Line { 
   Name     "dconc" 
   Labels    [0, 0] 
   SrcBlock    " SFunction " 
   SrcPort    3 
   DstBlock    "dconc" 
   DstPort    1 
 } 
 Line { 
   Name     "D" 
   Labels    [0, 0] 
   SrcBlock    " SFunction " 
   SrcPort    4 
   DstBlock    "D" 
   DstPort    1 
 } 
 Line { 
   SrcBlock    " Demux " 
   SrcPort    1 
   DstBlock    " Terminator " 
   DstPort    1 
 } 
      } 
    } 
    Block { 
      BlockType        Display 
      Name        "Clearance" 
      Ports        [1] 
      Position        [480, 610, 570, 640] 
      Decimation       "1" 
      Lockdown        off 
    } 
    Block { 
      BlockType        Gain 
      Name        "Convert ml\nto L" 
      Position        [880, 215, 910, 245] 
      Gain        "0.001" 
      ParameterDataTypeMode   "Inherit via internal rule" 
      ParameterDataType       "sfix(16)" 
      ParameterScaling       "2^0" 
      ParamDataTypeStr       "Inherit: Inherit via internal rule" 
      OutDataTypeMode       "Inherit via internal rule" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
      OutDataTypeStr       "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow off 
    } 
    Block { 
      BlockType        SubSystem 
      Name        "Convert urea concentration (mg/ml)\nto 
BUN" 
      Ports        [1, 1] 
      Position        [1085, 365, 1255, 455] 
      ForegroundColor       "blue" 
      PermitHierarchicalResolution "ExplicitOnly" 
      MinAlgLoopOccurrences   off 
      PropExecContextOutsideSubsystem off 
      RTWSystemCode       "Auto" 
      FunctionWithSeparateData off 
      Opaque        off 
      Array { 
 Type   "Handle" 
 Dimension  0 
 PropName  "AvailSigsLoadSave" 
      } 
      RequestExecContextInheritance off 
      MaskHideContents       off 
      MaskType        "Stateflow" 
      MaskDescription       "Embedded MATLAB block" 
      MaskDisplay       "disp('fcn');" 
      MaskSelfModifiable      on 
      MaskIconFrame       on 
      MaskIconOpaque       off 
      MaskIconRotate       "none" 
      MaskIconUnits       "autoscale" 
      System { 
 Name   "Convert urea 
concentration (mg/ml)\nto BUN" 
 Location  [257, 457, 812, 717] 
 Open   off 
 ModelBrowserVisibility off 
 ModelBrowserWidth 200 
 ScreenColor  "white" 
 PaperOrientation "landscape" 
 PaperPositionMode "auto" 
 PaperType  "usletter" 
 PaperUnits  "inches" 
 TiledPaperMargins [0.500000, 0.500000, 0.500000, 
0.500000] 
 TiledPageScale  1 
 ShowPageBoundaries off 
 ZoomFactor  "100" 
 Block { 
   BlockType    Inport 
   Name     "blood_urea_conc" 
   Position    [20, 101, 40, 119] 
   IconDisplay    "Port number" 
   OutDataType    "sfix(16)" 
   OutScaling    "2^0" 
 } 
 Block { 
   BlockType    Demux 
   Name     " Demux " 
   Ports     [1, 1] 
   Position    [270, 160, 320, 200] 
   Outputs    "1" 
 } 
 Block { 
   BlockType    "S-Function" 
   Name     " SFunction " 
   Tag     "Stateflow S-Function 
reconciled 5" 
   Ports     [1, 2] 
   Position    [180, 100, 230, 160] 
   FunctionName    "sf_sfun" 
   PortCounts    "[1 2]" 
   EnableBusSupport   on 
   Port { 
     PortNumber      2 
     Name      "bun" 
     RTWStorageClass     "Auto" 
     DataLoggingNameMode     "SignalName" 
   } 
 } 
 Block { 
   BlockType    Terminator 
   Name     " Terminator " 
   Position    [460, 171, 480, 189] 
 } 
 Block { 
   BlockType    Outport 
   Name     "bun" 
   Position    [460, 101, 480, 119] 
   IconDisplay    "Port number" 
   OutDataType    "sfix(16)" 
   OutScaling    "2^0" 
 } 
 Line { 
   SrcBlock    " Demux " 
   SrcPort    1 
   DstBlock    " Terminator " 
   DstPort    1 
 } 
 Line { 
   Name     "bun" 
   Labels    [0, 0] 
   SrcBlock    " SFunction " 
   SrcPort    2 
   DstBlock    "bun" 
   DstPort    1 
 } 
 Line { 
   SrcBlock    "blood_urea_conc" 
   SrcPort    1 
   DstBlock    " SFunction " 
   DstPort    1 
 } 
 Line { 
   SrcBlock    " SFunction " 
   SrcPort    1 
   DstBlock    " Demux " 
   DstPort    1 
 } 
      } 
    } 
    Block { 
      BlockType        Display 
      Name        "Dialysance" 
      Ports        [1] 
      Position        [1070, 505, 1160, 535] 
      Decimation       "1" 
      Lockdown        off 
    } 
    Block { 
      BlockType        Display 
      Name        "Dialysate Flow Rate\n(ml/min)" 
      Ports        [1] 
      Position        [435, 215, 525, 245] 
      Decimation       "1" 
      Lockdown        off 
    } 
    Block { 
      BlockType        UnitDelay 
      Name        "Dialysate concentration\ndelay" 
      Position        [990, 603, 1025, 637] 
    } 
    Block { 
      BlockType        DiscretePulseGenerator 
      Name        "Dialysis Schedule" 
      Ports        [0, 1] 
      Position        [695, 693, 740, 727] 
      PulseType        "Time based" 
      Period        "144" 
      PulseWidth       "12.5" 
    } 
    Block { 
      BlockType        Constant 
      Name        "Dialyzer Blood\nPressure" 
      Position        [440, 310, 470, 340] 
      Value        "70" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
    } 
    Block { 
      BlockType        Constant 
  168  
      Name        "Dialyzer Dialysate\nPressure" 
      Position        [500, 345, 530, 375] 
      Value        "50" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
    } 
    Block { 
      BlockType        Integrator 
      Name        "Integrator" 
      Ports        [1, 1] 
      Position        [635, 200, 665, 230] 
    } 
    Block { 
      BlockType        Constant 
      Name        "Kidney GFR%" 
      Position        [285, 685, 315, 715] 
      Value        "0" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
    } 
    Block { 
      BlockType        Constant 
      Name        "KoA" 
      Position        [200, 505, 230, 535] 
      Value        "16000" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
    } 
    Block { 
      BlockType        SubSystem 
      Name        "Optimize Dialysate Flow Rate" 
      Ports        [2, 2] 
      Position        [325, 439, 450, 546] 
      ForegroundColor       "blue" 
      PermitHierarchicalResolution "ExplicitOnly" 
      MinAlgLoopOccurrences   off 
      PropExecContextOutsideSubsystem off 
      RTWSystemCode       "Auto" 
      FunctionWithSeparateData off 
      Opaque        off 
      Array { 
 Type   "Handle" 
 Dimension  0 
 PropName  "AvailSigsLoadSave" 
      } 
      RequestExecContextInheritance off 
      MaskHideContents       off 
      MaskType        "Stateflow" 
      MaskDescription       "Embedded MATLAB block" 
      MaskDisplay       "disp('Dialysate');" 
      MaskSelfModifiable      on 
      MaskIconFrame       on 
      MaskIconOpaque       off 
      MaskIconRotate       "none" 
      MaskIconUnits       "autoscale" 
      System { 
 Name   "Optimize Dialysate Flow 
Rate" 
 Location  [257, 457, 812, 717] 
 Open   off 
 ModelBrowserVisibility off 
 ModelBrowserWidth 200 
 ScreenColor  "white" 
 PaperOrientation "landscape" 
 PaperPositionMode "auto" 
 PaperType  "usletter" 
 PaperUnits  "inches" 
 TiledPaperMargins [0.500000, 0.500000, 0.500000, 
0.500000] 
 TiledPageScale  1 
 ShowPageBoundaries off 
 ZoomFactor  "100" 
 Block { 
   BlockType    Inport 
   Name     "Qb" 
   Position    [20, 101, 40, 119] 
   IconDisplay    "Port number" 
   OutDataType    "sfix(16)" 
   OutScaling    "2^0" 
 } 
 Block { 
   BlockType    Inport 
   Name     "KoA" 
   Position    [20, 136, 40, 154] 
   Port     "2" 
   IconDisplay    "Port number" 
 } 
 Block { 
   BlockType    Demux 
   Name     " Demux " 
   Ports     [1, 1] 
   Position    [270, 220, 320, 260] 
   Outputs    "1" 
 } 
 Block { 
   BlockType    "S-Function" 
   Name     " SFunction " 
   Tag     "Stateflow S-Function 
reconciled 2" 
   Ports     [2, 3] 
   Position    [180, 100, 230, 220] 
   FunctionName    "sf_sfun" 
   PortCounts    "[2 3]" 
   EnableBusSupport   on 
   Port { 
     PortNumber      2 
     Name      "Qd" 
     RTWStorageClass     "Auto" 
     DataLoggingNameMode     "SignalName" 
   } 
   Port { 
     PortNumber      3 
     Name      "K" 
     RTWStorageClass     "Auto" 
     DataLoggingNameMode     "SignalName" 
   } 
 } 
 Block { 
   BlockType    Terminator 
   Name     " Terminator " 
   Position    [460, 231, 480, 249] 
 } 
 Block { 
   BlockType    Outport 
   Name     "Qd" 
   Position    [460, 101, 480, 119] 
   IconDisplay    "Port number" 
 } 
 Block { 
   BlockType    Outport 
   Name     "K" 
   Position    [460, 136, 480, 154] 
   Port     "2" 
   IconDisplay    "Port number" 
   OutDataType    "sfix(16)" 
   OutScaling    "2^0" 
 } 
 Line { 
   SrcBlock    " SFunction " 
   SrcPort    1 
   DstBlock    " Demux " 
   DstPort    1 
 } 
 Line { 
   SrcBlock    "Qb" 
   SrcPort    1 
   DstBlock    " SFunction " 
   DstPort    1 
 } 
 Line { 
   SrcBlock    "KoA" 
   SrcPort    1 
   DstBlock    " SFunction " 
   DstPort    2 
 } 
 Line { 
   Name     "Qd" 
   Labels    [0, 0] 
   SrcBlock    " SFunction " 
   SrcPort    2 
   DstBlock    "Qd" 
   DstPort    1 
 } 
 Line { 
   Name     "K" 
   Labels    [0, 0] 
   SrcBlock    " SFunction " 
   SrcPort    3 
   DstBlock    "K" 
   DstPort    1 
 } 
 Line { 
   SrcBlock    " Demux " 
   SrcPort    1 
   DstBlock    " Terminator " 
   DstPort    1 
 } 
      } 
    } 
    Block { 
      BlockType        Product 
      Name        "Product" 
      Ports        [2, 1] 
      Position        [580, 197, 610, 228] 
      InputSameDT       off 
      OutDataTypeMode       "Inherit via internal rule" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
      OutDataTypeStr       "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow off 
    } 
    Block { 
      BlockType        Product 
      Name        "Product1" 
      Ports        [2, 1] 
      Position        [660, 312, 690, 343] 
      InputSameDT       off 
      OutDataTypeMode       "Inherit via internal rule" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
      OutDataTypeStr       "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow off 
    } 
    Block { 
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      BlockType        Scope 
      Name        "Scope" 
      Ports        [1] 
      Position        [1340, 324, 1370, 356] 
      Floating        off 
      Location        [1, 46, 1601, 1169] 
      Open        off 
      NumInputPorts       "1" 
      List { 
 ListType  AxesTitles 
 axes1   "%<SignalLabel>" 
      } 
      TimeRange        "1440" 
      YMin        "110" 
      YMax        "300" 
      SaveName        "ScopeData1" 
      DataFormat       "StructureWithTime" 
      SampleTime       "0" 
    } 
    Block { 
      BlockType        Scope 
      Name        "Scope1" 
      Ports        [1] 
      Position        [1130, 824, 1160, 856] 
      Floating        off 
      Location        [1, 46, 1601, 1169] 
      Open        off 
      NumInputPorts       "1" 
      List { 
 ListType  AxesTitles 
 axes1   "%<SignalLabel>" 
      } 
      SaveName        "ScopeData2" 
      DataFormat       "StructureWithTime" 
      SampleTime       "0" 
    } 
    Block { 
      BlockType        SubSystem 
      Name        "Select proper\ndialysate volume" 
      Ports        [2, 1] 
      Position        [760, 204, 840, 251] 
      ForegroundColor       "blue" 
      PermitHierarchicalResolution "ExplicitOnly" 
      MinAlgLoopOccurrences   off 
      PropExecContextOutsideSubsystem off 
      RTWSystemCode       "Auto" 
      FunctionWithSeparateData off 
      Opaque        off 
      Array { 
 Type   "Handle" 
 Dimension  0 
 PropName  "AvailSigsLoadSave" 
      } 
      RequestExecContextInheritance off 
      MaskHideContents       off 
      MaskType        "Stateflow" 
      MaskDescription       "Embedded MATLAB block" 
      MaskDisplay       "disp('fcn');" 
      MaskSelfModifiable      on 
      MaskIconFrame       on 
      MaskIconOpaque       off 
      MaskIconRotate       "none" 
      MaskIconUnits       "autoscale" 
      System { 
 Name   "Select 
proper\ndialysate volume" 
 Location  [257, 457, 812, 717] 
 Open   off 
 ModelBrowserVisibility off 
 ModelBrowserWidth 200 
 ScreenColor  "white" 
 PaperOrientation "landscape" 
 PaperPositionMode "auto" 
 PaperType  "usletter" 
 PaperUnits  "inches" 
 TiledPaperMargins [0.500000, 0.500000, 0.500000, 
0.500000] 
 TiledPageScale  1 
 ShowPageBoundaries off 
 ZoomFactor  "100" 
 Block { 
   BlockType    Inport 
   Name     "d1" 
   Position    [20, 101, 40, 119] 
   IconDisplay    "Port number" 
   OutDataType    "sfix(16)" 
   OutScaling    "2^0" 
 } 
 Block { 
   BlockType    Inport 
   Name     "d2" 
   Position    [20, 136, 40, 154] 
   Port     "2" 
   IconDisplay    "Port number" 
 } 
 Block { 
   BlockType    Demux 
   Name     " Demux " 
   Ports     [1, 1] 
   Position    [270, 160, 320, 200] 
   Outputs    "1" 
 } 
 Block { 
   BlockType    "S-Function" 
   Name     " SFunction " 
   Tag     "Stateflow S-Function 
reconciled 3" 
   Ports     [2, 2] 
   Position    [180, 100, 230, 160] 
   FunctionName    "sf_sfun" 
   PortCounts    "[2 2]" 
   EnableBusSupport   on 
   Port { 
     PortNumber      2 
     Name      "d_act" 
     RTWStorageClass     "Auto" 
     DataLoggingNameMode     "SignalName" 
   } 
 } 
 Block { 
   BlockType    Terminator 
   Name     " Terminator " 
   Position    [460, 171, 480, 189] 
 } 
 Block { 
   BlockType    Outport 
   Name     "d_act" 
   Position    [460, 101, 480, 119] 
   IconDisplay    "Port number" 
   OutDataType    "sfix(16)" 
   OutScaling    "2^0" 
 } 
 Line { 
   SrcBlock    " SFunction " 
   SrcPort    1 
   DstBlock    " Demux " 
   DstPort    1 
 } 
 Line { 
   SrcBlock    "d1" 
   SrcPort    1 
   DstBlock    " SFunction " 
   DstPort    1 
 } 
 Line { 
   SrcBlock    "d2" 
   SrcPort    1 
   DstBlock    " SFunction " 
   DstPort    2 
 } 
 Line { 
   Name     "d_act" 
   Labels    [0, 0] 
   SrcBlock    " SFunction " 
   SrcPort    2 
   DstBlock    "d_act" 
   DstPort    1 
 } 
 Line { 
   SrcBlock    " Demux " 
   SrcPort    1 
   DstBlock    " Terminator " 
   DstPort    1 
 } 
      } 
    } 
    Block { 
      BlockType        Sum 
      Name        "Subtract" 
      Ports        [2, 1] 
      Position        [595, 317, 625, 348] 
      Inputs        "+-" 
      InputSameDT       off 
      OutDataTypeMode       "Inherit via internal rule" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^-10" 
      OutDataTypeStr       "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow off 
    } 
    Block { 
      BlockType        ToWorkspace 
      Name        "To Workspace" 
      Position        [1330, 395, 1390, 425] 
      VariableName       "y" 
      MaxDataPoints       "inf" 
      SampleTime       "-1" 
      SaveFormat       "Array" 
    } 
    Block { 
      BlockType        ToWorkspace 
      Name        "To Workspace1" 
      Position        [1130, 275, 1190, 305] 
      VariableName       "y1" 
      MaxDataPoints       "inf" 
      SampleTime       "-1" 
      SaveFormat       "Array" 
    } 
    Block { 
      BlockType        Constant 
      Name        "Total Blood Volume\n(ml)" 
      Position        [620, 470, 650, 500] 
      Value        "32000" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
    } 
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    Block { 
      BlockType        Display 
      Name        "Total Dialysate\n(L)" 
      Ports        [1] 
      Position        [845, 130, 935, 160] 
      Decimation       "1" 
      Lockdown        off 
    } 
    Block { 
      BlockType        Constant 
      Name        "Total Dialysate\nVolume (ml)" 
      Position        [665, 515, 695, 545] 
      Value        "12360" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
    } 
    Block { 
      BlockType        Constant 
      Name        "Ultrafiltration\nCoefficient" 
      Position        [375, 285, 405, 315] 
      Value        "0" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
    } 
    Block { 
      BlockType        Constant 
      Name        "Urea Generation Rate\n(mg/min)" 
      Position        [200, 645, 230, 675] 
      Value        "86.8055555555" 
      OutDataType       "sfix(16)" 
      OutScaling       "2^0" 
    } 
    Block { 
      BlockType        Scope 
      Name        "Floating\nScope1" 
      Ports        [] 
      Position        [185, 14, 215, 46] 
      IOType        "viewer" 
      Floating        on 
      Location        [376, 294, 700, 533] 
      Open        off 
      NumInputPorts       "1" 
      List { 
 ListType  AxesTitles 
 axes1   "%<SignalLabel>" 
      } 
      DataFormat       "StructureWithTime" 
      SampleTime       "0" 
    } 
    Line { 
      SrcBlock        "Blood Flow Rate" 
      SrcPort        1 
      Points        [40, 0] 
      Branch { 
 DstBlock  "Optimize Dialysate Flow Rate" 
 DstPort   1 
      } 
      Branch { 
 Points   [0, -55] 
 DstBlock  "Calculate B and D\nconcentration 
changes" 
 DstPort   2 
      } 
    } 
    Line { 
      Labels        [1, 0] 
      SrcBlock        "KoA" 
      SrcPort        1 
      Points        [40, 0] 
      Branch { 
 DstBlock  "Optimize Dialysate Flow Rate" 
 DstPort   2 
      } 
      Branch { 
 Points   [0, 60; 255, 0; 0, -140] 
 DstBlock  "Calculate B and D\nconcentration 
changes" 
 DstPort   4 
      } 
    } 
    Line { 
      Labels        [2, 0] 
      SrcBlock        "Optimize Dialysate Flow Rate" 
      SrcPort        2 
      Points        [10, 0] 
      DstBlock        "Clearance" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Optimize Dialysate Flow Rate" 
      SrcPort        1 
      Points        [10, 0; 0, -40] 
      Branch { 
 Labels   [1, 0] 
 DstBlock  "Calculate B and D\nconcentration 
changes" 
 DstPort   3 
      } 
      Branch { 
 Points   [0, -30; -115, 0; 0, -
165] 
 Branch { 
   Labels    [1, 0] 
   DstBlock    "Dialysate Flow Rate\n(ml/min)" 
   DstPort    1 
 } 
 Branch { 
   Points    [0, -25] 
   DstBlock    "Product" 
   DstPort    1 
 } 
      } 
    } 
    Line { 
      SrcBlock        "Total Blood Volume\n(ml)" 
      SrcPort        1 
      DstBlock        "Calculate B and 
D\nconcentration changes" 
      DstPort        7 
    } 
    Line { 
      SrcBlock        "Calculate B and 
D\nconcentration changes" 
      SrcPort        1 
      Points        [25, 0] 
      Branch { 
 Points   [25, 0] 
 Branch { 
   Points    [0, 170; -205, 0] 
   DstBlock    "Blood concentration\ndelay" 
   DstPort    1 
 } 
 Branch { 
   DstBlock    "Convert urea concentration 
(mg/ml)\nto BUN" 
   DstPort    1 
 } 
      } 
      Branch { 
 Points   [0, -120] 
 DstBlock  "To Workspace1" 
 DstPort   1 
      } 
    } 
    Line { 
      SrcBlock        "Blood concentration\ndelay" 
      SrcPort        1 
      Points        [40, 0; 0, 170; -320, 0; 0, -
330] 
      DstBlock        "Calculate B and 
D\nconcentration changes" 
      DstPort        5 
    } 
    Line { 
      Labels        [1, 0] 
      SrcBlock        "Calculate B and 
D\nconcentration changes" 
      SrcPort        3 
      DstBlock        "Dialysance" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Integrator" 
      SrcPort        1 
      DstBlock        "Select proper\ndialysate 
volume" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Dialysis Schedule" 
      SrcPort        1 
      Points        [25, 0; 0, -130] 
      Branch { 
 Points   [0, -50] 
 DstBlock  "Calculate B and D\nconcentration 
changes" 
 DstPort   10 
      } 
      Branch { 
 Points   [-205, 0] 
 DstBlock  "Product" 
 DstPort   2 
      } 
    } 
    Line { 
      SrcBlock        "Urea Generation 
Rate\n(mg/min)" 
      SrcPort        1 
      DstBlock        "Account for residual\nkidney 
function" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Kidney GFR%" 
      SrcPort        1 
      DstBlock        "Account for residual\nkidney 
function" 
      DstPort        2 
    } 
    Line { 
      SrcBlock        "Account for residual\nkidney 
function" 
      SrcPort        1 
      Points        [290, 0; 0, -165] 
  171  
      DstBlock        "Calculate B and 
D\nconcentration changes" 
      DstPort        9 
    } 
    Line { 
      SrcBlock        "Product" 
      SrcPort        1 
      DstBlock        "Integrator" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Total Dialysate\nVolume (ml)" 
      SrcPort        1 
      Points        [10, 0] 
      Branch { 
 Points   [15, 0; 0, -30] 
 DstBlock  "Calculate B and D\nconcentration 
changes" 
 DstPort   8 
      } 
      Branch { 
 Points   [0, -290] 
 DstBlock  "Select proper\ndialysate volume" 
 DstPort   2 
      } 
    } 
    Line { 
      SrcBlock        "Calculate B and 
D\nconcentration changes" 
      SrcPort        2 
      Points        [15, 0] 
      DstBlock        "Dialysate 
concentration\ndelay" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Dialysate 
concentration\ndelay" 
      SrcPort        1 
      Points        [50, 0; 0, 75; -55, 0] 
      Branch { 
 Points   [-270, 0; 0, -225] 
 DstBlock  "Calculate B and D\nconcentration 
changes" 
 DstPort   6 
      } 
      Branch { 
 Points   [0, 145] 
 DstBlock  "Scope1" 
 DstPort   1 
      } 
    } 
    Line { 
      SrcBlock        "Select proper\ndialysate 
volume" 
      SrcPort        1 
      DstBlock        "Convert ml\nto L" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Convert ml\nto L" 
      SrcPort        1 
      Points        [-85, 0] 
      DstBlock        "Total Dialysate\n(L)" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Convert urea concentration 
(mg/ml)\nto BUN" 
      SrcPort        1 
      Points        [30, 0] 
      Branch { 
 DstBlock  "To Workspace" 
 DstPort   1 
      } 
      Branch { 
 Points   [0, -70] 
 DstBlock  "Scope" 
 DstPort   1 
      } 
    } 
    Line { 
      SrcBlock        "Dialyzer Blood\nPressure" 
      SrcPort        1 
      DstBlock        "Subtract" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Dialyzer Dialysate\nPressure" 
      SrcPort        1 
      Points        [0, -20] 
      DstBlock        "Subtract" 
      DstPort        2 
    } 
    Line { 
      SrcBlock        "Subtract" 
      SrcPort        1 
      DstBlock        "Product1" 
      DstPort        2 
    } 
    Line { 
      SrcBlock        "Ultrafiltration\nCoefficient" 
      SrcPort        1 
      Points        [230, 0; 0, 20] 
      DstBlock        "Product1" 
      DstPort        1 
    } 
    Line { 
      SrcBlock        "Product1" 
      SrcPort        1 
      Points        [30, 0; 0, 65] 
      DstBlock        "Calculate B and 
D\nconcentration changes" 
      DstPort        1 
    } 
  } 
} 
# Finite State Machines 
# 
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    } 
    dst { 
      id        4 
      intersection       [7 0 -1 -1 23.5747 42.5747 0 0] 
    } 
    midPoint      [23.5747 24.9468] 
    chart      2 
    linkNode      [2 0 0] 
    dataLimits      [23.575 23.575 14.625 34.575] 
    subviewer      2 
    drawStyle      SMART 
    executionOrder     1 
    ssIdNumber      2 
  } 
  data { 
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    id       6 
    ssIdNumber      6 
    name      "UGR" 
    linkNode      [2 0 7] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       7 
    ssIdNumber      4 
    name      "GFR" 
    linkNode      [2 6 8] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       8 
    ssIdNumber      5 
    name      "urea_gen" 
    linkNode      [2 7 0] 
    scope      OUTPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  instance { 
    id       9 
    name      "Account for residual\nkidney function" 
    machine      1 
    chart      2 
  } 
  chart { 
    id       10 
    name      "Optimize Dialysate Flow Rate" 
    windowPosition     [352.266 253.688 200.25 189.75] 
    viewLimits      [0 156.75 0 153.75] 
    screen      [1 1 1600 1200 1.333333333333333] 
    treeNode      [0 11 0 0] 
    firstTransition     13 
    firstJunction     12 
    viewObj      10 
    machine      1 
    ssIdHighWaterMark     10 
    decomposition     CLUSTER_CHART 
    type      EML_CHART 
    firstData      14 
    chartFileNumber     2 
    disableImplicitCasting  1 
    eml { 
      name        "Dialysate" 
    } 
  } 
  state { 
    id       11 
    labelString      "eML_blk_kernel()" 
    position      [18 64.5 118 66] 
    fontSize      12 
    chart      10 
    treeNode      [10 0 0 0] 
    superState      SUBCHART 
    subviewer      10 
    ssIdNumber      1 
    type      FUNC_STATE 
    decomposition     CLUSTER_STATE 
    eml { 
      isEML        1 
      script        "function [Qd,K] = 
Dialysate(Qb, KoA)\n\n% a = Qb;\n% c = KoA;\n% \n% b = 1;\n% jmax = 
0;\n% \n% while b < 1000\n%     J = (a)*(((exp(((c)*(1-(a/b)))/(a))-
1))/((exp(((c)*(1-(a/b)))/(a))-(a/b))));\n%     if J > jmax\n%         
jmax = J;\n%     end\n%     b = b+1.000001;\n% end\n% \n% d = 5;\n% L = 
0;\n% P = 0.95*jmax;\n% \n% while L < P\n%     d = d+1.001;\n%     L = 
(a)*(((exp(((c)*(1-(a/d)))/(a))-1))/((exp(((c)*(1-(a/d)))/(a))-
(a/d))));\n%     if d > 1000\n%         break\n%     end\n% end\n% \n% K 
= L;\n% Qd = round(d);\nQd = 1030;\nK=1;\n" 
      editorLayout       "100 M4x1[139 133 1122 930]" 
    } 
  } 
  junction { 
    id       12 
    position      [23.5747 49.5747 7] 
    chart      10 
    linkNode      [10 0 0] 
    subviewer      10 
    ssIdNumber      3 
    type      CONNECTIVE_JUNCTION 
  } 
  transition { 
    id       13 
    labelString      "{eML_blk_kernel();}" 
    labelPosition     [32.125 19.875 102.544 14.964] 
    fontSize      12 
    src { 
      intersection       [0 0 1 0 23.5747 14.625 0 0] 
    } 
    dst { 
      id        12 
      intersection       [7 0 -1 -1 23.5747 42.5747 0 0] 
    } 
    midPoint      [23.5747 24.9468] 
    chart      10 
    linkNode      [10 0 0] 
    dataLimits      [23.575 23.575 14.625 34.575] 
    subviewer      10 
    drawStyle      SMART 
    executionOrder     1 
    ssIdNumber      2 
  } 
  data { 
    id       14 
    ssIdNumber      8 
    name      "Qd" 
    linkNode      [10 0 15] 
    scope      OUTPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       15 
    ssIdNumber      4 
    name      "Qb" 
    linkNode      [10 14 16] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       16 
    ssIdNumber      5 
    name      "K" 
    linkNode      [10 15 17] 
    scope      OUTPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       17 
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    ssIdNumber      7 
    name      "KoA" 
    linkNode      [10 16 0] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  instance { 
    id       18 
    name      "Optimize Dialysate Flow Rate" 
    machine      1 
    chart      10 
  } 
  chart { 
    id       19 
    name      "Select proper\ndialysate volume" 
    windowPosition     [352.266 253.688 200.25 189.75] 
    viewLimits      [0 156.75 0 153.75] 
    screen      [1 1 1600 1200 1.333333333333333] 
    treeNode      [0 20 0 0] 
    firstTransition     22 
    firstJunction     21 
    viewObj      19 
    machine      1 
    ssIdHighWaterMark     6 
    decomposition     CLUSTER_CHART 
    type      EML_CHART 
    firstData      23 
    chartFileNumber     3 
    disableImplicitCasting  1 
    eml { 
      name        "fcn" 
    } 
  } 
  state { 
    id       20 
    labelString      "eML_blk_kernel()" 
    position      [18 64.5 118 66] 
    fontSize      12 
    chart      19 
    treeNode      [19 0 0 0] 
    superState      SUBCHART 
    subviewer      19 
    ssIdNumber      1 
    type      FUNC_STATE 
    decomposition     CLUSTER_STATE 
    eml { 
      isEML        1 
      script        "function d_act = fcn(d1, 
d2)\n% This block supports the Embedded MATLAB subset.\n% See the help 
menu for details. \n\nif d1<d2\n    d_act = d1;\nelse d_act = 
d2;\nend\n" 
      editorLayout       "100 M4x1[594 516 671 364]" 
    } 
  } 
  junction { 
    id       21 
    position      [23.5747 49.5747 7] 
    chart      19 
    linkNode      [19 0 0] 
    subviewer      19 
    ssIdNumber      3 
    type      CONNECTIVE_JUNCTION 
  } 
  transition { 
    id       22 
    labelString      "{eML_blk_kernel();}" 
    labelPosition     [32.125 19.875 102.544 14.964] 
    fontSize      12 
    src { 
      intersection       [0 0 1 0 23.5747 14.625 0 0] 
    } 
    dst { 
      id        21 
      intersection       [7 0 -1 -1 23.5747 42.5747 0 0] 
    } 
    midPoint      [23.5747 24.9468] 
    chart      19 
    linkNode      [19 0 0] 
    dataLimits      [23.575 23.575 14.625 34.575] 
    subviewer      19 
    drawStyle      SMART 
    executionOrder     1 
    ssIdNumber      2 
  } 
  data { 
    id       23 
    ssIdNumber      4 
    name      "d1" 
    linkNode      [19 0 24] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       24 
    ssIdNumber      5 
    name      "d_act" 
    linkNode      [19 23 25] 
    scope      OUTPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       25 
    ssIdNumber      6 
    name      "d2" 
    linkNode      [19 24 0] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  instance { 
    id       26 
    name      "Select proper\ndialysate volume" 
    machine      1 
    chart      19 
  } 
  chart { 
    id       27 
    name      "Calculate B and D\nconcentration changes" 
    windowPosition     [367.266 238.688 200.25 189.75] 
    viewLimits      [0 156.75 0 153.75] 
    screen      [1 1 1600 1200 1.333333333333333] 
    treeNode      [0 28 0 0] 
    firstTransition     30 
    firstJunction     29 
    viewObj      27 
    machine      1 
    ssIdHighWaterMark     18 
    decomposition     CLUSTER_CHART 
    type      EML_CHART 
    firstData      31 
    chartFileNumber     4 
    disableImplicitCasting  1 
    eml { 
      name        "Dialyance" 
    } 
  } 
  state { 
    id       28 
    labelString      "eML_blk_kernel()" 
    position      [18 64.5 118 66] 
    fontSize      12 
    chart      27 
    treeNode      [27 0 0 0] 
    superState      SUBCHART 
    subviewer      27 
    ssIdNumber      1 
    type      FUNC_STATE 
    decomposition     CLUSTER_STATE 
    eml { 
      isEML        1 
      script        "function [bconc, dconc, D]  = 
Dialyance(Qf, Qb, Qd, KoA, cbi, cdi, Vb, Vd, urea_gen, sched)\n\n% a = 
(exp(1)) + ((KoA * (1 - (Qb/Qd))) / (Qb)) - (1);\n% b = (exp(1) + ((KoA 
* (1 - (Qb/Qd))))/(Qb))/(Qb);\n% c = 1/Qd;\n\n% D = (a)/(b-c);\n\nif 
sched == 0\n    cdi=0;\nend\n\nif Qb == Qd\n    Qd = Qd + 1;\nend\n\na = 
Qb;\nb = Qd;\nc = KoA;\nf = ((c)*(1-(a/b)))/(a);\n\nD = (exp(f)-
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1)/((exp(f)/a)-(1/b));\n\nmg_total = cbi * Vb;\n\nmgd_total = cdi * 
Vd;\n\ncbo = (cbi) - (D/Qb)*(cbi-cdi);\n\n% cdo = ((D/Qd)*(cbi-cdi)) + 
cdi;\n\nmg_removed = (cbi-cbo)*(Qb) + (Qf)*(cbo);\n\nif sched == 0\n    
mg_removed = 0;\nend\n\nnew_total = mg_total - mg_removed + 
urea_gen;\n\nbconc = new_total / Vb;\n\nnewd_total = mgd_total + 
mg_removed;\n\ndconc = newd_total / Vd;" 
      editorLayout       "100 M4x1[806 216 1616 1186]" 
    } 
  } 
  junction { 
    id       29 
    position      [23.5747 49.5747 7] 
    chart      27 
    linkNode      [27 0 0] 
    subviewer      27 
    ssIdNumber      3 
    type      CONNECTIVE_JUNCTION 
  } 
  transition { 
    id       30 
    labelString      "{eML_blk_kernel();}" 
    labelPosition     [32.125 19.875 102.544 14.964] 
    fontSize      12 
    src { 
      intersection       [0 0 1 0 23.5747 14.625 0 0] 
    } 
    dst { 
      id        29 
      intersection       [7 0 -1 -1 23.5747 42.5747 0 0] 
    } 
    midPoint      [23.5747 24.9468] 
    chart      27 
    linkNode      [27 0 0] 
    dataLimits      [23.575 23.575 14.625 34.575] 
    subviewer      27 
    drawStyle      SMART 
    executionOrder     1 
    ssIdNumber      2 
  } 
  data { 
    id       31 
    ssIdNumber      18 
    name      "Qf" 
    linkNode      [27 0 32] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       32 
    ssIdNumber      4 
    name      "Qb" 
    linkNode      [27 31 33] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       33 
    ssIdNumber      11 
    name      "Qd" 
    linkNode      [27 32 34] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       34 
    ssIdNumber      5 
    name      "bconc" 
    linkNode      [27 33 35] 
    scope      OUTPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       35 
    ssIdNumber      17 
    name      "dconc" 
    linkNode      [27 34 36] 
    scope      OUTPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       36 
    ssIdNumber      7 
    name      "KoA" 
    linkNode      [27 35 37] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       37 
    ssIdNumber      8 
    name      "cbi" 
    linkNode      [27 36 38] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       38 
    ssIdNumber      15 
    name      "cdi" 
    linkNode      [27 37 39] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
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      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       39 
    ssIdNumber      9 
    name      "Vb" 
    linkNode      [27 38 40] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       40 
    ssIdNumber      16 
    name      "Vd" 
    linkNode      [27 39 41] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       41 
    ssIdNumber      12 
    name      "D" 
    linkNode      [27 40 42] 
    scope      OUTPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       42 
    ssIdNumber      13 
    name      "urea_gen" 
    linkNode      [27 41 43] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       43 
    ssIdNumber      14 
    name      "sched" 
    linkNode      [27 42 0] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
 isSigned  1 
 wordLength  "16" 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  instance { 
    id       44 
    name      "Calculate B and D\nconcentration changes" 
    machine      1 
    chart      27 
  } 
  chart { 
    id       45 
    name      "Convert urea concentration (mg/ml)\nto BUN" 
    windowPosition     [367.266 238.688 200.25 189.75] 
    viewLimits      [0 156.75 0 153.75] 
    screen      [1 1 1600 1200 1.333333333333333] 
    treeNode      [0 46 0 0] 
    firstTransition     48 
    firstJunction     47 
    viewObj      45 
    machine      1 
    ssIdHighWaterMark     5 
    decomposition     CLUSTER_CHART 
    type      EML_CHART 
    firstData      49 
    chartFileNumber     5 
    disableImplicitCasting  1 
    eml { 
      name        "fcn" 
    } 
  } 
  state { 
    id       46 
    labelString      "eML_blk_kernel()" 
    position      [18 64.5 118 66] 
    fontSize      12 
    chart      45 
    treeNode      [45 0 0 0] 
    superState      SUBCHART 
    subviewer      45 
    ssIdNumber      1 
    type      FUNC_STATE 
    decomposition     CLUSTER_STATE 
    eml { 
      isEML        1 
      script        "function bun = 
fcn(blood_urea_conc)\n% This block supports the Embedded MATLAB 
subset.\n% See the help menu for details. \n\nbun = 
(46.66667)*(blood_urea_conc);\n" 
      editorLayout       "100 M4x1[157 230 1064 499]" 
    } 
  } 
  junction { 
    id       47 
    position      [23.5747 49.5747 7] 
    chart      45 
    linkNode      [45 0 0] 
    subviewer      45 
    ssIdNumber      3 
    type      CONNECTIVE_JUNCTION 
  } 
  transition { 
    id       48 
    labelString      "{eML_blk_kernel();}" 
    labelPosition     [32.125 19.875 102.544 14.964] 
    fontSize      12 
    src { 
      intersection       [0 0 1 0 23.5747 14.625 0 0] 
    } 
    dst { 
      id        47 
      intersection       [7 0 -1 -1 23.5747 42.5747 0 0] 
    } 
    midPoint      [23.5747 24.9468] 
    chart      45 
    linkNode      [45 0 0] 
    dataLimits      [23.575 23.575 14.625 34.575] 
    subviewer      45 
    drawStyle      SMART 
    executionOrder     1 
    ssIdNumber      2 
  } 
  data { 
    id       49 
    ssIdNumber      4 
    name      "blood_urea_conc" 
    linkNode      [45 0 50] 
    scope      INPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
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      } 
      complexity       SF_COMPLEX_INHERITED 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  data { 
    id       50 
    ssIdNumber      5 
    name      "bun" 
    linkNode      [45 49 0] 
    scope      OUTPUT_DATA 
    machine      1 
    props { 
      array { 
 size   "-1" 
      } 
      type { 
 method   SF_INHERITED_TYPE 
 primitive  SF_DOUBLE_TYPE 
      } 
      complexity       SF_COMPLEX_INHERITED 
      frame        SF_FRAME_NO 
    } 
    dataType      "Inherit: Same as Simulink" 
  } 
  instance { 
    id       51 
    name      "Convert urea concentration (mg//ml)\nto 
BUN" 
    machine      1 
    chart      45 
  } 
  target { 
    id       52 
    name      "sfun" 
    description      "Default Simulink S-Function 
Target." 
    machine      1 
    linkNode      [1 0 0] 
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